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ABSTRACT 
   
Molecular docking serves as an important tool in modeling protein-ligand 
interactions. Most of the docking approaches treat the protein receptor as rigid and move 
the ligand in the binding pocket through an energy minimization, which is an incorrect 
approach as proteins are flexible and undergo conformational changes upon ligand 
binding. However, modeling receptor backbone flexibility in docking is challenging and 
computationally expensive due to the large conformational space that needs to be 
sampled.  
A novel flexible docking approach called BP-Dock (Backbone Perturbation 
docking) was developed to overcome this challenge. BP-Dock integrates both backbone 
and side chain conformational changes of a protein through a multi-scale approach. In 
BP-Dock, the residues along a protein chain are perturbed mimicking the binding induced 
event, with a small Brownian kick, one at a time. The fluctuation response profile of the 
chain upon these perturbations is computed by Perturbation Response Scanning (PRS) to 
generate multiple receptor conformations for ensemble docking. To evaluate the 
performance of BP-Dock, this approach was applied to a large and diverse dataset of 
unbound structures as receptors. Furthermore, the protein-peptide docking of PICK1-
PDZ proteins was investigated. This study elucidates the determinants of PICK1-PDZ 
binding that plays crucial roles in numerous neurodegenerative disorders. BP-Dock 
approach was also extended to the challenging problem of protein-glycan docking and 
applied to analyze the energetics of glycan recognition in Cyanovirin-N (CVN), a 
cyanobacterial lectin that inhibits HIV by binding to its highly glycosylated envelope 
protein gp120. This study provide the energetic contribution of the individual residues 
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lining the binding pocket of CVN and explore the effect of structural flexibility in the 
hinge region of CVN on glycan binding, which are also verified experimentally. Overall, 
these successful applications of BP-Dock highlight the importance of modeling backbone 
flexibility in docking that can have important implications in defining the binding 
properties of protein-ligand interactions. 
Finally, an induced fit docking approach called Adaptive BP-Dock is presented 
that allows both protein and ligand conformational sampling during the docking. 
Adaptive BP-Dock can provide a faster and efficient docking approach for the virtual 
screening of novel targets for rational drug design and aid our understanding of protein-
ligand interactions. 
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CHAPTER 1 
 
INTRODUCTION 
 
“The secret of life is ‘molecular recognition’; the ability of one molecule to ‘recognize’ 
another through weak bonding interaction.” - Linus Pauling at 25th anniversary of the 
Institute of Molecular Biology at University of Oregon 
 
Molecular recognition via protein-ligand interactions plays a fundamental role in 
regulating diverse biological processes and diseases within living organisms. The 
knowledge of these molecular associations aids in understanding the mechanism of 
functional pathways and their roles (Andrusier et al., 2008). Computational tools such as 
molecular docking provide faster and efficient method to study protein-ligand 
interactions and facilitate the design of potentially active drugs (Andrusier et al., 2008). 
Molecular docking facilitates high throughput virtual screening by rapidly screening large 
libraries of lead molecules against a protein target, making it an essential component of 
modern pharmaceutical drug discovery programs (Kitchen et al., 2004). Protein-ligand 
docking starts with a known protein structure and a known ligand structure. The docking 
process involves: (i) rapidly generating an optimal protein-ligand bound conformation (ii) 
estimation of binding affinities of such protein-ligand complexes (Mobley & Dill, 2009). 
Although the first docking was pioneered in early 1980s (Kuntz et al., 1982), there are 
still tremendous research efforts going on to improve the docking algorithms. 
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Particularly, recapitulating the experimentally known binding information is the major 
challenge in docking, especially when the bound (holo) structure is not available. 
When searching for novel drugs, one does not have the bound structure to begin 
with and therefore virtual screening either relies on the unbound (apo) structure of protein 
or a receptor structure that has been crystallized with a different ligand (cross-docking). 
This poses a severe challenge as ligand binding can cause conformational changes in the 
protein. Two separate studies by Gutteridge & Thornton (Gutteridge & Thornton, 2005) 
and Najmanovich et al. (Najmanovich et al., 2000) showed that backbone conformational 
changes upon ligand binding are fairly common. They compared apo and holo structures 
from the PDB and observed that 20% of binding residues (Gutteridge & Thornton, 2005) 
and 25% of binding sites (Najmanovich et al., 2000) across a variety of proteins have a 
backbone RMSD of more than 1 Å; whereas 15% of the binding site residues have a side-
chain RMSD of more than 2 Å (Gutteridge & Thornton, 2005). Furthermore, 
computational studies have shown that protein-ligand binding energetics can change 
substantially even when a binding site structure is not perturbed very much (Mobley et 
al., 2007) i.e. sometimes even small conformational changes can cause big changes in the 
binding affinities. Moreover, virtual screening to an apo (either an unbound structure or 
homology model) structure decreases the accuracy of docking programs (McGovern & 
Shoichet, 2003). This suggests that the strength and quality of binding interactions is 
sensitive to minute details of the bound structure and therefore docking protocols that 
model these proteins conformational changes may have much higher accuracy (Mobley 
& Dill, 2009). Indeed, modeling the conformational transitions of the receptor associated 
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with ligand binding is the bottleneck for most of the available docking approaches 
(Seeliger & de Groot, 2010).  
One might believe that cross-docking experiments provide some relief with 
modeling of the large-scale conformational changes in proteins as they start with a bound 
conformation. Nonetheless, a protein undergoes ligand-induced conformational changes 
(induced-fit effects) as individual residues in the binding site of the protein change their 
side-chain conformation or even rearrange their backbone to bind different ligands (Lill, 
2011; Onufriev & Alexov, 2013). In a study by Murray et al., the authors observed that 
the active site is biased to the native ligand; when they tried docking a different ligand 
into the bound protein structure that was solved in complex with the native ligand 
(Murray et al., 1999). Another study of 206 bound protein pairs (each pair has the same 
protein bound to two different although similar ligands in the binding site) showed that 
83% of the protein cases undergo significant conformational changes in the binding sites 
between same pair members (Bostrom et al., 2006). Cross-docking tests have also been 
shown to have decreased accuracy compared to typical self-docking tests (Erickson et al., 
2004; Murray et al., 1999; Sutherland et al., 2007). Thus, it becomes very important in 
docking to investigate the changes in binding site architecture upon binding to different 
ligands. Certainly, modeling the protein flexibility associated with binding to specific 
ligands or accounting the critical conformational shift upon ligand binding is the Achilles’ 
heel of docking approaches. 
Most of the earlier docking methods keep the receptor protein as rigid and move 
the target ligand around the binding site of the protein while performing an energy 
minimization (Gerek & Ozkan, 2010; Zacharias, 2010; Totrov & Abagyan, 2008). The 
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major problems associated with rigid docking are: (i) proteins are not rigid and undergo 
various types of conformational changes and (ii) simply relying on pure energy 
minimization is an insufficient approach to predict correct binding affinities (Gerek & 
Ozkan, 2010). Several experimental techniques exist that can detect the conformational 
changes upon ligand binding in the protein receptors (Lexa & Carlson, 2012; Seeliger & 
de Groot, 2010). Additionally, in recent years, docking algorithms have significantly 
evolved to incorporate full flexibility of the ligand, and partial flexibility of the protein 
(Andrusier et al., 2008; Zacharias, 2010; Totrov & Abagyan, 2008; Lexa & Carlson, 
2012; Bienstock, 2012). However, direct modeling of the protein (i.e. receptor) flexibility 
still represents a challenging problem due to (i) the high dimensionality of 
conformational space that must be sampled, which significantly increases the 
computational time and also results in a higher rate of false-positive solutions, and (ii) the 
complexity of energy function (Totrov & Abagyan, 2008).  
Recently, docking methods have been developed that allows for a certain degree 
of receptor flexibility and can be categorized into two categories (i) ensemble docking 
and (ii) induced fit docking. These methods are based on the biological models that 
explain the differences between bound and unbound conformations of proteins. The 
ensemble docking model relies on the fact that proteins constantly undergo 
conformational changes and whenever a protein samples a bound conformational state 
and encounters a complementary molecule, the protein and ligand molecule interact and 
create a complex (Mashiach et al., 2010). This is also known as the conformational 
selection model (Ma et al., 1999; Kumar et al., 2000; Tsai et al., 2001; James et al., 2003; 
Ma & Nussinov, 2002). The induced fit model postulates that the structures of the 
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receptor and the ligand are partially compatible. When a ligand and protein comes in 
contact with each other, the interactive chemical forces induce conformational changes in 
them and allow them to form the bound protein-ligand complex. Both of these models are 
likely to hold true in nature (Grunberg et al., 2004) and therefore docking methods also 
mimic these two models of molecular recognition in their approaches. A complete detail 
of available molecular docking software packages, their advantages and issues associated 
with them has been discussed extensively in recent reviews (Grinter & Zou, 2014; 
Sliwoski et al., 2014; Sousa et al., 2013; Lexa & Carlson, 2012; Mobley & Dill, 2009). 
Early induced fit docking protocols only allowed side chain sampling as a 
measure of protein flexibility by using a rotamer library based on backbone dihedral 
angles such as AutoDock 4.0 (Morris et al., 2009), Dynasite/GOLD (Jones et al., 1997; 
Kallblad & Dean, 2003), FlexX (Rarey et al., 1996; Kramer et al., 1999), ICM/MC 
(Cardozo et al., 1995), RosettaLigand (Meiler & Baker, 2006) etc. Significant process has 
been made since then and induced fit docking (IFD) now allows the docking simulation 
to search for a new conformational space to perform direct changes in the binding site 
conformation (Lexa & Carlson, 2012). This can be done using molecular dynamics 
(Dominguez et al, 2003; Fitzjohn & Bates, 2003;  Smith et al., 2005; Krol et al., 2007), 
energy minimization (Krol et al., 2007; de Vries et al., 2007), Monte-Carlo (MC) 
minimization (Chaudhury & Gray, 2008; Wang et al., 2007; Chaudhury et al., 2007), 
normal mode analysis based methods (Lindahl & Delarue, 2005; May & Zacharias, 2008) 
etc. These IFD methods are very popular but they only model flexibility for a limited 
number of receptor residues such as Dock 4.0 (Huang & Zou, 2007), RosettaLigand  
(Davis & Baker, 2009), GLIDE/PRIME (Sherman et al., 2006; Sherman et al., 2006), and 
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AutoDock Vina (Trott & Olson, 2010), FLIPDock (Zhao & Sanner, 2007; Zhao & 
Sanner, 2008), PC-RELAX (Zacharias, 2004; Zacharias, 2008), FITTED (Corbeil et al., 
2007; Corbeil et al., 2008; Corbeil et al., 2009), Flesky (Nabuurs et al., 2007), FiberDock 
(Mashiach et al., 2010), GalaxyDock (Shin & Seok, 2012). Moreover, these methods 
require intensive computational resources and performing docking for larger systems 
becomes harder (Davis & Baker, 2009; Lexa & Carlson, 2012). There are also hinge-bent 
docking algorithms (Sandak  et al., 1998; Sandak et al., 1998; Schneidman-Duhovny et 
al., 2005; Schneidman-Duhovny et al., 2007) that allow hinge bending in docking where 
rigid sub-domains are docked separately and the consistent results are then assembled 
(Andrusier et al., 2008). Like IFD methods, they also have limited ability to handle 
docking of unbound molecules with significant backbone flexibility (Mashiach et al., 
2010). However, all these methods allow only for modest backbone changes and side-
chain sampling but do not allow sampling of large-scale backbone conformational 
changes such as closing of flaps in HIV-1 Protease upon ligand binding (Hornak et al., 
2006), loop conformational change in Aldose Reductase (Sotriffer et al., 2004), or 
opening of the two subdomains (fingers/thumb subdomains) to accommodate the 
substrate in HIV-1 reverse transcriptase (Zheng et al., 2013) etc. 
In contrast to modeling protein flexibility explicitly, ensemble-docking methods 
account for protein flexibility prior to the actual docking (pre-docking step) by making 
use of a limited number of discrete protein conformations such as RosettaBackrub (Lauck 
et al., 2010), MedusaDock (Ding & Dokholyan, 2013), AutoDock (Osterberg et al., 2002) 
and IFREDA (ICM-flexible receptor docking algorithm) (Cavasotto & Abagyan, 2004). 
Interestingly, few of the IFD docking methods also use a pre-existing ensemble of 
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conformations such as FlexX-Ensemble (Claussen et al., 2001), FLIPDock (Zhao & 
Sanner, 2007; Zhao & Sanner, 2008), FITTED (Corbeil et al., 2007; Corbeil et al., 2008; 
Corbeil et al., 2009), Dock4.0 (Huang & Zou, 2006a; Huang & Zou, 2006b), MDock 
(Huang & Zou, 2007). The docking time for these approaches scales linearly with the 
number of structures in the ensemble (Korb et al., 2012). The integration of multiple 
receptor conformation (MRC) sampling into the docking algorithm might improve 
computational speed and help us simplify data management (Totrov & Abagyan, 2008). 
The sources of ensemble generation vary from experimentally determined X-ray or NMR 
protein structures (Barril & Morley, 2005; Damm & Carlson, 2007; Philippopoulos & 
Lim, 1999; Carlson & McCammon, 2000; Kuzu et al., 2013) to computationally derived 
protein conformations from Molecular Dynamics (MD) simulations (Dietzen, 2012; 
Gerek & Ozkan, 2010), homology models (Gerek & Ozkan, 2010), or Normal Mode 
Analysis (Cavasotto et al., 2005; Atilgan et al., 2010; Bolia et al., 2012; Gerek & Ozkan, 
2011; Dietzen, 2012). The success of an ensemble docking approach depends on 
generating an ensemble of receptors that contains a wide range of binding site 
conformations realized in nature, while excluding the conformations that predict incorrect 
poses. Therefore, it becomes important to mimic nature and sample binding induced 
conformations using effective and intelligent sampling strategies while generating 
ensembles from any of the above-mentioned approaches (Totrov & Abagyan, 2008) 
(Gerek & Ozkan, 2010). 
To overcome these challenges in molecular docking, we developed a flexible 
docking scheme called BP-Dock (Backbone Perturbation-Dock) (Bolia et al., 2014) that 
will be discussed in detail in Chapter 3. BP-Dock is based on Perturbation Response 
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Scanning (PRS) (Atilgan et al., 2010; Atilgan & Atilgan, 2009) that calculates the 
fluctuation responses of residues in a coarse grained elastic network model of protein 
(Atilgan et al., 2001) using linear response theory (Ikeguchi et al., 2005; Yang et al., 
2014). PRS views a protein structure as an elastic network where α-carbon atoms 
represent the nodes of the elastic network (coarse-graining) and identical harmonic 
springs connect interacting α-carbons in their native fold. We can exert random external 
unit force on every single α-carbon atom of the chain and calculate the fluctuation 
responses of all the residues in a protein by PRS to generate an ensemble of structures 
(Bolia et al., 2014). Therefore in the BP-Dock approach, we mimic the ‘conformational 
selection’ model of nature by generating an ensemble of receptors that mimics the 
different conformations sampled in an unbound receptor before ligand binding. The 
ensemble is later docked with RosettaLigand to account for ligand flexibility and side 
chain rotamer sampling of the protein (Meiler & Baker, 2006). This enables us to 
integrate both backbone and side chain conformational changes of the receptor along with 
full ligand flexibility in our docking analysis. Therefore, with BP-Dock we can simulate 
the natural course of a binding event by computing the ligand induced mean-square 
fluctuation profile for the protein backbone by PRS. Indeed, it has been shown that the 
residue fluctuation responses obtained upon perturbation of a single residue capture the 
conformational change between the unbound and bound conformations (Atilgan et al., 
2010; Bolia et al., 2014; Bolia et al., 2012; Gerek & Ozkan, 2011). The multiple receptor 
conformation (MRC) ensemble generated from the perturbations includes the 
conformations sampled through the binding process, which in return increases the 
accuracy of binding affinity predictions. This flexible docking approach can determine 
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the functionally related motions upon ligand binding through a coarse-grain modeling 
approach that makes it computationally efficient to model large-scale backbone 
movements.   
In Chapter 3, we will discuss the BP-Dock methodology and its application to a 
large and diverse dataset using unbound structures as receptors (Bolia et al., 2014). The 
data set used for this study comprises of 5 diverse sets of protein-ligand complexes of 
HIV-1 Protease, Carbonic Anhydrase II, Alcohol Dehydrogenase, Alpha-Thrombin and 
Cytochrome C Peroxidase, where we compared the experimental binding affinities of 
each individual set with the binding energy scores obtained from unbound docking by 
BP-Dock. Here, we will show the ability of BP-Dock to model large-scale backbone 
conformational changes that helps in sampling bound-like conformation even in the 
highly flexible receptor of HIV-1 Protease. In addition to these sets, the Chapter also 
discusses the analysis of 20 individual protein complexes with available bound and 
unbound experimental structures and cross-docking tests for HIV and postsynaptic 
density-95/Dlg/ZO-1 (PDZ) domain proteins. Overall, our results highlight the 
importance of modeling backbone flexibility in docking for recapitulating the 
experimental binding affinities, especially when unbound structure is used. 
In Chapter 4, we will discuss the application of PRS based docking in 
characterizing the binding affinities of all the major PICK1 interacting proteins (Bolia et 
al., 2012). Protein interacting with C kinase (PICK1) contains a single N-terminal PDZ 
domain that interacts with the PDZ motifs of several proteins. The functional role of 
PICK1 is to control the trafficking of its binding partners and by facilitating their 
phosphorylation by recruiting protein kinase C-α (PKCα) (Staudinger et al., 1997). The 
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proteins interacting with PICK1 have roles in synaptic plasticity (Jin et al., 2006), 
neuronal cell morphology (Rocca et al., 2008) and mitochondrial-dependent apoptosis 
(Wang et al., 2007). In this chapter we will report the binding affinities of all PDZ motifs 
known to interact with PICK1 and elucidate the determinants of PICK1 binding. This 
analysis has important implications that may aid in the development of therapeutic agents 
aimed at regulating specific PICK1 interactions.  
In Chapter 5, we will extend the application of BP-Dock to glycan-cyanovirin-N 
(CVN) interactions (Bolia, Woodrum et al., 2014). Glycan recognition has always been a 
challenging field to study and CVN is emerging as a convenient model system to 
investigate glycan–protein interactions and to test computational approaches to glycan 
recognition. Here, we use BP-Dock integrated with experimental work to elucidate the 
determinants of carbohydrate recognition in CVN. We show the contributions of 
individual amino acids to affinity for di-mannose in CVN and provide a platform to 
efficiently evaluate changes in the binding pocket. Furthermore, we also show the use of 
MD simulations and other computational tools (discussed in Chapter 2) to study the 
structural dynamics of CVN (Li et al., submitted). Specifically, we study the effect of 
flexibility/rigidity of the hinge region of CVN to its binding affinity to di-mannose. To 
this aim, we used dynamic flexibility index (dfi), a position based metric based on PRS to 
quantify the resilience of a position to perturbations exerted at other parts in the chain. 
Our studies indicate that the capability of monomeric wild type CVN to resist mechanical 
perturbations is enhanced when compared to constructs in which the hinge region is more 
flexible. With the help of BP-Dock and experimental data, we also show that binding 
affinity for di-mannose would be more favorable for cyanovirin constructs containing a 
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wild type hinge region (having Proline at amino acid position 51), whereas affinity would 
be impaired in the case of mutants containing the P51G mutation in the hinge region. 
Overall, our results show that BP-Dock is a useful tool to rapidly screen the relative 
binding affinity pattern of in silico-designed mutants compared to wild type in CVN, 
supporting its use to design novel mutants with enhanced binding properties.  
In Chapter 6, we discuss about our recently developed induced-fit docking 
approach called Adaptive BP-Dock, which integrates BP-Dock with the flexible-
backbone protocol of RosettaLigand (Davis & Baker, 2009) in an adaptive manner. In 
Adaptive BP-Dock, we perturb all the binding site residues simultaneously in an unbound 
protein, while optimizing the ligand orientation through flexible-backbone protocol of 
RosettaLigand in an iterative fashion. We generate 1000 docked (receptor-ligand) 
trajectories for each perturbation (iteration) step and select the lowest energy docked pose 
for next iteration for a total of 10 iterations. With Adaptive BP-Dock, we aim to combine 
the potential of BP-Dock in providing full protein flexibility along with full ligand 
flexibility from RosettaLigand during the docking simulation. Thus, we can generate 
protein conformations on the fly while accommodating ligand into the binding site to 
mimic the actual ligand-binding process. Chapter 6 also presents the analysis of specific 
test cases that we have used to benchmark our Adaptive BP-Dock approach. Our analysis 
shows better correlation with experimental binding affinities for Adaptive BP-Dock. 
Overall, the results imply that Adaptive BP-Dock can easily capture binding induced 
conformational changes by simultaneous sampling of protein and ligand conformations. 
In short words, this thesis aims to utilize multi-scale computational approaches to 
study protein-ligand binding interactions. Chapter 2 presents a brief introduction to the 
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computational techniques used in our work. A novel ensemble docking approach for 
protein-ligand docking, using PRS and RosettaLigand is presented in Chapter 3 along 
with its applications to unbound protein structures. Chapter 4 looks specifically at PICK1 
interactions with other PDZ domains and the role of BP-Dock in elucidating the 
determinants of PICK1 binding. Chapter 5 provides insights about the role of structural 
dynamics on glycan-cyanovirin interaction and the energetics of individual residues in 
glycan binding using both all-atom MD simulations and coarse-grained PRS based 
approaches. A recent induced fit docking approach that integrates PRS with the flexible-
backbone protocol of RosettaLigand is presented in Chapter 6.  
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CHAPTER 2 
 
COMPUTATIONAL METHODS FOR STUDYING PROTEIN-LIGAND 
INTERACTIONS 
 
2.1 Introduction 
Despite the wealth of structural information in the Protein Data Bank (PDB) 
(Berman et al., 2000), the origins of specificity of protein ligand interactions for the vast 
majority of proteins remains unclear. Understanding this molecular recognition event of a 
protein and ligand helps to decode the mechanism and pathways associated with 
biological processes that are of great therapeutic importance. Computational methods 
such as Molecular Dynamics (MD) simulations or normal mode analysis (NMA) using 
all-atom empirical potentials that have been developed for proteins can elucidate the 
details of the molecular motions associated with ligand binding (McCammon & Harvey, 
1988; Go, Noguti, & Nishikawa, 1983; Brooks & Karplus, 1983). However, the use of 
atomistic approaches increases the computing time and makes it computationally 
inefficient for larger systems (Atilgan et al., 2001). Therefore, with the advent of coarse-
graining of bimolecular structures, it is now possible to study a large number of protein 
structures. Indeed, recent studies have shown the success of coarse-grained approaches 
and simplified force fields for describing the fluctuation dynamics of simple models and 
collective motions of complex systems such as larger proteins (> 1000 residues) (Hinsen, 
1998; Atilgan et al., 2001; Atilgan et al., 2010; Gerek et al., 2009; Yang et al., 2009; 
Bahar et al., 1997; Kondrashov et al., 2006).  Normal mode analysis (NMA) has been 
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shown to predict the most probable cooperative motions in proteins since the early 80s 
(Go et al., 1983; Brooks & Karplus, 1983) which has resulted in simpler coarse-grained 
approaches that are built upon NMA such as Elastic Network models (ENM) (Atilgan et 
al., 2001); Hinsen, 1998; Tirion, 1996) and Perturbation Response Scanning (PRS) 
(Atilgan & Atilgan, 2009; Atilgan et al., 2010). Despite the simplifications made in these 
coarse-grained models, they are robust and efficient in deriving the lowest frequency 
modes (also known as softest modes) that usually relate to the functional motions (Bahar 
& Rader, 2005; Cui & Bahar, 2005; Atilgan et al., 2010). In this chapter, we will discuss 
the methodological details of ENM and PRS and their applications in study of functional 
dynamics of proteins. 
 2.2 Coarse-grained Approaches 
2.2.1 Elastic Network Models 
The Elastic Network Model (ENM), also known as the Anisotropic Network 
Model (ANM) (Hinsen, 1998; Atilgan et al., 2001), is a simplified tool that replaces the 
detailed atomic potentials with uniform harmonic potentials between interacting atoms or 
residues in a given protein network. This simple model can be used to sample the large-
scale collective motions in proteins around the equilibrium state ( Atilgan et al., 2001). In 
the ANM, protein structure is coarse-grained to a single site per residue model (i.e. every 
residue is reduced to a single node represented by Cα atoms). These nodes are connected 
to each other by harmonic springs if they are within a specified cutoff distance rc. The 
potential of such an interconnected bead-and-spring model is given by: 
𝑉!"# = 𝛾2 𝑠!" − 𝑠!"! !!!,! 𝑓   𝑠!"!                                                                                                                                                                              
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                                  = 𝛾2 𝑋! − 𝑋! !   +    𝑌! − 𝑌! !  +   𝑍! − 𝑍! ! −   𝑠!"! ! 𝑓   𝑠!"!!!,!                         (2.1) 
Here γ is the uniform spring constant, N is the total number of residues in the protein, the 
instantaneous and equilibrated distance between residues i and j is 𝑠!"   and 𝑠!"!   resp., and 
X, Y, Z are the instantaneous Cartesian coordinates for residues i and j. The summation is 
performed over the pairs of residues/nodes within the cutoff distance rc through the 
Heaviside unit step function 𝑓   𝑠!"!  with 𝑓   𝑠!"!  =  1 if 𝑠!"!   ≤  rc, and 0 otherwise (Bahar 
& Rader, 2005; Atilgan et al., 2001; Tama & Sanejouand, 2001). Using this potential, we 
can perform the normal mode analysis to obtain the conformational motions of a protein. 
The second derivative of VANM with respect to the coordinates of residues in the protein 
leads to:  𝜕!𝑉!"#𝜕𝑋!! =   𝛾   𝑋! − 𝑋!    !/𝑠!"!!  
                                                                                      𝜕!𝑉!"#𝜕𝑋!𝜕𝑌! =   𝛾   𝑋! − 𝑋!    𝑌! − 𝑌!    /𝑠!"!!                                                                     (2.2) 
The second derivative of the potential can also be represented in a 3N x 3N Hessian 
matrix H or the matrix can be viewed as an organization of N x N super-elements of size 
3 x 3, 
                                     𝐇   = 𝐡!!             𝐡!"⋯     𝐡!"𝐡!"   𝐡!!     𝐡!"⋮                       ⋮              ⋱ ⋮𝐡!"               𝐡!"⋯     𝐡!!                                                                                               (2.3) 
Here, the ijth super element hij (where i ≠ j) of Hessian H is defined as 
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                                                                                𝐡!"   =
𝜕!𝑉𝜕𝑋!𝜕𝑋! 𝜕!𝑉𝜕𝑋!𝜕𝑌!      𝜕!𝑉𝜕𝑋!𝜕𝑍!𝜕!𝑉𝜕𝑌!𝜕𝑋!    𝜕!𝑉𝜕𝑌!𝜕𝑌! 𝜕!𝑉𝜕𝑌!𝜕𝑍!𝜕!𝑉𝜕𝑍!𝜕𝑋! 𝜕!𝑉𝜕𝑍!𝜕𝑌! 𝜕!𝑉𝜕𝑍!𝜕𝑍!
                                                                                    (2.4) 
The decomposition of the Hessian matrix yields 3N – 6 non-zero eigenvalues and 
eigenvectors (modes). The 3N eigenvalues and eigenvectors characterize the frequencies 
(each eigenvalue equals to the square of its frequency) and directions of the collective 
motion of residues in the protein. There are six eigenvectors that are trivial and have zero 
eigenvalues (i.e. zero frequency) and they relate to the global translational and rotational 
motion of the protein. The other 3N – 6 eigenvectors are orthogonal and they reflect the 
internal motion of the protein. The eigenvectors with the lowest frequencies usually 
correspond to the functionally related motions of a protein. Considering the 3N – 6 
eigenvectors after ignoring the six with zero eigenvalues, we can also obtain the pseudo 
inverse of the Hessian matrix as, 
                                                                                                 𝐇!𝟏 !!×!! =    1λ!!"!!!!! 𝐮!𝐮!!                                                                                                          (2.5) 
where ui and λi are the non-zero eigenvectors and eigenvalues associated with the 3N × 
3N Hessian matrix, H. Using H-1, we can determine the mean square fluctuations of 
individual residues: 
                                 ∆𝑅!! = ∆𝑋!! + ∆𝑌!! + ∆𝑍!!                                                                                                    = 𝑘!𝑇𝛾 𝐇!"!!,!"!!  !! + 𝐇!"!!,!"!!  !! + 𝐇!",!"  !!                                                       (2.6) 
 Likewise, the cross-correlation between different residues can be obtained using H-1 as: 
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                             ∆𝑅! ⋅ ∆𝑅! = ∆𝑋!∆𝑋! + ∆𝑌!∆𝑌! + ∆𝑍!∆𝑍!  
                                                                                                            = 𝑘!𝑇𝛾 𝐇!"!!,!"!!  !! + 𝐇!"!!,!"!!  !! + 𝐇!",!"  !!                                           (2.7) 
ANM has been widely used to shed insight into protein motions (Yesylevskyy et al., 
2006) and also in flexible docking (Gerek & Ozkan, 2010). Applications of ANM to 
Retinol binding protein (RBP) have shown that the most flexible regions of the protein 
predicted by the slowest low frequency and most cooperative collective modes are a pre-
requisite for the effective functioning of the recognition sites for substrates (Atilgan et al., 
2001).  
2.2.2 Perturbation Response Scanning 
ENMs provide information about the fluctuations of a protein around their 
equilibrium state and describe the contribution of different modes to those fluctuations. 
The strength of ENM lies in selecting the most relevant mode to functional motion such 
as ligand binding which also makes the method more restricted. Therefore, several 
modified EN models were devised where the system is perturbed and the response 
obtained from this perturbation provides information about underlying landscapes rather 
than simply providing the correlation between fluctuations. These perturbations can be 
introduced by either changing the force constants (Sacquin-Mora & Lavery, 2009) or 
modifying the distance between interacting pairs or atom/residues (Kundu et al., 2004), 
or by a combination of both (Ming & Wall, 2006). Another model based on ENM called 
Perturbation Response Scanning (PRS), analyzes the responses of the residues in a 
protein when it is perturbed around its equilibrium state (Atilgan et al., 2001; Atilgan & 
Atilgan, 2009; Atilgan et al., 2010). PRS uses the same coarse grained EN model of a 
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protein, where the perturbations are caused by inserting external random forces on the 
nodes (Cα atoms) and the linear responses (i.e. positional displacements) of the protein 
are recorded using Linear Response Theory (LRT) (Atilgan et al., 2001).   
Linear Response Theory (LRT) was proposed by Ikeguchi et.al. (Ikeguchi et al., 
2005) to predict the conformational changes in proteins upon ligand binding. In the 
framework of LRT, the lowest frequency normal modes describe the global pattern of 
equilibrium fluctuations and ligand-binding responses originates from the equilibrium 
fluctuations in the unperturbed (unbound) state of protein. The molecular responses to 
ligand binding for a protein are described by the product of the covariance matrix of the 
atomic fluctuations in the unperturbed state and the external forces applied by ligands 
acting on an atom j as, 
                                                                                                                ∆𝐫! = 1𝑘!𝑇 ∆𝐫!∆𝐫! !𝐟!!                                                                                                     (2.8) 
where, kB is the Boltzmann factor and T is the absolute temperature,  ∆𝐫! is the positional 
changes of an atom i due to the external force applied on atom j, ∆𝐫!∆𝐫! ! is the 
variance-covariance matrix of the atomic fluctuations in the unperturbed state of protein 
and fj is the external force applied on atom j. Several studies in the past have shown the 
success of LRT in predicting binding induced conformational changes in the protein 
(Ikeguchi et al., 2005; Essiz & Coalson, 2009; Gerek & Ozkan, 2010; Amemiya et al., 
2011).  
Recently Go and colleagues formulated a general linear response theory that can 
describe both time-dependent and time-independent conformational changes upon CO 
binding in Myoglobin (Yang et al., 2014). Using simple standard statistical mechanics, 
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they derived a general theory that can account for perturbation-induced conformational 
changes in a time-dependent manner: 
                                                                   ∆𝐫! 𝑡 ! = 1𝑘!𝑇 𝑑𝑡!!! ∆𝐫! 0 ∆𝐫! 𝑡! ! 𝐟! 𝑡 − 𝑡!                                               (2.9) 
where, ∆𝐫! 𝑡 ! is the change in positions for an atom i with time t under external forces 
f, ∆  𝐫! 0  is the velocity of atom j at the moment when constant external forces fj are 
applied, ∆𝐫! 0 ∆𝐫! 𝑡! ! is the velocity-position time-correlation function sampled in the 
absence of external force (denoted by 0). When 𝑡 → ∞, equation (2.9) can also be used to 
get the time-independent form of LRT since the term ∆𝐫! 0 ∆𝐫! 𝑡! ! converges: 
                                                                                                               ∆𝐫! ! = 1𝑘!𝑇 ∆𝐫!∆𝐫! ! 𝐟!                                                                                       (2.10) 
Using this theory, the authors were able to track the mechanical signal propagation upon 
ligand binding as a function of time, space and the perturbation forces that are the source 
of induced fit.  
This study by Go and colleagues and earlier work (Yang et al., 2014; Ikeguchi et 
al., 2005; Essiz & Coalson, 2009; Amemiya et al., 2011; Gerek & Ozkan, 2010) show 
that LRT is a robust tool that is mostly suited for proteins with small conformational 
changes that can be described by the low-frequency normal modes. However, 
applicability of LRT is invalidated when high frequency modes contribute to the 
conformational changes in a protein leading to unnaturally large forces at room 
temperature. Moreover, it is also difficult to describe large conformational changes that 
fall out of the linear regime of LRT.  However, it has been shown that with proper 
approximations, the linear region could be extended as long as the protein follows a 
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harmonic energy landscape (Ikeguchi et al., 2005; Essiz & Coalson, 2009). To this aim, 
PRS combines ENM models that bear a harmonic nature with LRT to provide a 
lengthened linear region to describe large conformational changes in a protein upon 
ligand binding.  
In PRS, we sequentially apply random external forces as a perturbation on a 
single residue and record the linear responses (displacements) of the other residues and, 
hence, the term perturbation response scanning (Atilgan & Atilgan, 2009). PRS is based 
on the EN model, where the Cα atoms are interconnected to each other with harmonic 
springs. As explained earlier, in an EN model all residue pairs are subjected to a uniform, 
single-parameter harmonic potential when they are located within an interaction range or 
cutoff distance, rc. The major drawback of using cutoff distances in ENM is that they are 
generally chosen arbitrarily. Moreover, the optimal value of cutoff distances varies for 
different proteins (Hinsen et al., 2000; Yang et al., 2009). Therefore, in our PRS 
approach, we do not use an arbitrary cutoff distance value; instead, we weigh the 
interaction strength between all residue pairs by the inverse of the square distance of their 
separation (Lin et al., 2008; Yang et al., 2009; Gerek & Ozkan, 2011). This approach has 
been successfully tested to capture the conformational changes upon binding in 25 
unbound protein structures (Gerek & Ozkan, 2011). 
At equilibrium, each node of the protein system is under the action of balanced 
internal forces. Therefore, in the absence of an external force, the summation of all the 
internal, residue-residue interaction forces for the entire protein comprised of N nodes 
and a total of M interactions is 0, given by,                                                                                                                                       𝐁 !!×! ∆𝐟 !×! = 0                                                                                        (2.11) 
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where, B is the 3N × M directional cosine matrix of residue-residue interactions and ∆f is 
a M × 1 column matrix of the residue-residue interaction forces, aligned in the direction 
of the bond between the two interacting residues.  
In the presence of an external force ∆F, the net force given by equation (2.11) 
should equal to the external force,                                                                                                                    𝐁 !!×! ∆𝐟 !×! = ∆𝐅 !!×!                                                                            (2.12) 
where, ∆F is a 3N × 1 vector containing the components of the externally applied force 
vectors on the selected residues. In the present scheme, this external force is applied to 
each node of the EN model of protein in all seven directions (X, Y, Z, XY, XZ, YZ and 
XYZ) to ensure isotropy. The external force vector when a force is applied on a residue i 
in XYZ direction can be represented as,                                                                                                    ∆𝐅 ! = 000…∆𝐹!!∆𝐹!!∆𝐹!! … 000   !×!!                                                  (2.13) 
Figure 2.1 shows the PRS model of a protein where Cα atoms represent the node of the 
EN model connected to each other with linear-elastic springs, at equilibrium (A), and 
when an external force ∆Fj is applied to a residue j (B). These external forces mimic the 
forces exerted by the ligand when it approaches the protein, introducing conformational 
changes defined by positional displacement vector, ∆R, and the change in bond distance 
between any two residues, ∆r. Therefore, the work done by external forces should be 
equal to the work done by internal forces, given by, 
                                                                                         ∆𝐅! !×!! ∆𝐑 !!×! = ∆𝐟! !×!    ∆𝐫 !×!                                                          (2.14) 
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Figure 2.1: PRS model of a polypeptide chain. (A) The equilibrium condition where the 
summation of internal forces on all the residues (shown as black dots) in the system is 0 
(equation (2.11)). (B) The perturbed system (equation (2.12)) where the residues change 
their original position when an external force ∆Fj is applied to a residue j. (source: (Gerek 
& Ozkan, 2011)) 
The bond distances between residues can also be expressed as a linear combination of 
positional displacements using,                                                                                                                          𝐁!×!!! ∆𝐑!!×! =   ∆𝐫!×!                                                                                          (2.15) 
Within the scope of the ENM, where residues are connected to each other with linear-
elastic springs, we can use Hooke’s law to express internal forces ∆f and bond vectors 
∆r, by,                                                                                                                             ∆𝐟 !×! = 𝐊 !×! ∆𝐫 !×!                                                                            (2.16) 
Here, the coefficient matrix K is a diagonal matrix with its ith element being the force 
constant of the ith bond. Upon multiplying equation (2.16) with B on both sides, and 
substituting ∆𝑟 and ∆𝑓 using equations (2.15) and (2.12) resp., we can obtain the external 
forces necessary to induce positional displacements,                                                                          ∆𝐅 !!×! =    𝐁 !!×! 𝐊 !×! 𝐁! !×!! ∆𝐑!!×!                                              (2.17) 
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Alternatively equation (2.17) can be rearranged to obtain response of the residue network 
expressed as positional displacements upon perturbing residues with an external force,                                                             ∆𝐑!!×! =    𝐁 !!×! 𝐊 !×! 𝐁! !×!! !! ∆𝐅 !!×!                                                  (2.18) 
The (BKB)T matrix is equivalent to the Hessian matrix, the second derivative of potential 
as shown earlier by Atilgan et al. (Atilgan et al., 2001).                                                                                                          ∆𝐑!!×! =   𝐇!!×!!!! ∆𝐅 !!×!                                                                                          (2.19) 
Equation (2.19) is similar to the equation (2.8) or (2.10) obtained from LRT (Ikeguchi et 
al., 2005; Yang et al., 2014). In equation (2.19), the positional fluctuations of a protein 
network are provided by a 3N × 3N Hessian inverse (H-1) matrix, which can also be 
represented as a matrix composed of N x N super-elements of size 3 x 3. The ijth off-
diagonal super-element of H-1 has the cross-correlations between the x,y,z components of 
∆Ri and ∆Rj, whereas the ith super-element of H-1 has the self-correlations between the 
x,y,z components of ∆Ri. We can also substitute the Hessian inverse with the 3 N × 3 N 
covariance matrix, G, obtained from the molecular dynamics simulations to obtain the 
positional displacements of the residues,                                                                                                           ∆𝐑!!×! =   𝐆!!×!! ∆𝐅 !!×!                                                                                          (2.20) 
Therefore, with PRS we can simulate the natural course of binding by mimicking 
the forces a ligand exerts on the binding site residues as the external force used for 
perturbation of the protein model. Then the fluctuation response of residues upon 
perturbation can be recorded using equation (2.19). These responses can be used to 
generate new conformations for ensemble docking (Chapter 3), for studying structural 
dynamics or allosteric interactions (Chapter 5) or can be even used to study the induced 
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fit model of binding (Chapter 6). This thesis will present the applications of PRS in 
exploring protein-ligand interactions. 
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CHAPTER 3 
 
BP-DOCK: MOLECULAR DOCKING FOR EXPLORING PROTEIN-LIGAND 
INTERACTIONS BASED ON UNBOUND STRUCTURES 
 
As excerpted from: 
Bolia, A., Gerek., Z. N. and Ozkan, S. B.“BP-Dock: a flexible docking scheme for 
exploring protein-ligand interactions based on unbound structures,”Journal of Chemical 
Information and Modeling 54, 913-925 (2014) 
3.1 Introduction 
Molecular docking is an effective tool for predicting the structure of protein-
ligand complex, studying the protein-ligand interactions and evaluating the binding 
affinity of such complexes (Andrusier et al., 2008). Indeed, it has become the primary 
component in many drug discovery programs especially for virtual screening (Kitchen et 
al., 2004; Kuntz et al., 1982; McGovern & Shoichet, 2003). However, it is still 
challenging to incorporate overall receptor flexibility, especially backbone flexibility in 
these approaches due to the large conformational space that needs to be sampled.  To this 
aim, we developed a flexible ensemble docking scheme called BP-Dock (Backbone 
Perturbation-Docking) based on Perturbation Response Scanning (PRS) (Atilgan & 
Atilgan, 2009; Atilgan et al., 2010), that is discussed in detail in Chapter 2. By PRS, we 
can simulate the natural course of a binding event by computing fluctuation responses of 
all the residues in a protein by exerting random external unit force on a single α-carbon  
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atom of the chain, especially those in the binding pocket (Atilgan & Atilgan, 2009; 
Atilgan et al., 2010). BP-Dock computes ligand induced mean-square fluctuation profile 
for the backbone of a protein by using PRS, which is then followed by all atom energy 
minimization of the perturbed protein conformation. This two-step multi-scale approach 
enables us to integrate both backbone and side chain conformational changes of a 
receptor into docking, and it is computationally efficient to model large-scale backbone 
movements. Indeed, it has been shown that the residue fluctuation responses obtained 
upon perturbation of a single residue can capture conformational change between 
unbound and bound conformations (Atilgan et al., 2010). As unbound docking, where an 
unbound (apo) form of the structure is used along with the ligand to obtain a complex 
form is a challenging problem in docking (McGovern & Shoichet, 2003), we applied our 
BP-Dock approach on unbound structures in this study. The two main goals for this study 
are (i) to check whether the unbound docking with BP-Dock can recapitulate the bound 
docking results, and (ii) to test if the method accurately captures the experimental binding 
affinities when an unbound receptor structure is used.  
To this aim, we tested our flexible docking approach for a data set of protein-
peptide, as well as, protein-small ligand complexes. The data set used for this study 
comprise of 5 diverse sets of protein-ligand complexes of HIV-1 Protease, Carbonic 
Anhydrase II, Alcohol Dehydrogenase, Alpha-Thrombin and Cytochrome C Peroxidase; 
where we compared the experimental binding affinities of each individual set with the 
binding energy scores obtained from unbound docking by BP-Dock. In addition to these 
sets, we also analyzed another 20 individual protein complexes with available bound and 
unbound experimental structures. Overall the unbound/bound pairs in our data set cover a 
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wide range of root-mean-square distance (RMSD) between bound and unbound 
conformations ranging from 0.103-1.65 Å (Table 3.1), which enable us to rigorously test 
the performance of BP-Dock on unbound structures having a diverse set of RMSDs from 
the bound structures. Furthermore, 13 proteins ranging from 59 to 537 residue long 
chains that were in complex with various types of ligands, including peptides with 
different lengths (from 2 to 10-mers) were chosen to provide an extensive pool of flexible 
degrees of freedom. We also performed “rigid docking” that does not incorporate the 
flexibility of the backbone and side chains outside the binding pocket, using both bound 
and unbound experimental structures. This enable us to compare the performance of 
unbound docking with BP-Dock with respect to rigid bound and unbound docking. To 
further determine the accuracy and sensitivity of our docking method, we also performed 
cross-docking tests for HIV and postsynaptic density-95/Dlg/ZO-1 (PDZ) domain 
proteins. Our analysis show that BP-Dock is a computationally efficient approach to 
incorporate full receptor flexibility to generate MRCs. Ensemble docking using MRC 
generated from unbound conformation can capture the bound docking results. Moreover, 
it can improve the binding affinity prediction in several cases. The success of the 
approach rests on generating a wide range of binding site conformations realized in 
nature.  
3.2 Methods 
3.2.1 Training Dataset 
We analyzed 5 different diverse sets of protein-ligand complexes (HIV-1 Protease 
(N = 20), Carbonic Anhydrase II (N = 9), Alcohol Dehydrogenase (N = 8), Alpha-
Thrombin (N = 13) and Cytochrome C Peroxidase (N = 18); where N is the number of 
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complexes for each protein set used in the study) and an individual set of another 20 
proteins with available bound (holo) and unbound (apo) structures that were retrieved 
from Protein Data Bank (PDB) (Berman et al., 2000). The name of proteins, PDB codes 
of their corresponding bound and unbound structures, chain length, root mean-square 
distance between bound and unbound structures, name of binding ligand/peptide and 
sequences of peptides, are displayed in columns of Table 3.1. The experimental binding 
affinities for the 5 test sets (total 68 test cases) were obtained from LPDB (Roche et al., 
2001) and Astex (Hartshorn et al., 2007) databases. The performance of rigid docking 
versus BP-Dock was also tested in cross-docking studies on the HIV-1 Protease set. The 
HIV-1 Protease benchmark set has 20 complexes and cross-docking tests were performed 
on 20×20 = 400 cases. Furthermore, we also analyzed the homology model of Channel-
interacting PDZ Protein (CIPP). Overall, we had a large and diverse data set of 494 
docking cases (including 400 cross-docking cases) to evaluate the performance of BP-
Dock. 
3.2.2 BP-Dock Methodology 
In the BP-Dock method, we mimic the nature of binding induced events as a first 
order approximation by perturbing the residues along the protein chain with a small 
Brownian kick, one at a time. The response fluctuation profile of the chain upon these 
perturbations is computed using the perturbation response scanning method (equation 
(2.19), discussed in Chapter 2) (Atilgan & Atilgan, 2009). These response fluctuation 
profiles can then be used to generate binding induced multiple receptor conformations for 
ensemble docking. As explained earlier, we start with an unbound structure of protein 
and represent the protein as a coarse-grained EN model of Cα atoms, whose potential is  
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Table 3.1: PDB codes of unbound and bound structures, chain length, RMSDs between 
bound and unbound structures, native peptides or ligands, and peptide sequences for the 
proteins used in this study (*Modeled Unbound structures were used in these cases) 
 
Protein 
PDB Code 
Chain Length RMSD (Å) 
Peptide/ Ligand 
Bound 
(Holo) 
Unbound 
(Apo) Name 
Sequence of 
Peptide 
PSD-95 1BE9 1BFE 119 0.470 Cript KQTSV 
GRIP 1N7F 1N7E 97 0.422 Liprin ATVRTYSC 
Syntenin 1OBX 1NTE 79 0.383 IL5R-a DSVF 
Syntenin 1OBY 1NTE 79 0.370 Syndecan-4 NEFYA 
Syntenin NA 1NTE 79 - Merlin FFEEL 
SH3 domain of GRB2 1IO6 1GFD 59 0.856 - RHYRPLPPLP 
SH3 domain of GRB2 NA 1GFD 59 - VPP VPPPVPPRRR 
Cyclophilin A 2CYH 2CPL 164 0.202 - AP 
Cyclophilin A 1AWQ 2CPL 164 0.453 Peptide HAGPIA 
Methyltransferase 1BC5 1AF7 274 0.429 Pentapeptide NWETF 
Aldose Reductase 2FZB 2ACR 315 0.366 [Tolrestat (TOL)]4 - 
Aldose Reductase 1T40 2ACR 315 0.187 IDD552 - 
Carboxypeptidase 2CTC 1M4L 307 0.103 HFA - 
Carboxypeptidase 7CPA 1M4L 307 0.216 FVF - 
TIM 4TIM 3TIM 250 (A,B) 0.303 2-PG - 
TIM 6TIM 3TIM 250 (A,B) 0.317 G3P - 
ABP 1LRH 1LR5 163(A,B,C,D) 0.171 NLA - 
 1GPK 1EA5 537 0.143 HUP - 
Adenosine Deaminase 1UML 1VFL 356 0.402 FR4 - 
Quinone Reductase 2 1SG0 1QR2 230 (A,B) 0.217 STL - 
HIV-Protease 1HBV 2PC0* 198 (A,B) 1.650 SB203238 - 
HIV-Protease 1HEG 2PC0* 198 (A,B) 1.614 SKF 107457 - 
HIV-Protease 1HIH 2PC0* 198 (A,B) 1.343 CGP-53820 - 
HIV-Protease 1HIV 2PC0* 198 (A,B) 1.422 U75875 - 
HIV-Protease 1HPS 2PC0* 198 (A,B) 1.606 SB206343 - 
HIV-Protease 1HTE 2PC0* 198 (A,B) 1.505 GR123976 - 
HIV-Protease 1HTF 2PC0* 198 (A,B) 1.436 GR126045 - 
HIV-Protease 1HTG 2PC0* 198 (A,B) 1.405 GR137615 - 
HIV-Protease 1HVI 2PC0* 198 (A,B) 1.344 A77003 (R,S) - 
HIV-Protease 1HVJ 2PC0* 198 (A,B) 1.347 A78791 (S,-) - 
HIV-Protease 1HVK 2PC0* 198 (A,B) 1.352 A76928 (S,S) - 
HIV-Protease 1HVL 2PC0* 198 (A,B) 1.347 A76889 (R,R) - 
HIV-Protease 1HVS 2PC0* 198 (A,B) 1.406 A77 - 
HIV-Protease 1SBG 2PC0* 198 (A,B) 1.561 IM1 - 
HIV-Protease 4HVP 2PC0* 198 (A,B) 1.538 MVT-101 - 
HIV-Protease 4PHV 2PC0* 198 (A,B) 1.373 L-700, 417 - 
HIV-Protease 5HVP 
 
2PC0* 198 (A,B) 1.427 
ACETYL-
PEPSTATIN 
- 
HIV-Protease 9HVP 2PC0* 198 (A,B) 1.512 A-74704 - 
HIV-Protease 1A30 2PC0* 198 (A,B) 1.490 Tri-peptide EDL 
HIV-Protease 1KZK 2PC0* 198 (A,B) 1.253 JE-2147 - 
Carbonic Anhydrase II 1OQ5 2ILI 259 0.134 Celecoxib - 
Carbonic Anhydrase II 1AVN 2ILI 259 0.254 Histamine - 
Carbonic Anhydrase II 1CIL 2ILI 259 0.239 ETS - 
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Table (3.1) continued 
Protein 
 
PDB Code 
Chain Length 
 
RMSD 
(Å) 
 
Peptide/Ligand 
Bound 
(Holo) 
Unbound 
(Apo) Name 
Sequence of 
Peptide 
Carbonic Anhydrase II 1CIM 2ILI 259 0.258 PTS - 
Carbonic Anhydrase II 1CIN 2ILI 259 0.244 MTS - 
Carbonic Anhydrase II 1CNW 2ILI 259 0.231 EG1 - 
Carbonic Anhydrase II 1CNX 2ILI 259 0.248 EG2 - 
Carbonic Anhydrase II 1CNY 2ILI 259 0.258 EG3 - 
Carbonic Anhydrase II 1OKL 2ILI 259 0.255 MNS - 
Alcohol Deydrogenase 1ADB 8ADH 374 1.218 CND - 
Alcohol Deydrogenase 1ADC 8ADH 374 1.219 PAD - 
Alcohol Deydrogenase 1ADF 8ADH 374 0.330 TAD - 
Alcohol Deydrogenase 1BTO 8ADH 374 1.137 SSB - 
Alcohol Deydrogenase 1HLD 8ADH 374 1.135 PFB,NAD - 
Alcohol Deydrogenase 1LDE 8ADH 374 1.148 FPI,NAD - 
Alcohol Deydrogenase 1LDY 8ADH 374 1.152 CXF,NAD - 
Alcohol Deydrogenase 3BTO 8ADH 374 1.160 SSB,NAD - 
Alpha-Thrombin 1A4W 1C5L 274(L,H,I) 0.351 QWE - 
Alpha-Thrombin 1AE8 1C5L 298(L,H,I) 0.331 AZL - 
Alpha-Thrombin 1BMM 1C5L 295(L,H,I) 0.455 BMS-186282 - 
Alpha-Thrombin 1BMN 1C5L 292(L,H,I) 0.423 BMS-189090 - 
Alpha-Thrombin 1D3D 1C5L 290(L,H,I) 0.352 BZT - 
Alpha-Thrombin 1D3P 1C5L 290(L,H,I) 0.317 BT3 - 
Alpha-Thrombin 1D4P 1C5L 290(L,H,I) 0.333 BPP - 
Alpha-Thrombin 1DWB 1C5L 298(L,H,I) 0.386 Benzyldiamine - 
Alpha-Thrombin 1DWC 1C5L 298(L,H,I) 0.386 MD-805  - 
Alpha-Thrombin 1DWD 1C5L 298(L,H,I) 0.378 NAPAP - 
Alpha-Thrombin 1HDT 1C5L 303(L,H,I) 0.511 BMS-183507 - 
Alpha-Thrombin 1UVS 1C5L 268(L,H,I) 0.479 BM51.1011 - 
Alpha-Thrombin 1OYT 1C5L 305(L,H,I) 0.387 FSN - 
Cytohchrome C Peroxidase 1AC4 1CCP* 291 0.286 TMT - 
Cytohchrome C Peroxidase 1AC8 1CCP* 291 0.299 TMZ - 
Cytohchrome C Peroxidase 1AEB 1CCP* 291 0.299 3MT - 
Cytohchrome C Peroxidase 1AED 1CCP* 291 0.299 DTI - 
Cytohchrome C Peroxidase 1AEE 1CCP* 291 0.309 ANL - 
Cytohchrome C Peroxidase 1AEF 1CCP* 291 0.299 3AP - 
Cytohchrome C Peroxidase 1AEG 1CCP* 291 0.299 4AP - 
Cytohchrome C Peroxidase 1AEH 1CCP* 291 0.299 24T - 
Cytohchrome C Peroxidase 1AEJ 1CCP* 291 0.299 NVI - 
Cytohchrome C Peroxidase 1AEK 1CCP* 291 0.299 IDM - 
Cytohchrome C Peroxidase 1AEM 1CCP* 291 0.299 MPI - 
Cytohchrome C Peroxidase 1AEN 1CCP* 291 0.286 25T - 
Cytohchrome C Peroxidase 1AEO 1CCP* 291 0.286 2AP - 
Cytohchrome C Peroxidase 1AEQ 1CCP* 291 0.299 2EZ - 
Cytohchrome C Peroxidase 1AES 1CCP* 291 0.310 IMD - 
Cytohchrome C Peroxidase 1AET 1CCP* 291 0.281 1MZ - 
Cytohchrome C Peroxidase 1AEU 1CCP* 291 0.286 2MZ - 
Cytohchrome C Peroxidase 1AEV 1CCP* 291 0.267 AMT - 
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given by equation (2.1) and Hessian, second derivative of potential by equation (2.2). 
Hessian is represented as equation (2.3). 
Using the PRS scheme, a random unit force (F) was applied sequentially to the α-carbon 
atom of each residue one at a time, and the resulting relative displacement of all residues 
was recorded using LRT. The overall response of residue network is calculated through 
equation (2.19),                                                                                                         ∆𝐑!!×! =   𝐇!!×!!!! ∆𝐅 !!×!                                                                                          (2.19) 
where ΔF vector contains components of externally applied force vectors on each single 
residue and H-1 is inverse of the Hessian matrix. The final perturbed coordinates Rper, for 
each residue are calculated using,                                                                                                 𝐑!"# !!×! =    𝐑! !!×! + 𝛼 ∆𝐑 !!×!                                                                      (3.1) 
where, R0 are the initial coordinates of the residues before perturbation and α is a scaling 
factor (Gerek & Ozkan, 2011; Bahar et al., 2010). In order to present a significant 
conformational change on the structure after perturbing, we multiply the response 
fluctuation vector with a scaling factor as PRS is based on LRT. The scaling factor is 
chosen such that it yields an ensemble of perturbed structures that have an RMSD 
deviation ranging from 0.25 to 1 Å from the original unbound structure.  
Perturbed structures were then clustered using k-means clustering (MacQueen, 
1967) to discard similar conformations generated from perturbations of different residues 
in the protein. This step was followed by an all-atom minimization of clustered structures 
using the AMBER 99SB force field (Hornak et al., 2006), along with a GB solvation 
model (Tsui & Case, 2000) to account for rotameric changes of side chains, and also to 
relieve any strain in the structure. One other alternative to couple the side-chains to the 
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perturbed backbone conformations is to update the side-chain positions using the internal 
coordinates of the initial structure and then follow up by energy minimization. We have 
also tested this approach in another study (Chapter 5) (Bolia, Woodrum et al., 2014) and 
observed that the RMSD between the conformations obtained after minimization with 
and without updated internal coordinates were in the range of 0.03 - 0.49 Å. We also 
observe that the docking results did not show any significant difference between the 
minimization approaches discussed above (Bolia, Woodrum et al., 2014). This could be 
because side-chain conformations are again repacked using either rotamer trials or a full 
combinatorial search in RosettaLigand (Meiler & Baker, 2006; Davis & Baker, 2009). 
All these steps lead to a set of conformations that constitute multiple binding induced 
receptor conformations. Finally, an ensemble docking for all these individual 
conformations of MRC can be performed using any other rigid docking software. In this 
study, the docking simulation for each structure in the ensemble was performed using 
RosettaLigand (Meiler & Baker, 2006; Davis & Baker, 2009) protocol in the Rosetta 
program. RosettaLigand incorporates ligand flexibility by changing torsional angles and 
backbone of the ligand, while optimizing the side chain of the binding pocket. In this 
study, we perturbed the ligand position and orientation randomly with translation of mean 
0.1Å and rotations of mean 3º, respectively. For each case, coordinates of the ligand were 
taken from the crystallographic complex of the bound protein. We computed 10,000 
trajectories to generate a comprehensive ensemble of conformations of receptor-ligand 
complexes for each protein, which also produced a well-converged distinct binding 
funnel in energy score/RMSD plots. Final docked conformations were selected based on 
the lowest free energy pose in the protein-binding site. The lowest free energy pose has 
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the lowest Rosetta energy score amongst all other docked poses. The scoring function of 
Rosetta is a weighted sum of twelve different energy terms including Van der Waals, 
solvation, hydrogen bonding, torsional, Coulombic and harmonic restraints (Meiler & 
Baker, 2006). After selecting the lowest Rosetta energy score pose, we reassessed the 
binding energy score of the complex using X-Score (Wang et al., 2002). X-Score is an 
empirical scoring function developed to re-rank the protein-ligand complex obtained 
from various docking approaches and gives a more accurate estimation of the binding 
free energies. X-Score was also shown to have the best correlation with the experimental 
binding affinities as compared to other available scoring functions in a study by Wang et 
al (Wang et al., 2003). Likewise, our binding affinities obtained by rescoring the lowest 
energy pose with X-Score provide a better correlation with experimental affinities. The 
BP-Dock approach is outlined in Figure 3.1.  
3.2.3 Modeling Unbound Proteins and Non-Native Peptides 
The homology model of CIPP was constructed using MODELLER (Sali & 
Blundell, 1993) with a minimal sequence similarity of 50% to the target. Before 
introducing flexibility in the homolog structure of CIPP, it was subjected to an energy 
minimization of 50 steepest descent iterations followed by 1000 conjugate gradient 
iterations using the AMBER 99SB force field (Hornak et al., 2006), along with a GB 
solvation model (Tsui & Case, 2000). We also modeled mutated unbound proteins for 
HIV-1 Protease and Cytochrome C peroxidase test set. The starting unbound structures 
were obtained from PDB (2PC0 for HIV-1 Protease and 1CCP for Cytochrome C 
peroxidase) (Berman et al., 2000). The mutations corresponding to the desired bound 
protein were introduced in the unbound structure using PyMOL (DeLano), which was 
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followed by an all atom energy minimization on the modeled unbound protein, following 
the same procedure that was performed on CIPP. This all atom energy minimization help 
to 
 
Figure 3.1: Flow chart of BP-Dock docking. In our flexible docking approach using PRS 
model, we generated an ensemble of receptor conformations through several steps: (i) 
sequentially exerting random external force on each single-residue the unbound protein 
structure or homology model, (ii) calculating the response fluctuation vector using 
Perturbation Response Scanning (PRS) method, (iii) constructing the low resolution 
deformed structures (i.e. backbone) using the response vectors after each single residue 
perturbation, (iv) clustering the perturbed conformations using k- clustering method, and 
(v) all-atom minimization of each clustered conformation. Once the multiple receptor 
conformations (MRCs) ensemble was completed, we performed a docking simulation 
using the RosettaLigand option in the ROSETTA package for each minimized structure 
in the ensemble. (vi) Lastly, the binding energies of the bound protein-ligand complexes 
with the lowest Rosetta energy score were evaluated with X-Score.  
 
accommodate the necessary side-chain rotamer changes around the residue subjected to 
the point mutation. For a non-native peptide docking to PDZ proteins, we used the 
  35 
original crystal structure of the native peptide and mutated each position in the native 
peptide to the corresponding amino acid of the desired peptide and performed an all-atom 
energy minimization on the modeled peptide-protein complex using the AMBER 99SB 
force field (Hornak et al., 2006), along with a GB solvation model (Tsui & Case, 2000). 
3.2.4 Ensemble Docking with Backrub 
We used the Backbone Sampling method (Friedland et al., 2009) from the 
RosettaBackrub design server (Lauck et al., 2010) to generate multiple receptor 
conformations for ensemble docking. The server utilizes the "Backrub" method for 
flexible protein backbone modeling that was first described by Davis et al (Meiler & 
Baker, 2006). Briefly, this method randomly makes one of three types of moves: (i) a 
rotamer change (50% of the time), (ii) a local backbone conformational change (Backrub 
move) consisting of a rigid body rotation of a random peptide segment about the axis 
connecting the endpoint Cα atoms (25% of the time), or (iii) a composite move with a 
Backrub change and one or two rotamer changes (25% of the time). After each move, the 
positions of the C-β and H-α atoms were modified to minimize bond angle strain 
(Friedland et al., 2009). We docked these ensembles of proteins obtained from Backrub 
to their respective peptides using RosettaLigand (Meiler & Baker, 2006). 
3.3 Results and Discussion 
3.3.1 Docking Results for the 5 Protein Datasets 
In this study, we applied BP-Dock approach to the unbound structure in order to 
test if we can predict the binding affinities of several peptide/ligands when they are 
docked into an unbound structure. We first compare the performance of our flexible 
docking with rigid docking for 5 different sets of protein-ligand complexes: HIV-1 
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Protease (PR), Carbonic Anhydrase II (CA II), Alcohol Dehydrogenase (AD), Alpha-
Thrombin (AT) and Cytochrome C Peroxidase (CCP). For each set, we had different 
bound structures (i.e. with different ligands) but only one unbound structure. For HIV-
Protease, we performed docking using an apo wide open conformation to test the 
accuracy of BP-Dock approach in predicting the binding specificity observed in a closed 
holo structure using an open unbound form. Thus, we aim to determine whether our BP-
Dock approach can capture the different bound conformations with correct binding 
energies through generating an ensemble of conformations from a single unbound 
structure in a quick and efficient manner. Rigid docking was also performed on crystal 
structures for both bound and unbound structures using RosettaLigand (Meiler & Baker, 
2006). For PR and CCP, we used the modeled unbound structure due to point mutations 
in bound structures (See Methods). The lowest RosettaLigand energy scores and X-
Scores for: (i) rigid bound and unbound docking and (ii) flexible docking for unbound 
structure using BP-Dock for all the 5 different data sets are reported in Table 3.2. The 
available experimental binding affinities for all the test cases were obtained from LPDB 
(Roche et al., 2001) and Astex (Hartshorn et al., 2007) databases, and are reported in 
Table 3.2. The correlation plots of X-Score energies for (i) rigid bound, (ii) rigid unbound 
and (iii) BP-Dock unbound versus the experimental binding free energies for the 5 test 
sets are plotted in Figure 3.2. The X-Score energies of BP-Dock unbound docking have a 
higher correlation with experimental binding energies compared to rigid unbound 
docking for all the five test sets. Interestingly, both the BP-Dock unbound X-Score and 
RosettaLigand energy scores for HIV-Protease show a much better correlation with 
experimental binding energies than rigid unbound docking. Indeed, unbound docking by 
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BP-Dock is even better than rigid bound docking for PR and CA II. Moreover, when we 
compare the RosettaLigand energy scores, we observe that BP-
Dock provides better correlation with experimental binding energies than rigid unbound 
docking for all the five test sets (Figure 3.3). Strikingly, rigid unbound docking scores are 
negatively correlated with the experimental binding energies for CA II, AD and CCP data 
sets when the complexes were not re-evaluated by X-Score. On the other hand, BP-Dock 
performs better than rigid unbound docking and is also better compared to rigid bound 
docking for all the test sets except AD. 
The overall correlation coefficients (R) of X-Score energies with binding experimental 
energies for all the 68 test cases clearly show the success of BP-Dock through 
incorporation of backbone flexibility (R = 0.65). It is significantly higher than rigid 
unbound docking (R = 0.56), and also higher than rigid bound docking (R = 0.60). 
Moreover, when we consider proteins having relatively larger conformational changes 
upon binding (bound-unbound RMSD > 1 Å), we still observe the same trend, in which 
the rigid unbound docking cannot capture correct binding conformations for such cases 
(R = 0.44), whereas, BP-Dock provide a better correlation (R = 0.56) in estimating 
native-like binding affinities, and is even slightly better than rigid bound docking (R = 
0.49). This is due to the fact that rigid docking can only optimize side chains lining the 
binding pocket and cannot sample large backbone movements (or conformational 
changes) associated with binding unlike BP-Dock. Therefore, incorporating backbone 
flexibility in an unbound structure becomes even more crucial in proteins with larger 
RMSD difference. With BP-Dock, we can significantly improve the binding affinity  
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Table 3.2: RosettaLigand energy scores and X-Scores for rigid bound, rigid unbound and 
flexible BP-Dock docking for unbound structures with available experimental data 
 
 
 
 
 
 
 
 
 
Protein 
PDB Code 
Chain 
Length 
ROSETTALIGAND (kcal/mol) X-Score (kcal/mol) 
Exp. ∆G 
(kcal/mol) 
Rigid BP-Dock Rigid BP-Dock 
Bound Unbound Bound Unbound Unbound Bound Unbound Unbound 
(Holo) (Apo) (Holo) (Apo) (Apo) (Holo) (Apo) (Apo) 
 
 
 
 
 
 
 
 
 
HIV Protease 
 
 
 
 
 
 
 
 
 
 
1HBV 3IXO 198 -357.51 -558.7 -390.74 -10.28 -8.78 -9.23 -8.68 
1HEG 3IXO 198 -64.8 -563.82 -402.3 -10.56 -8.19 -8.86 -10.38 
1HIH 3IXO 198 -491.08 -569.36 -397.08 -11.1 -9.33 -10.08 -10.97 
1HIV 3IXO 198 -462.25 -555.32 -393.39 -12.2 -9.13 -10.08 -12.64 
1HPS 3IXO 198 -394.35 -586.28 -416.19 -16.65 -12.55 -14.31 -12.66 
1HTE 3IXO 198 -210.93 -559.65 -383.46 -9.06 -8.36 -8.38 -7.69 
1HTF 3IXO 198 -394.32 -568.62 -402.59 -14.05 -11.04 -11.68 -11.04 
1HTG 3IXO 198 -528.38 -582.81 -413.38 -19.05 -14.77 -14.39 -13.20 
1HVI 3IXO 198 -513.57 -564.07 -401.71 -12.22 -9.85 -10.69 -13.74 
1HVJ 3IXO 198 -496.71 -563.75 -399.83 -12 -10.09 -10.86 -14.26 
1HVK 3IXO 198 -518.85 -568.48 -399.62 -12.53 -9.26 -11.09 -13.79 
1HVL 3IXO 198 -490.64 -565.61 -401.29 -12 -9.98 -10.89 -12.27 
1HVS 3IXO 198 -434.77 -559.28 -408.65 -11.57 -9.84 -10.39 -13.81 
1SBG 3IXO 198 -368.53 -568.57 -405.08 -11.04 -9.14 -9.9 -10.38 
4HVP 3IXO 198 -290.75 -567.84 -381.94 -10.88 -8.77 -9.43 -8.33 
4PHV 3IXO 198 -476.11 -599.01 -432.82 -21.58 -17.6 -18.41 -12.56 
5HVP 3IXO 198 -418.5 -563.39 -398.59 -10.62 -8.62 -8.64 -10.50 
9HVP 3IXO 198 -237.85 -565.45 -403.47 -12.23 -9.73 -10.2 -11.38 
1A30 3IXO 198 -517.82 -538.3 -372.12 -7.48 -6.09 -6.45 -5.77 
1KZK 3IXO 198 -572.92 -545.99 -394.12 -11.78 -9.22 -10.7 -13.94 
 
 
 
 
Carbonic 
Anhydrase II 
 
 
 
 
1OQ5 2ILI 259 -715.26 -756.01 -773.92 -8.52 -8.47 -8.49 -10.29 
1AVN 2ILI 259 -592.57 -751.43 -701.87 -5.79 -5.47 -5.4 -2.88 
1CIL 2ILI 259 -721.24 -752.23 -767.82 -7.51 -7.49 -7.8 -12.94 
1CIM 2ILI 259 -685.56 -752.41 -765.94 -7.23 -7.23 -7.34 -12.1 
1CIN 2ILI 259 -700.59 -752.19 -769.06 -7.24 -7.29 -7.23 -11.97 
1CNW 2ILI 259 -623.88 -758.62 -773.11 -6.24 -6.56 -6.56 -10.6 
1CNX 2ILI 259 -628.09 -759.78 -773.72 -6.67 -6.87 -6.93 -10.11 
1CNY 2ILI 259 -559.46 -758.64 -773.63 -6.63 -6.75 -6.8 -10.78 
1OKL 2ILI 259 -755.5 -756.12 -772.95 -7.8 -7.89 -7.84 -12.39 
 
 
 
Alcohol 
Dehydrogenase 
 
 
 
 
1ADB 8ADH 374 -716.52 -536.87 -1009 -10.47 -8.3 -8.88 -11.45 
1ADC 8ADH 374 -635.01 -539.07 -997.2 -10.41 -8.72 -8.7 -6.42 
1ADF 8ADH 374 -664.17 -535.33 -997.55 -8.16 -8.38 -7.65 -6.24 
1BTO 8ADH 374 -999 -454.08 -962.59 -6.66 -6.4 -6.47 -8.93 
1HLD 8ADH 374 -1001.88 -552.66 -1009.89 -13.33 -10.93 -10.67 -7.58 
1LDE 8ADH 374 -952.57 -536.52 -1005.22 -11.87 -9.52 -9.79 -9.41 
1LDY 8ADH 374 -930.53 -540.04 -1008.14 -12.28 -10.12 -10.03 -11.06 
3BTO 8ADH 374 -1088.23 -546.46 -1006.28 -12.31 -9.89 -9.95 -8.43 
  39 
Table (3.2) continued 
 
 
predictions for proteins with larger conformational changes by integrating both backbone 
and side chain flexibility through our multi-scale approach. 
3.3.2 Cross-Docking Results for HIV-1 Protease 
In cross-docking studies, a ligand A (say, from protein A) is docked to a different 
receptor (say, protein B, bound to a different ligand) to evaluate the performance of a 
docking method in recapitulating the protein conformational changes associated with  
 
Protein 
PDB Code 
Chain 
Length 
ROSETTALIGAND (kcal/mol) X-Score (kcal/mol) 
Exp. ∆G 
(kcal/mol) 
Rigid BP-Dock Rigid BP-Dock 
Bound Unbound Bound Unbound Unbound Bound Unbound Unbound 
(Holo) (Apo) (Holo) (Apo) (Apo) (Holo) (Apo) (Apo) 
Alpha 
Thrombin 
1A4W 1C5L 274 -572.9 -791.4 -787.2 -9.43 -8.92 -8.8 -8.13 
1AE8 1C5L 298 -758.2 -790.99 -784.3 -8.42 -8.19 -8.12 -8.99 
1BMM 1C5L 295 -445.95 -796.63 -791.14 -9.15 -9.07 -9.09 -9.75 
1BMN 1C5L 292 -513.89 -792.21 -789.85 -9.66 -9.3 -9.44 -11.58 
1D3D 1C5L 290 -626.78 -794.97 -789.76 -10.16 -9.89 -9.23 -3.27 
1D3P 1C5L 290 -612.8 -796.24 -790.58 -9.43 -9.5 -8.42 -2.93 
1D4P 1C5L 290 -605.2 -796.04 -791.08 -9.64 -9.93 -9.2 -2.28 
1DWB 1C5L 298 -798.4 -783.67 -777.29 -6.7 -6.63 -6.61 -3.98 
1DWC 1C5L 298 -800.78 -789.23 -784.77 -8.82 -8.76 -8.55 -10.6 
1DWD 1C5L 298 -811.38 -797.11 -791.32 -10.22 -10.04 -9.83 -11.57 
1HDT 1C5L 303 -217.53 -795.04 -789.04 -9.66 -9.59 -9.52 -10.66 
1UVS 1C5L 268 -603.35 -788.95 -782.21 -8.74 -8.84 -8.62 -7.41 
1OYT 1C5L 306 -825.83 -792.24 -791.47 -9.23 -9.11 -8.94 -9.71 
 
 
 
 
Cytochrome 
C Peroxidase 
 
 
 
 
1AC4 1CCP 291 -753.91 -887.07 -897.53 -5.3 -5.29 -5.27 -3.85 
1AC8 1CCP 291 -790.67 -889.01 -899.96 -6.42 -6.28 -6.29 -4.78 
1AEB 1CCP 291 -790.68 -889.59 -900.82 -5.8 -5.7 -5.69 -4.81 
1AED 1CCP 291 -788.54 -886.36 -897.54 -6.14 -6.03 -6.04 -5.86 
1AEE 1CCP 291 -803.13 -893.8 -904.99 -5.49 -5.83 -5.33 -3.96 
1AEF 1CCP 291 -792.96 -893.39 -914.1 -6.57 -6.21 -6.62 -6 
1AEG 1CCP 291 -795.32 -893.45 -904.04 -6.26 -6.11 -6.09 -5.99 
1AEH 1CCP 291 -793.03 -897.21 -902.31 -6.23 -6.01 -6.02 -4.96 
1AEJ 1CCP 291 -790.57 -891.97 -902.97 -6.07 -6 -5.98 -5.21 
1AEK 1CCP 291 -793.62 -891.75 -902.36 -6.76 -6.64 -6.65 -4.92 
1AEM 1CCP 291 -795.62 -894.37 -905.32 -6.48 -6.4 -6.4 -4.92 
1AEN 1CCP 291 -753.99 -887.28 -898.04 -6.73 -6.06 -6.74 -7.07 
1AEO 1CCP 291 -764.09 -894.73 -904.55 -6.47 -6.36 -6.34 -5.02 
1AEQ 1CCP 291 -790.59 -891.23 -901.78 -6.31 -6.26 -6.26 -4.73 
1AES 1CCP 291 -777.02 -890.29 -900.74 -5.69 -5.59 -5.58 -4.33 
1AET 1CCP 291 -808.57 -890.68 -900.81 -5.78 -5.76 -5.73 -5.82 
1AEU 1CCP 291 -756.73 -891.24 -901.34 -5.92 -6 -6 -5.94 
1AEV 1CCP 291 -783.98 -891.28 -902.13 -6.44 -5.85 -5.85 -6.06 
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Figure 3.2: Correlation plots of binding energy scores evaluated from X-Score vs. 
experimental binding energies for HIV-1 Protease (PR), Carbonic Anhydrase II (CA II), 
Alcohol Dehydrogenase (AD), Alpha-Thrombin (AT) and Cytochrome C Peroxidase 
(CCP). 
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Figure 3.3: Correlation plots of RosettaLigand energy scores vs. experimental binding 
energies for HIV-1 Protease (PR), Carbonic Anhydrase II (CA II), Alcohol 
Dehydrogenase (AD), Alpha-Thrombin (AT) and Cytochrome C Peroxidase (CCP). 
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Figure 3.4: The plot of average accuracy of χ1 angle prediction as a function of χ1 angle 
threshold (°) for BP-Dock cross-docking and rigid cross-docking on HIV-1 Protease 
bound structures (A) for two flexible residues (two ARG8’s), and (B) for four flexible 
residues (two ARG8’s and two ILE50’s). 
 
ligand binding. Therefore, in this study, we performed cross-docking using the flexible 
BP-Dock as well as rigid docking approach on Protein B–ligand A complex for the 20 
bound structures from the HIV-1 Protease set leading to 20×20, 400 test cases. The 
lowest RosettaLigand energy docked pose form the Protein B–ligand A cross-docking 
experiment is then compared with the experimental bound structure of protein A–ligand 
A to check the accuracy of prediction of conformational changes, following the analysis 
of Osterberg et al (Osterberg et al., 2002) and Shin & Seok (Shin & Seok, 2012). We 
investigated the flexibility of two ARG8’s and two ILE50’s from the two chains of HIV-
1 Protease. ARG8 and ILE50 were purposefully selected since they have the largest steric 
clashes caused by swapping ligands (Morris et al., 2009). Thus, we compare the 
prediction accuracy of the side-chain χ1 angle of the cross-docked complex (i.e. ligand A 
from Protein A, in complex with receptor from Protein B) to χ1 angle of the native 
complex (i.e. experimental structure of Protein A bound to ligand A) for flexible residues 
  43 
ARG8 and ILE50 from the two chains. The predicted χ1 angle was considered accurate if 
its value is within a range (angle threshold (°)) of native χ1 angle. The plots of prediction 
accuracy of χ1 angle as a function of χ1 angle threshold (°) for the flexible BP-Dock and 
rigid cross-docking results are shown in Figure 3.4. The plots for two flexible residues 
(ARG8 of the two chains) are shown in Figure 3.4(A) and that for four flexible residues 
(two ARG8s and two ILE50s) are shown in Figure 3.4(B). Clearly, for both the cases, 
BP-Dock approach show better prediction accuracies for χ1 angle, compared to the rigid 
cross-docking, which confirmed that even in the case of lower backbone deviation, 
incorporating backbone flexibility improves proper side-chain orientations during 
docking. 
3.3.3 Analysis for 20 Individual Bound-Unbound Proteins 
Table 3.3 shows the RosettaLigand energy scores and X-Scores of 20 individual 
proteins for: (i) rigid bound and unbound docking with RosettaLigand and (ii) flexible 
docking for unbound structure using BP-Dock. In most of the cases, rigid docking with 
bound structure show a better affinity prediction as compared to rigid docking of 
unbound structure. This is unsurprising since the prediction accuracy of docking 
calculations decreases with the quality of receptor from bound to unbound protein to 
modeled structures (McGovern & Shoichet, 2003). However, the flexible BP-Dock 
scheme do a similar or better job in indicating bound-like binding scores for most of the 
unbound proteins as compared to rigid unbound docking. Overall, these results support 
the fact that improvement obtained with our flexible docking approach relies on correctly 
predicting binding relevant motions through perturbation of unbound structures. 
Moreover, in order to have a better understanding of the advantages and limitations of 
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BP-Dock, we investigated various test cases separately, including the receptors with 
larger conformational changes upon binding, the receptors with larger chains, and those 
in complex with large peptides. 
3.3.4 Analysis for Proteins having Critical Conformational Changes upon Binding 
For proteins such as Aldose Reductase, the bound and unbound conformations do 
not necessarily have a large RMSD difference; however, loops and regions near the 
binding pocket may differ significantly. These loops are often related to diverse 
biological functions that can change their conformation upon ligand binding. For 
example, the bound (PDB id: 2FZB) and unbound (PDB id: 2ACR) structures of Aldose 
Reductase (AR) are quite similar to each other with an RMSD of 0.36 Å, yet there is a 
significant difference in the loop region near the binding pocket (residues 121- 130) as 
shown in Figure 3.5(A). The all-atom RMSD of the loop between bound and unbound 
conformation is ~ 0.6 Å. Upon applying perturbations (i.e. an external Brownian kick) to 
the unbound structure of AR and computing response fluctuation profiles of the whole 
chain, we generated an ensemble of conformations that mimics the complete ligand- 
binding event. Interestingly, one conformation in the ensemble is very similar to the 
native bound-like conformation as shown in blue in Figure 3.5(A), where the loop 
perfectly aligns with the bound conformation. 
This indicate the capability of our flexible approach in correctly predicting the 
binding induced conformational changes when an unbound form of protein is used, even 
without the presence of any ligand. Moreover, it also show that BP-Dock is distinctly 
different from other multiple receptor docking approaches based on normal mode 
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analysis. Indeed, a recent study has shown that selecting the most relevant mode/modes 
related to binding is rather difficult in those approaches and makes the method more  
Table 3.3: RosettaLigand energy scores and X-Scores for rigid bound, rigid unbound and 
flexible BP-Dock docking for unbound structure 
 
Protein 
Peptide/ 
PDB Code 
ROSETTALIGAND (kcal/mol) X-Score (kcal/mol) 
Ligand Rigid     BP-Dock Rigid BP-Dock 
  Bound Unbound Bound Unbound Unbound Bound Unbound Unbound 
  
(Holo) (Apo) (Holo) (Apo) (Apo) (Holo) (Apo) (Apo) 
PSD-95 KQTSV 1BE9 1BFE -230.78 -166.29 -273 -7.27 -7.38 -7.32 
GRIP ATVRTYSC 1N7F 1N7E -241.76 -218.37 -229.36 -8.14 -7.74 -7.82 
Syntenin DSVF 1OBX 1NTE -208.24 -215.09 -205.67 -7.29 -6.95 -7.16 
Syntenin NEFYA 1OBY 1NTE -225.2 -221.41 -211.88 -7.99 -7.5 -7.85 
Syntenin FFEEL NA 1NTE -179.21 -121.47 -183.71 -6.83 -6.24 -7.02 
SH3 domain of GRB2 RHYRPLPPLP 1IO6 1GFD -126.24 -131.36 -146.09 -8.12 -7.4 -7.48 
SH3 domain of GRB2 VPPPVPPRRR NA 1GFD -119.31 -99.82 -127.97 -7.98 -7.01 -7.37 
Cyclophilin A AP 2CYH 2CPL -474.43 -476.3 -479.82 -6.65 -6.21 -6.52 
Cyclophilin A HAGPIA 1AWQ 2CPL -479.63 -493.49 -497.5 -7.86 -7.1 -7.16 
Methyltransferase NWETF 1BC5 1AF7 -598.01 -642.08 -781.48 -9.12 -8.39 -8.65 
Aldose Reductase TOL4 2FZB 2ACR -782.2 -721.69 -876.52 -8.73 -8.04 -8.96 
Aldose Reductase IDD552 1T40 2ACR -799.57 -786.34 -873.39 -8.96 -5.95 -8.78 
Carboxypeptidase HFA 2CTC 1M4L -890.48 -883.57 -972.95 -7.17 -6.96 -7.29 
Carboxypeptidase FVF 7CPA 1M4L -729.44 -882.88 -974.06 -10.18 -8.86 -9.79 
TIM 2PG 4TIM 3TIM -1170.66 -871.05 -1454.37 -6.46 -6.02 -6.09 
TIM G3P 6TIM 3TIM -1070.71 -871.29 -1457.93 -6.34 -5.76 -6.01 
ABP NLA 1LRH 1LR5 -382.41 -372.43 -402.68 -8.09 -8.19 -8.24 
Acetylcholinesterase Huperzine A 1GPK 1EA5 -1564.29 -1546.05 -1651.73 -8.72 -8.55 -8.76 
Adenosine Deaminase FR233624 1UML 1VFL -846.1 -943.34 -1098.53 -9.73 -9.93 -9.89 
Quinone Reductase 2 Resveratrol 1SG0 1QR2 -1415.7 -1310.89 -1338.84 -11.55 -11.22 -11.67 !   
restricted, since some higher frequency modes can be responsible for binding induced 
conformational changes (Dietzen, 2012). However, with the BP-Dock approach, the most 
relevant modes are automatically induced by perturbing the individual residues of the 
receptor; therefore, we do not need to search for correct modes that are most related to 
binding. 
The flexible BP-Dock results for docking of four Tolrestat molecules (TOL4) to 
unbound AR show a binding energy prediction of -8.96 kcal/mol (RosettaLigand Score: -
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876.52 kcal/mol), even more favorable than rigid docking prediction of bound structure 
(X-Score: -8.73 kcal/mol, RosettaLigand score: -782.2 kcal/mol). On the other hand, the 
rigid docking of unbound AR lead to a less favorable binding energy score for TOL4 (X-
Score: -8.04 kcal/mol, RosettaLigand score: -721.69 kcal/mol). When we compare the 
docked poses of unbound conformation from rigid and flexible docking, we observe that 
the ligand formed only 3 hydrogen bonds in case of rigid unbound docking (Figure 
3.5(B)) whereas, TOL4 formed four hydrogen bonds with Tyr 48, Trp111, Leu301 and 
Cys303 in case of BP-Dock docking (Figure 3.5(C)). The loss of a hydrogen bond can 
possibly explain a less favorable binding energy score for rigid unbound docking, as 
these residues have been shown critical for binding (Sotriffer et al., 2004; Steuber et al., 
2006). Earlier, Sotriffer et al. (Sotriffer et al., 2004) have shown that the specificity 
binding region of AR, constituted by the residues Leu300, Trp111, and Thr113, can only 
be accessible to ligand by the correct orientation of Leu300 (Sotriffer et al., 2004). 
Interestingly, in the analysis of BP-Dock pose, we observe that side chain of Leu300 and 
Trp111 get shifted to open up a wider space in the binding pocket compared to that of the 
unbound complex, thus avoiding any clashes with TOL4. This emphasizes that by 
introducing perturbations and computing the response, our approach may have led to this 
specific orientation change, which in return made the binding site of Aldose Reductase 
much more feasible and approachable to Tolrestat, especially near the specificity region. 
We also analyzed large proteins having different conformational changes upon 
binding to several different ligands such as Carboxypeptidase (CPA) (307 residues) and 
Trypanosomal Triosephosphate Isomerase (TIM) (250 residues in each chain A and B). 
For both of these test cases, the previous docking studies have failed in predicting the 
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correct binding poses (Meiler & Baker, 2006; Davis & Baker, 2009). From our docking 
results, we observe that the RosettaLigand energy scores for rigid bound docking for 
CPA indicate higher affinity for L-Phenyl Lactate (or HFA) than FVF ligand, in 
contradiction to experimental results (Teplyakov et al., 1993) (Kim & Lipscomb, 1991). 
On the other hand, RosettaLigand energy scores of flexible BP-Dock for unbound 
structure of CPA are in agreement with the experimental observations (Table 3.3). 
However, re-scoring the lowest binding energy poses with X-Score help in correctly 
estimating the binding energy preferences for all the three type of dockings (rigid bound, 
rigid unbound and BP-Dock unbound). Nonetheless, for the SH3 domain of GRB2 and 
Cyclophilin A, we also observe that the RosettaLigand energy scores for rigid docking of 
bound structure are less favorable than those for the rigid unbound structure, but re-
scoring help again in correcting this anomaly. Furthermore, for the TIM protein, both the 
RosettaLigand energy scores as well as X-Scores for rigid bound docking failed in 
correctly predicting the binding affinities for the two ligands: 2-phosphoglycerate (2PG) 
and Glycerol-3-phosphate (G3P); whereas BP-Dock succeeded in correctly predicting 
these differences (Noble et al., 1991).  
3.3.5 Analysis of PDZ Domains 
We also tested whether we can predict the binding selectivities of several PDZ 
domain proteins (PDZs), where the backbone dynamics are crucial in binding affinity 
predictions (Gerek & Ozkan, 2010; Gerek et al., 2009; Smith & Kortemme, 2010). PDZ 
domains have been categorized into three main classes according to the specificity of the 
interaction depending on its C-terminal four amino acids of their binding peptides. Class I  
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Figure 3.5: (A) The bound (2FZB) and unbound (2ACR) ribbon diagrams of Aldose 
Reductase are shown in red and blue, respectively. The RMSD for the loop region 
(encircled, Phe121-Val130) between the bound and unbound structures is ~ 0.6 Å. One of 
the perturbed conformations using the BP-Dock scheme (shown in green) is similar to the 
bound structure, especially around the specified loop.  Hydrogen bond interactions of the 
best docked poses from unbound docking of four Tolrestat molecules with (B) rigid 
docking, and (C) with flexible BP-Dock. The specified loop region is colored red. The 
hydrogen bond interactions are studied with Chimera (Pettersen et al., 2004) and the 
images are prepared using PyMOL (DeLano). 
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Table 3.4: Rigid and flexible docking predictions for homolog structure of CIPP 
 
Homolog 
Protein Peptide 
Peptide 
Class 
RosettaLigand Score (kcal/mol) X-Score (kcal/mol) 
Rigid 
Unbound 
BP-Dock 
Unbound 
Rigid 
Unbound 
BP-Dock 
Unbound 
  
  
     CIPP 
 
  
KQTSV I -135.93 -150.73 -7.07 -7.08 
DSVF I -130.02 -146.03 -6.43 -6.33 
NEFYA II -136.26 -150.24 -7.09 -6.92 
EYLGLDVPV  II -137.92 -151.87 -7.15 -7.49 
 
type PDZs bind to a C-terminal motif with the sequence [X-Ser/Thr-X-U-COOH], Class 
II type PDZs prefer the sequence [X-U-X-U-COOH], and Class III type binds to the 
sequence [X-Glu/Asp-X-U-COOH] where X is any amino acid and U is a hydrophobic 
amino acid. Although the PDZ binding site is well defined and PDZ motifs are classified 
based on their sequence type, there is still little information available on the binding 
affinity and stoichiometry of PDZ binding motifs and blocking peptides (Songyang et al., 
1997). We focused on the most common Class I and Class II types for this study. 
Among our test PDZ cases, PSD-95 binds to Class I peptide, whereas GRIP binds 
to Class II (Gerek & Ozkan, 2010). The docking results for PDZ domain proteins (Table 
3.3) show that the rigid unbound docking fail to predict bound-like affinities for both 
PSD-95 and GRIP. However, BP-Dock unbound docking show similar or more favorable 
(for PSD-95) binding energy scores than rigid bound docking. Furthermore, BP-Dock 
results on the PDZ2 domain of Syntenin indicate that it has dual specificity for Class I 
(IL5R-α) and Class II (Syndecan) peptides with a slightly higher affinity towards Class II 
peptide. This result is also consistent with experimental observations indicating that it 
binds slightly better to Syndecan (Kd ~ 2.9 µM) than to IL5R-α (Kd ~ 43.8 µM) (Kang et 
al., 2003). Moreover, we were able to predict that Merlin (-FFEEL) peptide has the least 
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significant affinity toward PDZ2 domain of Syntenin as also shown experimentally (Kd ~ 
1 mM) (Kang et al., 2003). 
Furthermore, we also looked at the binding selectivities of the homolog structure 
CIPP. One of the most difficult tasks for any docking protocol is to correctly predict the 
binding affinities for homolog structures. Therefore, in this study, we applied our flexible 
docking approach to a homology model for CIPP of PDZ, whose binding selectivity has 
already been verified experimentally (Kang et al., 2003). Table 3.4 shows the lowest 
RosettaLigand energy scores and X-Scores of the modeled CIPP with Class I (Cript and 
IL5R-α) and Class II (Syndecan and Erbin) peptides for rigid and our flexible docking 
method. Figure 3.6(A) shows the RosettaLigand energy score vs. RMSD plot for the BP-
Dock complex of CIPP with Class I (IL5R-α) and Class II (Syndecan) peptides. The 
formation of a well-converged distinct binding funnel in energy score/RMSD plots 
indicates successful docking (Meiler & Baker, 2006). CIPP prefer to bind Syndecan with 
a higher affinity of -6.92 kcal/mol as compared to -6.33 kcal/mol for IL5R-α, which is in 
agreement with the experimental results (Kang et al., 2003). Further analysis of CIPP 
complex with both Class I and Class II peptides show that CIPP residues formed 
hydrogen bonds with both IL5R-α (Class I) and Syndecan (Class II) as shown in Figure 
3.6(B). Syndecan peptide forms 5 hydrogen bonds via the interaction of three crucial 
residues Leu 13, Ile 15 and Lys 68. However, IL5R-α peptide forms only 3 hydrogen 
bonds with Leu 13 and Lys 68. The lesser number of hydrogen bonds formed by IL5R-α 
peptide can possibly explain its lower binding affinity with CIPP. 
 
  51 
 
Figure 3.6: (A) The RosettaLigand energy score versus RMSD of the docked complex of 
CIPP with Class I and Class II peptides of Syntenin. (B) The hydrogen bond interactions 
of CIPP with Class I and Class II peptides, as analyzed using the best docked pose 
obtained from flexible BP-Dock docking. The ribbon diagrams are prepared using 
PyMOL (DeLano). 
 
Table 3.5: Comparison of flexible docking for ensembles generated with BP-Dock vs. 
Backrub 
 
!
Protein Peptide Peptide Classification 
Peptide 
Binding 
Specificity 
RosettaLigand Score (kcal/mol) X-Score (kcal/mol) 
Rigid 
Bound 
BP-Dock 
Unbound 
Backrub 
Unbound 
Rigid 
Unbound 
BP-Dock 
Unbound 
Backrub 
Unbound 
PSD-95 KQTSV I I -230.78 -273 -221.83 -7.27 -7.32 -6.66 
PSD-95 ATVRTYSC II I NA -271 -223.04 NA -7.1 -7.31 
GRIP ATVRTYSC II II -241.76 -229.36 -218.37 -8.14 -7.82 -7.74 
GRIP KQTSV I II NA -223.97 -215.32 NA -7.1 -7.15 
Syntenin DSVF I I and II both -208.24 -205.67 -219.09 -7.29 -7.16 -7.18 
Syntenin NEFYA II 1 and II both -225.2 -211.88 -219.57 -7.99 -7.85 -6.99 
CIPP KQTSV I II NA -150.73 -149.6 NA -7.08 -7.23 
CIPP EYLGLDVPV II II NA -151.87 -154.6 NA -7.49 -7.29 
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3.3.6 Analysis of Backrub Results 
Another commonly used method to incorporate backbone movements in Rosetta 
is the “Backrub” method (Friedland et al., 2009; Davis et al., 2006). This method 
randomly perturbs a segment of 2–12 residues through a rigid body rotation by an angle 
of up to 11º-40º to model the conformational changes in a protein (Friedland et al., 2009; 
Davis et al., 2006). For comparison, we also generated ensembles of PDZs using the 
RosettaBackrub server (Lauck et al., 2010), and we used these ensembles for docking 
with RosettaLigand. Table 3.5 shows the docking results of six PDZ-ligand pairs for the 
ensembles generated by both Backrub and BP-Dock. We observe that by using BP-Dock, 
we can discriminate the higher binding preferences of Syntenin towards Syndecan (i.e. 
the binding energies evaluated from X-Score for the lowest RosettaLigand score 
complexes are -7.85 kcal/ mol and -7.16 kcal/mol for Syndecan and IL5R-α peptides, 
respectively). However, Backrub ensemble docking failed in estimating the binding 
preferences of CIPP for IL5R-α and Syndecan peptides (i.e. the binding energies of the 
lowest score docked poses are -6.99 kcal/ mol for Syndecan peptide and -7.18 kcal/mol 
for IL5R-α peptide). 
For a more rigorous comparison, we also performed cross-docking on PSD-95 and GRIP. 
We selected Liprin, a Class II peptide for docking to PSD-95 and CRIPT, a Class I 
peptide for docking to GRIP. As shown in Table 3.5, the binding energy of BP-Dock 
pose obtained with X-Score indicates a higher affinity for the Class I peptide compared to 
the Class II peptide. Similarly, GRIP prefers Class II peptide in comparison to the Class I 
peptide. Overall, BP-Dock ensemble docking is successful in predicting the binding 
affinities of PSD-95 and GRIP. Backrub ensemble docking also correctly predicts the 
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preference of GRIP towards the Class II peptide. However, in the case of PSD-95, the 
binding energy scores indicates a higher affinity for the Class II (-7.31 kcal/mol) than the 
Class I peptide (-6.66 kcal/mol), contradictory to the results from previous studies (Gerek 
& Ozkan, 2010). Figures 3.7(A-B) shows the self-docking and cross-docking energy 
score/RMSD plots of PSD-95 when docked using the ensembles of (i) BP-Dock and (ii) 
Backrub. In order to further investigate the difference in binding energy scores for the 
two flexible ensemble dockings, we analyzed the hydrogen bond pattern of the 
complexes obtained from these two separate ensemble docking. The lowest energy 
complex obtained from BP-Dock show that P-0 and P-2 residues of the Class I peptide 
form five hydrogen bonds with Leu18, Phe20, Ile22 and Ser34 of PSD-95 (Figure 
3.7(C)). On the other hand, the docked pose with the lowest energy score obtained from 
backrub indicates that the peptide forms only three hydrogen bonds with Leu18, Phe20 
and Glu68 (Figure 3.7(D)). Moreover, analysis of cross-docking with the Backrub 
ensemble shows that the number of hydrogen bonds have been increased to five in the 
case of the Class II peptide docked pose. This might have attributed to an increase in the 
binding affinity of PSD-95 for the Class II peptide when the Backrub ensemble was used 
for docking. Overall, this comparison suggests that in unbound ensemble docking, 
accuracy in predicting binding affinity increases when the ensemble consists of correct 
binding induced conformations. Indeed, Backrub and BP-Dock can be merged to increase 
overall accuracy. 
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Figure 3.7: The RosettaLigand energy score versus RMSD of PSD-95 with CRIPT and 
Liprin peptides obtained from the flexible docking with (A) BP-Dock and (B) Backrub 
ensembles. The hydrogen bond interactions of the CRIPT peptide with PSD-95 as 
analyzed using the lowest energy docked pose obtained from (C) BP-Dock and (D) 
Backrub ensembles. The ribbon diagrams are prepared using PyMOL (DeLano). 
 
3.4  Conclusion 
Incorporation of backbone flexibility helps in sampling the bound-like 
conformation; which is crucial for accurate complex geometry and binding affinity 
predictions especially for docking with unbound structures. This is because small 
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conformational changes in the backbone upon protein binding can lead to significant 
changes in the side-chain orientations. Our analysis of unbound docking in comparison 
with bound docking suggested that conformations generated through perturbations should 
simulate similar changes that occur when a ligand interacts with the receptor during the 
binding event in order to increase the accuracy of docking. The most intriguing aspect of 
the BP-Dock approach is that we were able to mimic the induced effects of peptide/ligand 
binding using the unbound structure, even in the absence of any ligand or peptide. Thus, 
BP-Dock approach can be utilized to increase the accuracy of binding scores when 
unbound structures or unbound models are used. 
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CHAPTER 4 
 
BINDING ENERGY DETERMINANTS OF PDZ-PICK1 INTERACTIONS  
 
As excerpted from: 
Bolia, A., Gerek, Z. N., Keskin, O., Ozkan, S. B. and Dev, K. K.“The binding affinities of 
proteins interacting with the PDZ domain of PICK1,”Proteins 80, 1393-1408 (2012) 
4.1 Introduction 
PDZ (PSD95/DlgA/Zo-1) domains are common to over 150 proteins that are 
otherwise unrelated (Ponting, 1997). These domains are ~90 residues long and consist of 
six β-strands (βA to βF) and two α-helices (αA and αB).  In canonical PDZ domains, the 
PDZ domain binds the C-terminus-located PDZ motif of its interacting partner in an 
elongated groove between the βB sheet and the αB helix of the PDZ domain that is 
termed the PDZ binding groove (Jemth & Gianni, 2007). The amino acids in PDZ 
domains are numbered according to their topographical location, for example, αB1 is the 
first residue on the αB helix (Sheng & Sala, 2001). The selectivity of a PDZ domain for 
its ligands is dictated by the first residue of the α-helix B (αB1) of the PDZ domain. The 
residue in the αB1 position of a type I PDZ domain is histidine, in type II is generally 
hydrophobic and in type III is usually tyrosine (Sheng & Sala, 2001). The amino acids of 
PDZ motifs (or ligands) are numbered in elation to the residue at the extreme C-terminus, 
which is referred to as position 0 (P0).  The next residue from the C-terminus is said to 
occupy the -1 position (P-1).  Type I PDZ domains bind PDZ motifs consisting of X-
Thr/Ser-X-hydrophobic residues, type II recognize a X-hydrophobic-X-hydrophobic 
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residue motif, while type III interact with a X-Asp-Glu-X-hydrophobic residue motif; 
where X denotes any amino acid  (Sheng & Sala, 2001). The relatively loose consensus of 
PDZ motifs allows PDZ domains to bind to a range of ligands.   
Protein interacting with C kinase (PICK1) is 416 residues in length containing a 
single N-terminal PDZ domain that interacts with the PDZ motifs of several proteins, 
which have roles in synaptic plasticity (Dev et al., 2000; Gardner et al., 2005; Hanley & 
Henley, 2005; Jin et al., 2006; Kim et al., 2001; Lin & Huganir, 2007; Terashima et al., 
2008; Xia et al., 1999), neuronal cell morphology (Rocca et al., 2008), and 
mitochondrial-dependent apoptosis (Wang et al., 2007). The functions of PICK1 are 
largely fulfilled by controlling the trafficking of its binding partners and by facilitating 
their phosphorylation by recruiting protein kinase C-α (PKCα) (Staudinger et al., 1997). 
The proteins interacting with PICK1 have roles in epilepsy (Bertaso et al., 2008; Zhang et 
al., 2008), pain (Baron et al., 2002; Garry et al., 2003), and also in brain trauma, stroke, 
excitotoxicity and cell death (Bell et al., 2009; Dixon & Edwards, 2009; Joch et al., 
2007). Recent evidence from genetic association studies and characterization of PICK1 
knockout animals suggests a role for PICK1 in drug abuse and dependence, 
schizophrenia and psychosis (Beneyto & Meador-Woodruff, 2006; Bousman  et al., 2009; 
Dev & Henley, 2006; Dracheva et al., 2005; Fujii et al., 2006; Ghasemzadeh et al., 2009; 
Hong et al., 2004; Ishiguro et al., 2007; Matsuzawa et al., 2007). PICK1 has also been 
reported to be expressed in insulin-producing pancreatic beta-cells where it may play a 
role in the neuroendocrine system (Jensen et al., 2009).   
The PICK1 residues that interact with P-2 and P0 residues of PDZ motifs have 
been best studied. Interestingly, for the ‘P-2 binding pocket’, Lys83 (usually a histidine in 
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other PDZ domains) in PICK1 creates a hydrogen bond with P-2 residues to preserve 
class I motif binding and a hydrophobic interaction to satisfy class II motif binding 
(Elkins et al., 2007; Madsen et al., 2005; Perez et al., 2001). Additional residues involved 
in interaction with P-2 residues include Thr82, Val84 and Ala87 in the αB helix of PICK1 
(Elkins et al., 2007; Madsen et al., 2005). There are also a number of residues in PICK1 
that create a ‘P0 binding pocket’. Firstly, the PDZ domain of PICK1 contains an 8–9 
amino acid carboxylate (-COO-) binding domain (CBD) containing the residues Lys27 
and Asp28 (‘KD motif’) commonly found in Type II PDZ domains interact with P0 
residues (Dev et al., 2000; Staudinger et al., 1997). Secondly, the Ile37 residue in the βB 
strand of PICK1 plays a critical role in interaction with P-2 and P0 residues. Thirdly, the 
carboxylate binding motif comprises GLGF motif, which in PICK1 are residues Leu32-
Ile33-Gly34-Ile35 (LIGI motif) in the βB sheet. The residues Ile33 and Ile35 of the LIGI 
motif and the Val86, Ala87, Ile90 residues of the αB helix also interact with P0 residues of 
PDZ motifs (Madsen et al., 2005). Residues at P0 and P-2 also seem to influence each 
other, for example a small residue at P0 (valine) would allow Ile37 in PICK1 to adopt 
multiple conformations allowing versatility of the P-2 binding pocket (Elkins et al., 
2007).   
There are over 150 proteins that contain PDZ domains, making this a large family 
of potential drug targets. However, to date, PDZ interactions represent a drug target that 
still remains largely untapped (Dev et al., 2004). Recently, drugability of PICK1 has been 
suggested by discovery of a lead compound, FSC231, which inhibits PICK1 interactions 
(Thorsen et al., 2010; Bach et al., 2010). Recent studies have also helped characterize the 
structure-activity relationship of the various domains found in PICK1 giving insight into 
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the binding properties of its PDZ domain. In this study, we extended the application of 
BP-Dock to further characterize the binding affinities of all the major PICK1 interacting 
proteins. Here, we report the binding affinities of all PDZ motifs know to interact with 
PICK1. These results further elucidate the determinants of PICK1 binding and may aid in 
the development of therapeutic agents aimed at regulating specific PICK1 interactions.  
4.2 Methods 
4.2.1 Dataset 
All PICK1 PDZ domain structures interacting with peptides listed in Table 4.1 
were analyzed in this study. The atomic coordinates for the proteins used in this study 
were obtained from RCSB Protein Data Bank (www.rcsb.org), with PDB Ids 2GZV, 
2PKU and 1GZV. The crystal structure of PICK1 protein bound with the PKCα peptide 
(PDB code: 2GZV) was retrieved from the PDB (http://www.rcsb.org/pdb) (Berman et 
al., 2000). This structure was used as a template and the following procedure was carried 
out in our docking calculations: first, the original PKCα peptide was redocked into a 
known PDZ domain of the bound conformation (self-docking); then, the computational 
point mutations were introduced into the X-ray structure of the PKCα peptide via Swiss 
PDB Viewer (Guex & Peitsch, 1997) to obtain other peptides listed in Table 4.1.   
4.2.2 Rescoring with DrugScore 
BP-Dock docking was performed for all the peptides listed in Table 4.1 with the 
ensemble of structures generated for PICK1 using PRS as discussed in Chapter 3. 
However in this study, instead of using X-Score (Wang et al., 2002)for rescoring the 
lowest free energy pose, we re-assessed the binding energy score of this complex using 
DrugScore (Gohlke et al., 2000). Thus, we submitted the receptor part of the docked pose 
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in PDB format and the ligand coordinates in mol2 format into DrugScore online 
(http://pc1664.pharmazie.uni-marburg.de/drugscore/). DrugScore is a knowledge-based 
scoring function for protein-ligand interactions that employs statistically derived pair 
potentials using the distance-dependent occurrence frequencies by which a particular 
ligand atom type is found in contact with a protein atom type. Higher negative values 
indicate a higher binding affinity prediction. With DrugScore, the binding selectivity 
preferences for various peptides of PICK1 PDZ domain proteins were found to be more 
significant than others. 
4.3 Results and Discussion 
4.3.1 Binding Affinities of PICK1 Interacting Proteins 
To date almost 60 proteins have been shown to interact with PICK1, which were 
sorted according to their PDZ binding type (Table 4.1). Using BP-Dock docking 
approach (see methods in Chapter 3 for details), we computed the binding affinities of all 
the PDZ motifs known to interact with PICK1 (Figure 4.1). This data displays the poses 
of PICK1 complexes corresponding to the lowest binding energies and their re-scored 
binding affinity values. Importantly, the predicted binding energy scores agree 
qualitatively with experiments where the data is available. For example, the dopamine 
transporter (DAT) peptide (-WLKV) binds to the PDZ domain of PICK1 with higher 
affinity than the PKCα peptide (-QSAV) (Madsen et al., 2005). In agreement the 
predicted binding affinity of DAT (-291.93 kcal/mol) was found to be higher than PKCα 
(-217.18 kcal/mol). 
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Table 4.1: PDZ interactions are indicated as PDZ, with PDZ binding motif residues and 
type of binding motif in brackets (I and II, or X for atypical) 
 
 
Interacting Protein Family 
 
Family Members 
 
Binding site 
 
Reference 
 
LDL receptor-related protein  
 
LRP1B PDZ – ETVA (II) Shiroshima et al 2009 
 
Glutamate transporter 
 
GLT1b PDZ – ETCI (I) Bassan et al 2008 
 
Coxsackie B & adenovirus receptor 
 
CAR PDZ – GSIV (I) Excoffon et al 2004 
 
Kainate receptors (KAR) 
 
GluR5(2b), (2c), GluR6 PDZ – ETVA (I) Hirbec et al 2003 
 
Guanine-nucleotide-exchange factor 
 
Kalirin-7 PDZ – STYV (I) Penzes et al 2001 
 
Protein Kinase C 
 
PKCα PDZ – QSAV (I) Staudinger et al 1995; 1997 
 
Protein phosphatase 
 
Calcineurin (phosphatase 2B) PDZ – VDV (II) Iida et al 2008 
 
E3 ubiquitin ligase 
 
Parkin PDZ – WFDV (II) Joch et al 2007 
 
Nicotinic Acetylcholine receptors 
 
α7 nAChRs PDZ – c-term (X) Baer et al 2007 
 
Cell-adhesion molecules 
 
Nectin 1α, 2α, 2δ, 3α, 3β, 4 PDZ – EWYV (II) Reymond et al 2007 
 
Junction adhesion molecule 
 
JAM-A, B, C PDZ – SFLV (II) Reymond et al 2007 
 
Synthesis of L-serine 
 
Serine racemase PDZ – SVSV (II) Fujii et al 2006 
 
Synaptic cell-adhesion molecules 
 
Neuroligin 1, Neuroligin 2 PDZ – TTRV (II) Meyer et al 2004 
 
Syntenin 
 
Syntenin PDZ – IPEV (II) Torres et al 1998 
 
Acid-sensing ion channel 
 
ASIC1a, 2a, 2b / BNaC1 PDZ – EIAC (II) Hruska-Hageman et al 2002; Duggan et al 2002 
 
Prolactin releasing peptide receptor 
 
PrRP receptor PDZ – SVVI (II) Lin et al  2001 
 
Serotonin transporter 
 
SERT PDZ – LNAV (II) Torres et al 2001 
 
Noradrenaline transporter 
 
NET PDZ – WLAI (II) Torres et al 2001 
 
Epidermal growth factor receptor 
 
ErbB2/HER2 PDZ – DVPV (II) Julin-Bastard et al 2001 
 
Dopamine transporter 
 
DAT PDZ – WLKV (II) Torres et al 2001 
 
Metabotropic glutamate receptors 
 
mGluR3, 4a, 7b, 7a, 8a, 8b PDZ – NLVI (II) Boudin et al 2000; Dev et al 2000; El Far O et al 2000; Hirbec et al 2002 
 
Chloride/bicarbonate exchangers 
 
Anion exchanger-1, -2 PDZ – AMPV (II) Cowan et al 2000 
 
Membrane water channels 
 
Aquaporin-1, -2, -9  PDZ – SVIM (II) Cowan et al 2000 
 
AMPA receptors 
 
GluR2, GluR3, GluR4 PDZ – SVKI (II) Dev et al 1999; Xia et al 1999 
 
Muscle specific tyrosine kinase 
 
MuSK PDZ – TVSV (II) Xia et al 1999; Torres et al 1998 
 
Ephrin Receptor tyrosine kinase 
 
EphB2, EphA7 PDZ – SVEV (II) Torres et al 1998 
 
Eph Receptor ligand 
 
Ephrin B1 PDZ – YYKV (II) Torres et al 1998 
 
Netrin receptor 
 
UNC5H1  PDZ – EAEC (X) Williams et al 2003 
 
ADP-ribosylation factors 
 
ARF1, ARF3 PDZ – RNQK (X) Takeya et al 2000 
 
TPA Inducible Sequence 
 
TIS21 PDZ – internal Lin et al  2001 
 
Actin-Related Proteins 
 
Arp2/3 c-term acid region Rocca et al 2008 
 
Neuronal Ca2+ sensor (NCS) 
 
NCS-1 BAR Jo et al 2008 
 
Islet Cell Autoantigen (diabetes) 
 
ICA69 BAR Cao et al 2007 
 
Glutamate receptor interacting protein 
 
GRIP BAR  Lu et al 2005 
 
Microfilament G-actin polymers 
 
F-actin BAR Rocca et al 2008 
 
Soluble NSF attachment proteins 
 
α-SNAP, β-SNAP BAR Hanley et al 2002 
 
Catalytic subunit of protein kinase 2 
 
CK2α n.d. Xiao et al 2009 
 
Golgi-associated protein 
 
GPOC n.d. Xiao et al 2009 
 
KAR interacting protein GluR6 
 
KRIP6 n.d. Laezza et al 2008 
  
Furthermore, experimental analysis indicates that the affinity of GLT1b (-ETCI) 
for PICK1 is significantly better than that of PKCα (Bassan et al., 2008) and slightly 
better than that of GluR2 (Bassan et al., 2008), on the other hand it is slightly lower than 
that of the DAT (Madsen et al., 2005). Likewise, our predicted affinity value of GLT1b  
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Interactor 
& Peptide 
Sequence 
Structure of docked 
pose Ebind (kcal/mol) 
Interactor 
& Peptide 
Sequence 
Structure of docked 
pose Ebind (kcal/mol) 
Interactor 
& Peptide 
Sequence 
Structure of docked 
pose Ebind (kcal/mol) 
 
Ephrin B1  
 
-YYKV  
(Type II) 
 
 
 
ARF1 
 
-RNQK 
(Atypical) 
 
Aquaporin-9 
 
-SVIM 
(Type II) 
 
 
Parkin  
 
-WFDV  
(Type II) 
  
 
ErbB2/HER2 
 
-DVPV 
(Type II) 
 
 
mGluR7a 
 
- NLVI 
(Type II) 
 
DAT  
 
-WLKV  
(Type II) 
 
Neuroligin  
 
-TTRV 
(Type I) 
 
 
 
SERT 
 
-LNAV 
(Type II) 
 
 
JAM-A, B, C 
 
-SFVL  
(Type II) 
  
EphB2 
 
-SVEV 
(Type II) 
 
 
BNaC1  
 
-EIAC 
(Type II) 
 
 
Nectin 
 
-EWYV 
(Type II) 
 
 
 
GLT1b 
 
-ETCI 
(Type I) 
 
 
CAR 
 
-GSIV 
(Type I)  
 
Syntenin  
 
-IPEV 
(Type II) 
 
 
MuSK 
 
-TVSV 
(Type II) 
 
 
PKCα 
 
-QSAV 
(Type I) 
 
 
NET 
 
-WLAI 
(Type II) 
 
Serine 
racemase  
 
-SVSV 
(Type II) 
 
Calcineurin  
 
-VDV 
(Type II) 
 
-262.11 
-260.81 
 
-183.12 
-246.09 
-221.09 
 
 
 
-247.76 -291.93 
291.932 
-246.30 
- 
-233.98 
 
-234.51 
 
-215.91 -242.25 
 
-236.60 
 
-289.93 
 
 
-278.25 
 
-338.85 
 
-297.37 
 
-289.97 
 
-280.73 -242.86 
-217.38 
 
 -217.18 
 
 
 
 
PrRP  
 
-SVVI 
(Type II) 
 
 
Kalirin-7 
 
-STYV 
(Type I) 
 
 
 
GluR5-2b  
 
-ETVA 
(Type I) 
 
Anion 
Exchanger-1 
 
-AMPV 
(Type II) 
 
 
GluR2  
 
-SVKI 
(Type II) 
 
 
UNC5H 
 
-EAEC 
(Atypical) 
 
 
-236.79 
 
-270.14 
-265.25 
-215.78 
 
 -211.88 
 
 
-240.14 
 
 
 
Figure 4.1: The sorted binding affinity values of C-terminal peptides interacting with the 
PDZ domain of PICK1 and the ribbon diagrams of the complex structure with the best 
score. Higher negative values indicate a higher binding affinity prediction. The key 
residues near the binding pocket making side interactions with the peptide are also 
shown. 
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(-246.09 kcal/mol) is in between the affinities of DAT (-291.93 kcal/mol) and GluR2 (-
236.79 kcal/mol) peptides. On the other hand, binding energy scores obtained by rigid 
docking do not correlate with the order of experimental binding affinities. Rigid docking 
predicts that GluR2 and DAT peptides have the same affinity and higher than PKCα. 
 
Figure 4.2: Alignments were performed using Vector NTI software and the following 
accession numbers were used: Human PICK1 Q9NRD5; Human PSD-95 P78352; 
NHERF O14745; Disks large homolog 1 Human Q1295; CSKP O14936; Syntenin1 
O00560; NOS1 P29475. Bovine PICK1 Q2T9M1; Macaque PICK1 Q4R7Q5; Murine 
PICK1 Q62083; Orangutan PICK1 Q5REH1; Rat PICK1 Q9EP80, Drosophila 
NP609582, C. Elegans NP502796. The residues important for interaction with PDZ 
motifs are highlighted in bold. The residues underlined appear to be well conserved in 
PDZ domains type I, II and III. 
 
4.3.2 The K27 and K83 Binding Hotspots in PICK1 
Our collaborator Dr. Ozlem Keskin provided us with the bioinformatics analysis 
for categorizing the binding properties of PICK1. They performed sequence alignments 
of several PDZ domains to reveal the regions of PICK1 critical in ligand recognition 
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(Figure 4.2). This data showed that the PICK1 residues Lys83 together with Thr82, Val84, 
and Ala87 create a P-2 binding pocket that interact with P-2 residues of PDZ ligands, 
whereas the ‘KD motif’ (Lys27 and Asp28), the Ile37 residue and the GLGF-like motif 
(LIGI) (Ile33, Ile35) create a P0 binding pocket that bind P0 residues of PDZ ligands 
(Figure 4.3).  
 
 
 
Figure 4.3: The cartoon shows residues identified as important in binding PDZ motifs. 
The PDZ motif of GluR2 is shown for example purposes. In general the ‘P-2 binding 
pocket’ is composed of Lys83 together Thr82, Val84, and Ala87. The ‘P0 binding pocket’ is 
composed of the ‘KD motif’ (Lys27 and Asp28), the Ile37 residue, and the GLGF-like 
motif (LIGI) (Ile33, Ile35). 
 
Using structural database, they also modeled four of the best studied PDZ motifs 
of PICK1 and their hot spots (i.e. critical residues in recognition of peptide motifs) that 
were examined using the method of alanine mutational drop in binding affinity through 
the HotPoint Server (Tuncbag et al., 2010). They observed that the Lys83 residue, the ‘KD 
motif (Lys27), the Ile37 residue, the GLGF-like motif (LIGI) (Ile33, Ile35) and the I90 
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residue represented hotspots in recognition of PDZ motifs. Previous studies have shown 
that mutation of K27A (in the ‘KD motif’) in PICK1 prevents binding to both class I 
(PKCα, -QSAV) and class II (GluR2, -SVKI) motifs (Dev et al., 2000) (Xia et al., 1999) 
(Staudinger et al., 1997). In contrast, a K27E mutation in PICK1 reduces binding to P0 
residues and disrupts interactions with class II motifs (GluR2, -SVKI) while maintaining 
binding with class I motifs (PKCα, -QSAV) (Elkins et al., 2007) (Dev et al., 2004). This 
may explain why the ‘KD motif’ is conserved in type II PDZ domains but not found in 
type I PDZ domains (Figure 4.2). Importantly, the replacement of Lys83 with His83 
(K83H) in PICK1 enhances the affinity for class I motifs (PKCα, -QSAV), and decreases 
the affinity for class II motifs (DAT, -WLKV) (Madsen et al., 2005). In contrast, 
mutation of Lys83 to Val83 (K83V) in PICK1 enhances affinities for both class I (PKCα, -
QSAV) and class II (DAT, -WLKV) PDZ motifs (Elkins et al., 2007; Madsen et al., 
2005; Pan et al., 2007). Based on these experimental studies, we have focused on four 
mutations K27E, K27A, K83H and K83V of PICK1 (Table 4.2). Using BP-Dock, we 
obtained the docked models and binding affinities for wild type and mutant (K27E, K27A, 
K83H and K83V) PICK1 complexes with various peptides. In agreement with 
experimental observations (Dev et al., 2004), we observed that the binding energy score 
of GluR2 (-SVKI) significantly decreases, whereas that of PKCα (-QSAV) enhances with 
K27E PICK1 (Table 4.2).  Moreover, the data showed a disruption in binding affinity of 
GluR7 (-NLVI) upon K27E mutation as observed experimentally (Dev et al., 2000). In 
most cases, the K27E mutation and the K27A mutation increased the binding affinity for 
class I peptides whereas it decreased those for class II peptides (Table 4.2). However, 
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there were outliers; for example, binding energy of GluR5-2b (class I peptide) decreased, 
while binding of DAT and NET (class II peptides) increased upon K27A mutation. 
Table 4.2: Binding affinities for wild-type and mutated versions of PICK1 are shown. 
Higher negative values indicate a higher binding affinity prediction 
 
Interactor Peptide Sequence PDZ motif 
Ebind (kcal/mol) 
Wild type 
PICK1 
K27E 
PICK1 
K27A 
PICK1 
K83H 
PICK1 
K83V 
PICK1 
 Ephrin B1 YYKV (Type II) -338.85 -320.45 -304.43 -301.76 -301.91 
 Parkin WFDV (Type II) -297.37 -285.42 -271.51 -272.62 -288.87 
 DAT WLKV (Type II) -291.93 -274.00 -301.13 -297.99 -292.42 
 JAMABC SFVL (Type II) -289.97 -278.34 -282.91 -283.15 -269.94 
 Nectin EWYV (Type II) -289.93 -270.72 -278.20 -285.37 -280.40 
 Syntenin IPEV (Type II) -280.73 -269.23 -269.87 -264.24 -265.12 
 NET WLAI (Type II) -278.25 -267.13 -276.93 -285.33 -273.70 
 PrRP SVVI (Type II) -270.14 -234.65 -242.45 -255.71 -249.70 
 AnionExch AMPV (Type II) -265.25 -259.05 -249.38 -246.14 -248.84 
 ARF1 RNQK (Atypical) -262.11 -257.45 -230.85 -249.81 -230.45 
 ErbB2/HER2 DVPV (Type II) -260.81 -246.30 -260.07 -252.42 -256.86 
 Neuroligin TTRV (Type I) -247.76 -263.31 -245.44 -252.19 -248.31 
 EphB2 SVEV (Type II) -246.30 -214.34 -225.32 -227.38 -228.25 
 GLT1b ETCI (Type I) -246.09 -270.72 -258.22 -254.00 -258.20 
 MuSK TVSV (Type II) -242.86 -201.42 -227.86 -205.02 -215.32 
 Serineracemace SVSV (Type II) -242.25 -208.70 -217.03 -229.20 -229.92 
 Kalirin7 STYV (Type I) -240.14 -258.17 -242.46 -240.24 -256.37 
 GluR2 SVKI (Type II) -236.79 -213.58 -233.20 -222.56 -236.57 
 Aquaporin9 SVIM (Type II) -236.60 -205.88 -241.84 -230.91 -221.42 
 mGluR7a NLVI (Type II) -234.51 -230.76 -226.53 -222.23 -219.57 
 SERT LNAV (Type II) -233.98 -205.26 -232.99 -229.09 -211.48 
 BNaC1 EIAC (Type II) -221.09 -205.11 -219.56 -224.44 -217.72 
 CAR GSIV (Type I) -217.38 -221.33 -220.35 -227.85 -228.99 
 PKCa QSAV (Type I) -217.18 -232.90 -223.56 -220.36 -225.46 
 Calcineurin VDV (Type II) -215.91 -202.02 -206.73 -196.11 -203.61 
 GluR5-2b ETVA (Type I) -215.78 -220.31 -201.31 -206.15 -207.75 
 UNC5H EAEC (Atypical) -211.88 -200.28 -202.17 -196.33 -195.11 
 
 
Binding energy of PKCα (-QSAV), but not DAT (-WLKV) was also higher with 
K83H PICK1, as previously reported (Madsen et al., 2005). In general, mutations at 
position Lys83 (K83V and K83H) did not perturb the class I type interactions, and in some 
cases caused an increase in binding energies, while they disturbed the interactions with 
class II peptides (Table 4.2). As in the case of K27A, DAT and NET (class II) peptides 
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were not affected from K83V and K83H mutations. All mutations also disturbed the 
binding of PICK1 to atypical peptides.  
In order to compare the accuracy of flexible BP-Dock docking in predicting 
binding affinities, we also computed the binding scores without incorporating the 
flexibility of PICK1. Thus, we just mutated the residues in the wild type crystal structure 
for the cases where the experimental data was available and then performed an energy 
minimization to obtain a reasonable mutant structure. These energy minimized mutant 
structures were used for RosettaLigand docking (Davis & Baker, 2009; Meiler & Baker, 
2006). The flexible docking results with PRS shows better agreement with the 
experimental affinity data (Staudinger et al., 1997; Madsen et al., 2005; Dev et al., 2004) 
as shown in Table 4.3 compared to the rigid docking results. For PKCα, our flexible 
docking method can capture the increase in binding affinity upon K83V and K83H mutants 
fairly comparable to the experimental affinity results (Dev et al., 2000; Staudinger et al., 
1997; Madsen et al., 2005; Dev et al., 2004), yet rigid docking fails to predict these. 
Moreover, rigid docking also mispredicts the change in binding affinity of DAT in K83H 
or K83V mutation. Overall, these results suggest that the conformational dynamics of 
PICK1 is critical in binding affinities, and besides affecting critical interactions, 
mutations lead to change in conformational dynamics, which affects binding affinities 
(Gerek & Ozkan, 2010; Gerek et al., 2009; Smith & Kortemme, 2010). 
4.3.3 GluR2 with Wild Type and Mutant PICK1 Complexes   
In GluR2, the carboxyl group of P0 Ile (-ESVKI) forms a hydrogen bond in the 
LIGI motif of PICK1, whereas the side chain of P-1 Lys (-ESVKI) makes minimal 
contact with PICK1 (Pan et al., 2007). In addition, the P-2 Val (-ESVKI) interacts with 
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the side chain of Lys83 and the methyl group of Ala87 of PICK1.  The negatively charged 
P-3 phosphorylated Ser (-ESVKI) also interacts with the positively charged Lys83 in 
PICK1. 
Table 4.3: Flexible docking results show better agreement with the experimental affinity 
data as compared to the rigid docking results 
 
Peptide 
 
 
Mutation 
 
 
Rigid Docking  
 
 
Flexible Docking with PRS 
 
Experimental 
Affinity  
 
 
∆∆E# 
 
 
Agreement 
with 
Experiments 
 
∆∆E#  
 
 
Agreement 
with 
Experiments 
 
GluR2 (-SVKI) K27E -30 √ -23.206 √ Decrease 
Pkcα (-QSAV) 
 
 
K27A 0 √ 6.38 √  Still interacts  
K27E 1 √ 15.715 √ Still interacts  
K83H -5 X  3.18 √  Increase  
K83V -6 X  8.28 √  Increase  
DAT (-WLKV) 
 
K83H 0 X  6.056 X  Decrease  
K83V -3 X  0.486 √  Increase  
 
Finally, a stabilizing hydrogen bond and side chain interactions are also found 
between the amino group of Lys83 on PICK1 and the carbonyl of P-4 Glu (-ESVKI) (Pan 
et al., 2007). In agreement with these observations, our docking method indicates that P-3 
Ser (-SVKI) interacts with the Lys83 at the αB1 position. Furthermore, we observed that 
P-2 Val (-SVKI) forms a hydrophobic association with the aliphatic side chain of Lys83 of 
PICK1 and also interacts with the Ile37 of PICK1. This strong hydrophobic interaction 
appeared to increase the binding affinity (-236.79 kcal/mol) of GluR2 for WT PICK1 as 
proposed earlier (Madsen et al., 2005). The K27E PICK1 interaction with GluR2 showed 
destabilization between P-3 Ser and Ile37 and a loss of interaction between P-2 Val and 
Lys83, which could have accounted for the decreased binding affinity (-213.58 kcal/mol). 
The K27A PICK1 also showed a similar loss of interaction between P-2 Val and Lys83 and 
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decreased binding (-233.20 kcal/mol). We observed that the interaction between P-3 Ser 
and Lys83 were lost in K83H PICK1. Furthermore, the phosphorylated P-3 Ser did not 
interact with the His83 in PICK1, which explains the decrease in binding affinity of K83H 
PICK1 (-222.56 kcal/mol). For K83V PICK1, the interactions between P-3 Ser and Val83, 
and P-2 Val and Ala87, which were not observed between WT PICK1 and GluR2, might 
have compensated for the loss of interaction between P-3 Ser and Lys83 and explain the 
similar binding affinities of K83V PICK1 (-236.57 kcal/mol) and WT PICK1. 
 
Figure 4.4: Ribbon diagram showing interactions of Pkcα (-QSAV) for WT-PICK1 (A) 
& K83H-mutant PICK (B) and those of DAT (-WLKV) for WT-PICK1 (C) & mutant 
K83V-PICK1 (D) The critical residues interacting with Pkcα and DAT peptide are 
shown in green. The mutated residues Lys83, Val83 and His83 are shown in magenta. The 
residues whose interaction with the Pkcα got lost after K83H mutation are shown in grey. 
 
4.3.4 PKCα with Wild Type and Mutant PICK1 Complexes   
We observed that P-2 Ser and P0 Val of the PKCα motif (-QSAV) interacts with 
Ala87 (P-2 binding pocket) of PICK1. We also observed that P-2 Ser interacts with side 
chains of Ile37 (P-2 binding pocket) and P0 Val interacts with Ile33, Ile35 and Ile90  
 
  70 
(P0 binding pocket) of PICK1, in agreement with previous observations (Elkins et al., 
2007; Madsen et al., 2005) (Figure 4.4(A)). Our analysis on the lowest energy docked 
pose of K27E PICK1 with PKCα showed an interaction between P-2 Ser and Lys83 in 
PICK1. As proposed earlier, this interaction increases the binding affinity of PKCα for 
K27E PICK1 (-232.90 kcal/mol) as compared to WT PICK1 (-217.18 kcal/mol). We 
found that the interactions of P0, P-1, P-2 and P-3 residues of PKCα (-QSAV) were more 
stable with K27A PICK1 (-223.56 kcal/mol). Interestingly, the P-2 Ser interacts with His83 
in the PDZ domain of K83H PICK1 (Figure 4.4(B)), which is not observed at the P-2 
residue in Class II peptides.  As proposed in previous studies (Elkins et al., 2007; Madsen 
et al., 2005; Perez et al., 2001; Dev et al., 2004), the K83H mutation allowed a hydrogen 
bond between P-2 Ser in PKCα (-QSAV) and His83 in PICK1, which might have 
compensated for the loss of interaction between P-2 Ser and Lys83 in PICK1. Thus, the 
interaction between P-2 Ser and His83 might account for the slight increase in the binding 
affinity of PKCα for K83H PICK1 (-220.36 kcal/mol). Likewise, interaction between P-2 
Ser and Val83 might have compensated for the loss of interaction between P-2 Ser and 
Lys83 in K83V PICK1. This might explain the increase in binding affinity for K83V PICK1 
(-225.46 kcal/mol). 
4.3.5 DAT with Wild Type and Mutant PICK1 Complexes   
Our data also showed that P-2 Leu in DAT (-WLKV) interacts with Val84 and 
Ala87 (P-2 binding pocket) in PICK1 and also with Ile37 of the βB strand of PICK1 
(Figure 4.4(C)). These interactions might contribute towards the high binding affinity of 
DAT for PICK1 (-291.93 kcal/mol). The data indicated that a hydrophobic interaction 
between aliphatic side chain of P-1 Lys in DAT (-WLKV) and Phe53 of PICK1 is 
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stabilized significantly in K27A PICK1. In contrast, the interaction between P-2 Leu of 
DAT (-WLKV) and Ser36 of PICK1 is destabilized in K27A PICK1, whereas it is 
stabilized in K27E PICK1. Therefore, we propose that the P-2 Leu and Ser36 might be an 
unfavorable interaction and the destabilization of this interaction along with the 
stabilization of hydrophobic interaction of aliphatic side chain of P-1 Lys of DAT and 
Phe53 in K27A PICK1 could increase the binding affinity (-301.13 kcal/mol) compared to 
K27E PICK1 (-274.00 kcal/mol). Analysis also showed that interactions between P-2 Leu 
of DAT (-WLKV) with His83, Val84 and Ile37 in PICK1 became more stabilized in K83H 
PICK1. Thus, these strong interactions between P-2 Leu of DAT (-WLKV) and the 
crucial residues of PICK1 increases the binding affinity of DAT for K83H PICK1 (-
297.99 kcal/mol). Likewise, we observed that the interactions between P-2 Leu with 
Val83 and Val84 became more stabilized in K83V PICK1 (Figure 4.4(D)). Although we 
observed increased binding energies for K83V and K83H PICK1, the experimental 
analysis suggests an increase in affinity of DAT for K83V PICK1, while a decrease in 
binding affinity for K83H PICK1. To investigate this further, we also found that some 
hydrogen bond interactions were lost between DAT peptide and K83H PICK1 mutant 
suggesting a possible reason for decrease in binding affinity for K83H PICK1 as seen in 
experimental results. However, our scoring function was not sensitive enough to capture 
this effect in its binding score. Overall, our analysis suggests that the K83V mutation is 
not perturbed due to a more stabilized interaction of P-2 Leu of DAT (-WLKV) with the 
mutant residue at Val83 as proposed earlier (Madsen et al., 2005), yet it is not sensitive to 
small changes in binding affinity detected by experimental methods.  
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Figure 4.5: The lowest binding energy scores and their corresponding structures of 
docking FSC231 compound to (A) the wild type and (B) the mutant (K83H) of PICK1s 
are displayed as ribbon diagrams. The key residues of the PICK1 domain making side 
interactions with FSC231 are also shown.   
 
4.3.6 Computational Docking Analysis of PICK1 Compound FSC231 
The first small-molecule inhibitor (FSC231) of the PDZ domain in PICK1 has 
been identified among ~44,000 compounds with a fluorescent polarization assay 
(Thorsen et al., 2010; Bach et al., 2010). The fluorescent polarization binding 
experiments showed that the FSC231 compound has higher affinity for the K83H mutant 
than for the wild type of PICK1 (Thorsen et al., 2010). We also analyzed and predicted 
the affinity for PICK1 compound FSC231 using BP-Dock docking explained earlier. Our 
collaborators provided us the chemical structure of the compound that was generated 
using the PRODGR server 
(http://davac1.bioch.dundee.ac.uk/programs/prodrg/prodrg.html) and then refined using a 
geometric-based conformational sampling technique called FRODA (Framework 
Rigidity Optimized Dynamics Algorithm) (Wells, Menor, Hespenheide, & Thorpe, 2005) 
to generate a variety of different topological structures of the compound. These structures 
were docked into the wild type and K83H mutant of PICK1 structures. The predicted 
binding energy values agree with fluorescent polarization binding experiments showing a 
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higher affinity of FSC231 for the K83H mutant (-99.50 kcal/mol) than for the wild type (-
95.69 kcal/mol) (Figure 4.5).  
4.4 Conclusion 
In this chapter, we used BP-Dock to categorize the binding properties of PICK1. 
Here, BP-Dock approach comes with two additional advantages: (i) firstly, we can 
generate a set of conformations that includes the conformations sampled during binding 
process and (ii) secondly, we can, based on the rapid computational speed, apply this 
approach to a vast majority of ligands (PDZ motifs) or different mutants of a receptor 
(PDZ domain) and obtain a virtual screening library for a given receptor (PDZ domain) in 
a short period of time. Moreover, perturbation on the residues applied by PRS also 
allowed us to create a different set of ensemble for mutant versions of PICK1 compared 
to that of the wild type PICK1 receptor (PDZ domain). This increased the prediction 
accuracy of our peptide affinities by docking. With BP-Dock approach, our predicted 
binding energy scores agreed qualitatively with the available experimental data. Notably, 
the binding affinity changes were unlikely to be obtained if a single crystal structure of 
PICK1 had been used in our computational analysis. Thus, the accuracy in our flexible 
docking method lies in incorporating the binding-induced conformational changes 
through PRS. The small conformational changes in the backbone can lead to a significant 
change in the side chain, thus simulating the changes of how a ligand (PDZ motif) 
interacts with the receptor (PDZ domain). In closing, we suggest these new 
computational analyses methods will advance our understanding of the structure and 
binding relationships of PICK1 and could aid in the further development of drugs that 
regulate selective PDZ interactions. 
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CHAPTER 5 
 
DISSECTING THE ENERGETICS OF GLYCAN-CYANOVIRIN BINDING 
 
As excerpted from: 
Bolia, A., Woodrum, B. W., Cereda, A., Ruben, M. A., Wang, X., Ozkan, S. B. and 
Ghirlanda, G.“A Flexible Docking Scheme Efficiently Captures the Energetics of 
Glycan-Cyanovirin Binding,”Biophysical Journal 106(5), 1142-1151 (2014) 
and 
Li., Z., Bolia, A., Maxwell, J. D., Bobkov, A. A., Ghirlanda, G., Ozkan, S. B. and 
Margulis, C. J.“A Rigid Hinge Region is Necessary for High Affinity Binding of Di-
mannose to Cyanovirin and Associated Constructs,”Biochemistry (submitted). 
5.1 Introduction 
Cyanovirin (CVN), a 101 amino acid lectin isolated from Nostoc Ellipsosporum, 
exemplifies a novel class of therapeutic agents that target the surface glycans of HIV and 
other enveloped viruses (Mori & Boyd, 2001; Esser et al., 1999; Botos & Wlodawer, 
2003; Barrientos et al., 2003; Bolmstedt et al., 2001; Balzarini, 2007; Scanlan et al., 
2007). Its potent activity against HIV is mediated by high affinity binding to the 
mannose-rich glycans that decorate the surface of gp120, and requires multivalent 
interactions through two binding domains within the protein (Fromme et al., 2008; 
Fromme et al., 2007; Liu et al., 2009; Matei et al., 2010; Keeffe et al., 2011). CVN is 
unique among lectins in recognizing a glycan unit, Mana(1-2)Mana, with high affinity 
and specificity: glycan array analysis reveals that only mannose-rich structures containing 
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the specific glycosydic linkage α-Man-(1,2)-α-Man are recognized (Patsalo et al., 2011; 
Koharudin et al., 2008). For these reasons, the protein is emerging as a convenient model 
system to investigate glycan-protein interactions and to test computational approaches to 
glycan recognition.  
The structure of CVN reveals a novel beta sheet fold that comprises two quasi-
symmetric domains, defined as A (residues 1-38/90-101) and B (residues 39-89), 
connected on each side by a short 310 helix. Despite backbone RMSD of 0.76 Å, the two 
domains are approximately 25% identical in sequence, resulting in slightly different 
glycan selectivity and affinity. Experimental and computational simulation data show a 
preference for linear trimannose in domain A, and a preference for di-mannose (Mana(1-
2)Mana) in domain B (Mori & Boyd, 2001; Esser et al., 1999; Botos & Wlodawer, 2003; 
Barrientos et al., 2003; Bolmstedt et al., 2001; Balzarini, 2007; Scanlan et al., 2007; 
Fromme et al., 2007; Liu et al., 2009; Matei et al., 2010; Keeffe et al., 2011; Bewley & 
Otero-Quintero, 2001; Matei et al., 2008; Fujimoto et al., 2008; Bewley, 2001; Botos et 
al., 2002; Vorontsov & Miyashita, 2009). Domain B is generally considered the high 
affinity binding site: the reported binding constants are in good agreement and show low 
micromolar affinity for Mana(1-2)Man (Fromme et al., 2008; Fromme et al., 2007; Liu et 
al., 2009; Matei et al., 2010; Keeffe et al., 2011; Bewley, 2001; Matei et al., 2008; 
Bewley et al., 2002; Shenoy et al., 2002).  Structural data of CVN and of mutants 
containing an intact domain B in the apo and di-mannose-bound forms (Fromme et al., 
2008; Fromme et al., 2007; Patsalo et al., 2011; Koharudin et al., 2008; Bewley & Otero-
Quintero, 2001; Bewley, 2001; Botos et al., 2002; Shenoy et al., 2002), complemented by 
binding studies using oligomannose derivatives (Sandström et al., 2004), contributed to 
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mapping the key interactions in the glycan recognition event both on the protein as well 
as on the glycan. The origins of the unique specificity and high affinity of wt-CVN for di-
mannose, however, are poorly understood (Woodrum et al., 2013). In particular, the 
energetic contribution of backbone versus side-chain interactions, and the role of water-
mediated hydrogen bonds, in determining binding affinity are still in debate.  
Here, we analyze glycan binding by CVN and its mutants by applying Backbone 
Perturbation Docking (BP-Dock) that is discussed in detail in Chapter 3. Compared to 
computationally expensive traditional molecular dynamics calculations performed on 
CVN (Margulis, 2005; Xia & Margulis, 2009; Xia et al., 2011; Ramadugu et al., 2009; 
Ramadugu et al., 2014), this method allows for rapid in silico screening of a series of 
mutants.  
This study was divided in two parts. For the first part of this study, we limited our 
analysis to the high affinity site, domain B. We benchmarked our method by comparing 
two well-characterized mutants of CVN (Figure 5.1), one that comprises an intact domain 
B and a non-functional domain A due to four mutations in the domain A (m4 mutations), 
(Figure 5.1(B)) and one in which binding to domain B has been abolished by inserting 5 
mutations in domain B (Figure 5.1(C)). However, both the domain A (CVNmut(DB)) and 
domain B (P51G-m4-CVN) mutants also contain mutation in the hinge region as 
constructs with the P51G mutation preferentially exists as monomers whereas wild type 
cyanovirin can form domain swapped dimers in certain conditions. The computed 
binding affinities are consistent with high affinity binding for one, and with no binding 
for the other. Extending our docking analysis to single mutants of P51G-m4-CVN, we 
observed that some mutations lead to less favorable binding energy scores, while others 
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do not. Based on these predictions, we experimentally characterized five mutants, and 
obtained binding affinities in agreement with the predictions. Our work demonstrates that 
rapid docking can be an efficient tool in predicting binding affinity patterns of various 
mutants in glycan recognition. However, the method relies on the accurate prediction of 
the initial unbound mutant structure. With such tools, it should be possible to predict 
mutations that change affinity and specificity for given glycan targets.  
 
Figure 5.1: (A) Crystal structure of P51G-m4-CVN (PDB ID: 2RDK) with di-mannose 
bound. (B) Domain B of P51G-m4-CVN shown with residues focused on in this study 
highlighted in yellow (nitrogen atoms colored blue, oxygen atoms colored red). (C) 
Domain B of CVN(mutDB) (PDB ID: 3CZZ) with residues that differ from that of P51G-
m4-CVN highlighted in yellow.  Domain B of CVN(mutDB) does not bind di-mannose.  (D) 
The sequences of the two mutants are shown aligned with domain A shown in black, 
domain B shown in grey.  The differences between P51G-m4-CVN and CVN(mutDB) in 
domain B are highlighted. 
 
For the second part of our study, we focused on the mutation in the hinge region 
of CVN i.e. P51G. Since the hinge region is an integral part of the high affinity-binding 
site of CVN, we investigated whether this mutation affects the shape, flexibility and 
binding affinity of domain B for di-mannose. Our collaborators provided us the MD 
simulation data for P51G-m4-CVN mutant and wt-CVN, which was used to study the 
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flexibility profile of wt-CVN and P51G-m4-CVN using our dynamic flexibility index 
(dfi) analysis (Gerek et al., 2013; Butler et al., 2015;  Kim et al., 2015; Zou et al., 2015) 
that is also based on PRS (Atilgan & Atilgan, 2009) (discussed in Chapter 2). Our results 
showed that capability of monomeric wild type CVN to resist mechanical perturbations is 
enhanced when compared to the P51G mutation constructs in which the hinge region is 
more flexible. In addition to the hinge region, we found that another key dynamic 
element at the high affinity binding site is the hairpin where Asn42 is located. Our 
computational results validated by isothermal titration calorimetry (ITC) experiments 
(performed by other members of Dr. Ghirlanda’s group) indicate that Asn42, at the 
hairpin, in combination with Asn53, at the hinge region, are critical for the opening and 
closing of the binding site at domain B which in turn is crucial for glycan binding. 
Overall, our analysis showed that the rigidity in the hinge region provided by P51 is 
absent when this residue is mutated to glycine, and this accomplishes two very important 
goals; (1) it favors the formation of the dimer therefore conferring a higher degree of 
multivalency, (2) in the case of the monomeric form it enhances the binding affinity at 
the high affinity site; these advantages are absent when this residue is mutated to glycine. 
5.2 Methods 
5.2.1 Modeling of Single Point Mutant Structures 
We analyzed bound mutant structures of P51G-m4-CVN (Fromme et al., 2008; 
Fromme et al., 2007) and CVN(mutDB) (Matei et al., 2008) in this study. The crystal 
structures for P51G-m4-CVN (PDB code: 2RDK) and CVN(mutDB) (PDB code: 3CZZ) 
were retrieved from the Protein Data Bank (http://www.rcsb.org/pdb) (Berman et al., 
2000). These structures were used as templates for binding affinities to di-mannose sugar 
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in our flexible docking simulations. For modeling of single point mutants, we first 
checked the possible impact of single point mutations on the local structure, or the overall 
stability of the protein. By analyzing the hydrogen-bond network of each individual site 
within the binding pocket, we found that the side chains of some residues, such as Asn42 
and Thr57, make critical hydrogen-bonds with the backbone or side-chain of other 
positions of CVN (Table A.1 in Appendix A). Thus, mutating these positions to Ala 
could alter the stability or lead to local structural change. To capture those effects, we 
introduced the point mutations into the X-ray structure via Swiss PDB Viewer (Guex & 
Peitsch, 1997), and performed short (3 ns) replica exchange molecular dynamics 
(REMD) simulations to obtain well-equilibrated mutant models.  The initial point mutant 
structure was seeded into the REMD (Sugita & Okamoto, 1999) simulation; temperature 
of the replicas ranged from 270 K to 450 K. Replica spacing was set such that the swap 
likelihood between replicas approached 0.45. The AMBER force field (ff99SB) (Hornak 
et al., 2006) with a GB implicit solvent (Tsui & Case, 2000) model and a SA penalty term 
of 5 cal/mol Å was used. An alpha-carbon covariance matrix was calculated from a 1 ns 
window of the trajectory, the convergence was checked by the observed high correlation 
between the slowest fluctuation profiles of the two successive windows. After clustering 
the snapshots of the lowest replica, the most dominant structure (i.e. lowest free energy 
state) was used as the predicted mutant model structure for BP-Dock docking (explained 
in Chapter 3). 
5.2.2 Allosteric Response Ratio 
Here, we extend the applicability of PRS (Atilgan & Atilgan, 2009) in identifying 
allosteric binding sites in a protein. Using PRS, we can predict the residues that are 
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critical in allosteric pathways by identifying the positions that gives the highest mean 
square fluctuation response upon perturbing the binding sites (Gerek & Ozkan, 2011). 
Earlier, our group had defined an index called the allosteric response ratio, 𝒳j for a 
residue that is the ratio of average fluctuation response of residue j upon perturbations 
induced on binding site residues to average response of residue j upon perturbing all the 
other residues, given by, 
                                                                                                                𝒳! =    𝐴!"
!!"#!!!!"!𝑁!"𝐴!"!!!!𝑁 − 1                                                                                                                   (5.1) 
where, Aij is the fluctuation response profile of residue j upon perturbing residue i that can 
be calculated using equation (2.19), NBP is the number of residues in the binding pocket 
and NBPm corresponds to the the number of residues in the binding pocket. We calculated 𝒳j for each residue and sort out all 𝒳j to identify the critical residues that are 
allosterically significant i.e. are more sensitive to perturbations of the binding pocket 
residues. Using this approach, we identified the critical residues in domain B of CVN that 
are allosterically linked to the binding site.  
5.2.3 Dynamic Flexibility Index  
To investigate whether the flexibility profile of wt-CVN differs from that of 
P51G-m4-CVN, we calculated the dynamic flexibility index (dfi) (Gerek et al., 2013; 
Butler et al., 2015) for each position in CVN. The dfi, which is a position specific metric, 
uses PRS (Atilgan & Atilgan, 2009) and computes the normalized total fluctuation 
response of a specific position to the random perturbations introduced at all the other 
parts of the chain. Thus, dfi quantifies the resilience of a position to perturbations exerted 
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at other parts in the chain. Since dfi is based on PRS, it consists of applying a random 
Brownian kick as a mechanical perturbation to a given single residue in the chain. Here, 
instead of using Hessian inverse, we used the covariance matrix generated from the last 
10ns of 200ns long MD simulations (provided by our collaborators) to obtain the 
positional displacements of all the residues. Then, we computed the fluctuation response 
profile of all other residues to this perturbation using equation (2.20). Repeating this 
random perturbation to each of the positions in the chain one at a time, we are able to 
generate a dfi value for every residue in the protein using, 
                                                                                                                          𝑑𝑓𝑖 = ∆𝑅!!!!!! ∆𝑅!!!!!!!!!!                                                                                                   (5.2) 
where, ∆𝑅!! is the magnitude of positional displacements of residue j in response to 
perturbation at residue i. The dfi profiles were later used to compute rank profiles, which 
are labeled as % profiles. 
5.3 Results and Discussion 
5.3.1 Docking Results for CVN Mutants 
In this study, we focused on domain B of CVN, which has higher affinity and 
specificity for di-mannose (Mana(1-2)Manα) in wt-CVN, and for which extensive 
mutational analysis is available. We used two engineered forms of CVN, P51G-m4-CVN 
and CVN(mutDB), which present the two extremes of the binding affinity range: P51G-m4-
CVN contains a wild type domain B and thus binds di-mannose with high affinity 
(Fromme et al., 2008; Fromme et al., 2007), while CVN(mutDB) contains an impaired 
domain B and thus does not bind di-mannose at concentrations as high as millimolar 
(Barrientos et al., 2006). P51G-m4-CVN and CVN(mutDB) each contain a P51G mutation 
  82 
in the hinge region that stabilizes the monomeric form relative to the domain-swapped 
form of CVN (L. G. Barrientos et al., 2002). The two mutants have been thoroughly 
characterized, with crystal structures available for CVN(mutDB) (Matei et al., 2008) and for 
P51G-m4-CVN in its apo and bound forms (Fromme et al., 2008; Fromme et al., 2007). 
Using the crystallographic coordinates as a starting point, we performed BP-Dock 
docking by generating ensembles of binding induced conformations after subjecting each 
protein to PRS. Specifically, we first obtained backbone conformational changes upon 
perturbing different positions with a random force. We generated the full-atom models by 
adding the side-chains and performing an all atom minimization for each conformation in 
the ensemble. We used RosettaLigand to dock the di-mannose ligand into the cavity or  
 
Figure 5.2: The RosettaLigand energy scores (in kcal/mol) versus RMSD of the docked 
complex for CVN mutants and di-mannose sugar. P51G-m4-CVN is shown in blue 
circles and CVN(mutDB) in red squares. The funnel shape of the graph indicates good 
docking for P51G-m4-CVN. In agreement with experiments P51G-m4-CVN-di-mannose 
has significantly low binding energy score (-17.25 kcal/mol) while the complex of 
CVN(mutDB) (-9.28 kcal/mol) does not. 
binding pocket for each structure in the ensemble and scored the lowest energy poses as 
described in chapter 3. The binding energy of di-mannose to domain B of P51G-m4-CVN 
calculated by X-Score is -7.58 kcal/mol and the RMSD of the ligand obtained from the 
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lowest energy docked pose is only 0.19 Å. In contrast, analysis of CVN(mutDB) shows a 
drastic increase in the binding energy (-4.68 kcal/mol), corresponding to a change in 
dissociation constant of four orders of magnitude, and a ligand RMSD of 0.38 Å obtained 
from the lowest energy docked pose. Figure 5.2 compares the binding profile of P51G-
m4-CVN and of CVN(mutDB) for di-mannose, where the docking profile observed for 
P51G-m4-CVN indicates a well-converged distinct binding funnel. In contrast, 
CVN(mutDB) shows a poor docking profile, in which energetically degenerate structures 
have high RMSDs.  
Next, we analyzed each residue’s energetic contribution to binding by 
systematically mutating each position in P51G-m4-CVN to the corresponding amino acid 
in CVN(mutDB): Glu41, Asn42, Thr57, Arg76 were changed to Ala, and Gln78 to Gly.  We 
also mutated residue 41 to glycine, which is the most common substitution at that 
position in the CVN-homologous family of proteins, CVNH (Patsalo et al., 2011; 
Percudani et al., 2005). In addition to the positions mutated in CVN(mutDB), we also 
selected the position 53 in our analysis as this mutation had the highest allosteric 
response ratio when all the binding site residues in domain B are perturbed. N53, which 
lines the binding pocket and interacts with the glycan, was mutated to serine, since serine 
is the most common substitution at this position in CVNH (Patsalo et al., 2011; Percudani 
et al., 2005).  
In the absence of crystal structures for the mutants, we generated starting models 
by introducing the individual point mutations into the coordinates of P51G-m4-CVN and 
performing a short REMD run (3ns). Starting from the most dominant structure of the 
lowest temperature REMD run (i.e. the structure with the lowest free energy), we applied 
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our flexible docking approach to each mutant (See Methods for details). The mutations at 
positions 41, 42 and 57 resulted in decreased affinity compared to that of P51G-m4-CVN 
(Table 5.1).  Position 42 accounts for most of the loss of binding energy between the 
intact domain B in P51G-m4-CVN and the defective domain B in CVN(mutDB): the X-
Score binding energy of N42A (-5.37 kcal/mol) is within close proximity of the non-
binder CVN(mutDB) (i.e. -4.68 kcal/mol). This drastic loss in binding energy score may 
indicate the critical role of N42 in stabilizing the structure of the binding pocket. The side 
chain of N42 forms hydrogen bonds to the backbone of neighboring residues (Table A.1 
in the Appendix A); further, this position is very well conserved in the CVNH family 
(Patsalo et al., 2011; Percudani et al., 2005). T57A, E41A and E41G also showed 
significant decrease in binding affinity, albeit not as drastic as N42A. In contrast, the 
binding energy score of N53S mutant (-7.06 kcal/mol) is comparable to P51G-m4-CVN 
(-7.58 kcal/mol). To verify the accuracy of our predictions, other members from our 
group recombinantly expressed E41A, E41G, T57A, N42A, and N53S on the background 
of P51G-m4-CVN (Fromme et al., 2007; Fromme et al., 2008), and subjected them to 
experimental characterization. The biophysical characterization by CD, thermal 
denaturation experiments and 2-D NMR showed that the N42A and T57A mutations 
slightly affect the stability of the protein. 
As observed in P51G-m4-CVN, N53S binds di-mannose with dissociation 
constants in the low micromolar range and in intermediate exchange conditions, 
indicative of tight binding. On the other hand, a single-point mutation of E41A, E41G 
and T57A resulted in much weaker dissociation constants (in the low millimolar range)  
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Table 5.1: Binding energy scores (Ebind) evaluated from X-Score along with 
corresponding RMSDs of the ligand (RMSDligand) and protein side chain positions in the 
binding site (RMSDsidechain) of the lowest energy docked pose for various CVN mutants 
are shown. Higher negative values indicate a higher binding affinity prediction 
 
Protein 
 
RMSDligand 
(Å) 
 
RMSDsidechain 
(Å) 
X-Score  
Ebind 
(kcal/mol) 
Experimental 
Kd 
P51Gm4CVN 0.19 0.189 -7.58 low µM 
CVN(mutDB) 0.38 1.866 -4.68 no binding49 
E41A 0.74 1.155 -6.7 541 ± 118 µM 
E41G 0.82 1.261 -6.82 389 ± 73 µM 
N42A 1.08 1.808 -5.37 no binding 
T57A 0.99 1.08 -6.46 low mM 
R76A 1.06 1.036 -6.9 NA 
Q78G 0.98 0.845 -6.85 NA 
N53S 0.88 1.365 -7.06 low µM 
 
and in fast exchange on the NMR timescale. However, mutation N42A abolished binding 
to di-mannose (Bolia, Woodrum et al., 2014). The melting temperatures of all the 
mutants are reported in Table A.2 in Appendix A and the thermal denaturation profiles on 
the mutants are shown in Figure 1 in Appendix A. The HSQC spectra of P51G-m4-CVN 
is shown in Figure 2 in Appendix A, and HSQC spectra of E41A and E41G mutants 
along with example plots and fitting of molar equivalents vs normalized peak shifts are 
shown in Figure 3 in Appendix A.  
Overall, the experimental characterizations of these five mutants show that BP-
Dock can capture the binding affinity pattern. X-score binding energy scores suggest that 
the mutations of E41A, E41G, and T57A result in lower binding affinity for di-mannose 
compared to P51G-m4-CVN, indicating the critical role of those side chains in glycan 
recognition. Mutation N42A was more disruptive than the other mutations, with binding 
score closer to the non-binder CVN(mutDB). 
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5.3.2 Analysis of the Docked Poses of CVN Mutants 
Furthermore, to understand the drastic decrease in binding affinity of CVN(mutDB) relative 
to P51G-m4-CVN, we analyzed the hydrogen bond network in the lowest energy docked 
poses of P51G-m4-CVN:di-mannose and CVN(mutDB):di-mannose using Chimera with a 
cutoff of 4.0 Å. This approach is commonly used in docking studies to roughly estimate 
critical ligand-receptor interactions (Gray et al., 2003). The network for P51G-m4-
CVN:di-mannose complex comprises main chain nitrogen atoms of Asn42 and Asp44 as 
donors, main chain oxygen atoms of Asn42, Ser52, Asn53, Lys74 as acceptors and side 
chain Oγ of Thr57 acting as both acceptor and donor (Figure 5.3(A)). This hydrogen 
bond network is similar to the hydrogen bond network identified in previous studies 
(Vorontsov & Miyashita, 2011; Matei et al., 2011). In addition, we observed side chain 
hydrogen bonding interactions of OE2 of Glu41 as acceptor and NE of Arg76, NH2 of 
Arg76 and NE2 of Gln78 as donor with the di-mannose (Figure 5.3(A)), previously seen 
only in the case of trimannose binding (Fujimoto & Green, 2012).  CVN(mutDB) retains all 
the main chain hydrogen bonds at Ala42, Asp44, Ser52, Asn53, Lys74; in contrast, all 
side chain hydrogen bonding interactions observed in P51G-m4-CVN are lost. Only one 
side chain hydrogen bond, with OE1 of Glu56 as acceptor, was observed for CVN(mutDB). 
These results emphasize the critical role played by side chain interactions of residue 41, 
57, 76 and 78 in di-mannose.  
Comparison of the hydrogen bond networks for E41A, N42A and T57A mutants 
to that of P51G-m4-CVN:di-mannose complex showed rearrangements in main chain and 
side chain networks. Specifically, in N42A:di-mannose the main chain hydrogen bond of 
the nitrogen of Asn42 and Asp44 as donors, and oxygen of Lys74 as acceptor were lost;  
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Figure 5.3: Main chain hydrogen bond network and side chain hydrogen bond network 
for the lowest energy docked pose of (A) P51G-m4-CVN (B) N42A (C) E41A (D) T57A 
and (E) N53S. The di-mannose sugar is shown in cyan. The residues that form hydrogen 
bond with the sugar are shown in yellow and the hydrogen bond in magenta. 
 
the side chain interaction of OE2 Glu41, NE and NH2 of Arg76 and NE2 Gln 78 were 
lost, however, side chain interactions of OD1 Asp44 and OD1 Asn53 were gained, 
preserving the interaction with OG1 of Thr57 (Figure 5.3(B)). In E41A:di-mannose the 
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main chain carbonyl oxygen of Lys74 as acceptor was lost and another oxygen of Ser52 
and Asn53 were gained as acceptors; the side chain OE2 Glu41, NE and NH2 of Arg76, 
NE2 Gln 78 and OG1 of Thr57 were lost and OD1 Asp44 and OD1 Asn53 were gained 
(Figure 5.3(C)). The T57A mutant retains all the main chain hydrogen bond interactions 
with di-mannose; however, it loses all the side chain interactions except OD1 of Asp44, 
which explains the slightly higher decrease in binding affinity as compared to E41A 
mutant (Figure 5.3(D)).  E41G displays similar hydrogen bond network (Figure A.4 in 
Appendix A). The analysis shows that compared to the hydrogen bond network of the 
P51G-m4-CVN:di-mannose complex, N42A loses the highest number of hydrogen bonds 
to di-mannose, most  of which are  backbone hydrogen bonds. The loss of hydrogen 
bonds in T57A and E41A corresponds mostly to side chain hydrogen bonds. These 
findings suggest that the identity of the side chains at positions 41 and 57 play a critical 
role in di-mannose binding. Conversely, our results suggest that N42 defines the integrity 
(the local stability) of the binding pocket by making critical side chain to backbone 
hydrogen bonds to the neighboring beta sheet. While polar to Ala  mutations have 
disruptive effects on binding, we observe that conservative Asn to Ser mutation at 
position 53 preserves a hydrogen bond pattern conducive to binding. The interactions of 
main chain N of Asn42, OE2 of Glu41, OG1 of Thr57 and NE2 of Gln78 were lost, but 
additional side chain interaction of N Asp44, O of Ser53, OD1 of Asp44, OG of Ser53 
were gained compared to P51G-m4-CVN:di-mannose (Figure 5.3(E)). The detailed 
hydrogen bond analysis is also provided in Table A.3 in Appendix A.  
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5.3.3 Analysis of the Role of Flexibility in the Hinge Region of CVN and its Mutants 
In the study mentioned above, we identified the individual contributions to 
binding affinity by the residues in the pocket of domain B using BP-Dock and 
experimental techniques. In this section, we extend our study to the hinge region of CVN 
as the hinge region in the vicinity of Pro51 is directly associated with the protein’s ability 
to access the domain swapped dimer form (Barrientos et al., 2002). To this aim, our 
collaborators performed four independent 200ns long MD simulations for unbound wt-
CVN (PDB: 2EZM) and P51G-m4-CVN (PDB: 2Z21) at 300K and 330K. The 
comparison of alignments at two different temperatures of wild type CVN and the mutant 
from the four independent runs showed that the average pocket structure is almost 
identical across simulations in the case of wt-CVN at 300K and at 330K as shown in 
Figure 5.4(A). 
In contrast, the average structure for the P51G-m4-CVN mutant changes more 
pronouncedly across same temperature trajectories and across different temperatures 
(Figure 5.4(B)). In other words they observed that the hinge region of wt-CVN is 
significantly more rigid. Resilience to changes in the hinge region in the case of wild type 
can also be expected upon perturbations induced by forces associated with approaching 
ligands. On the other hand, the P51G mutation provides extra flexibility to the region. To 
support this evidence, we also performed our dfi analysis (see Methods for detail) to 
investigate the difference in flexibility of the hinge region between wt-CVN and P51G-
m4-CVN mutant. The % dfi values for wt-CVN and P51G-m4-CVN are shown as a plot 
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Figure 5.4: Alignment of eight trajectory averaged structures (4 gray structures at 300K 
and 4 black structures at 330K) in the case of wt-CVN (left) and the P51G-m4-CVN 
mutant (right). At both temperatures, the average structure of the hinge region is almost 
unchanged in the case of wt-CVN. The opposite is true in the case of the mutant where 
the hinge takes on different conformations. We notice that the hairpin in the vicinity of 
Asn42 appears to also be more mobile at high temperature in the case of the mutant. 
 
and also on the ribbon diagram in Figure 5.5 and are consistent with the results from 
molecular dynamics simulations. The hinge region shows lower % dfi value for wt-CVN 
as compared to P51G-m4-CVN. The relatively higher values of % dfi for P51G-m4-CVN 
in the hinge region suggest that glycine at position 51 induces flexibility, whereas proline 
in wt-CVN makes the hinge region stiffer. Conversely, having a low % dfi value for 
proline in the hinge region of wt-CVN also indicates dynamic stability, as it suggests that 
the residue can absorb and transfer any perturbation throughout the chain in a dynamic 
cascade fashion, thus leading to a lesser flexible pocket. This analysis shows that the 
hinge region around position 51 is significantly stiffer in the case of wt-CVN when 
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compared to P51G-m4-CVN, thus locking the backbone conformation of the binding 
pocket. 
Furthermore, the MD simulations analysis shows that the mobility of the hairpin 
in the vicinity of Asn42 significantly increase at higher temperatures. Here, we define the 
distance between carbonyl oxygen in Asn53 to the amide hydrogen in Asn42 as an order 
parameter that we will call Dpocket. When Dpocket is smaller than certain distance the 
binding pocket is closed and does not support glycan binding. On the other hand, when 
Dpocket is larger the binding pocket is open and binding is allowed. Using the data from all 
the simulations, our collaborators, Dr. Margulis and colleagues observed the probability 
of observing different values of Dpocket at different temperatures for wt CVN and P51G-
m4-CVN mutant (Figure A.5 in Appendix A). Their analysis over extensive 800 ns 
simulations at the two temperatures showed that the probability (sum of frequencies in 
Figure A.5 in Appendix A) of finding the pocket open for binding (Dpocket>4 Å) follows 
the trend; wt-CVN 330K > wt-CVN 300K > P51G-m4-CVN 300K > P51G-m4-CVN 
330K. This suggests that in the monomeric form, rigidity in the hinge region protects the 
structure of the high affinity binding site of wt-CVN and that the P51G mutation should 
be detrimental to binding.  
5.3.4 Binding Affinity Predictions for WT-CVN and P51G-m4-CVN 
In this section, we investigate deeper into our hypothesis that close interactions 
between Asn42 and Asn53 can be linked to a potential decrease in binding affinity 
between di-mannose and protein. To this aim, we performed docking calculations using 
BP-Dock docking that includes flexibility of protein, which is extremely important in this 
study. To explore these issues, we pursued both rigid and flexible docking approaches.  
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Figure 5.5: (A) A plot of the % dfi values in the case of wt-CVN and P51G-m4-CVN. 
The hinge region is highlighted with a red box. The % dfi profiles for the hinge-region 
are also shown on the ribbon diagram of (B) wt-CVN and (C) P51G-m4-CVN with Pro51 
and Gly51 in sticks. 
 
The rigid docking procedure was carried out using RosettaLigand (Davis & Baker, 2009; 
Meiler & Baker, 2006) and the flexible docking approach was based on the BP-Dock 
protocol (discussed in Chapter 3). In the rigid protocol, we docked di-mannoseonto the 
apo crystal structure for P51G-m4-CVN (PDB code: 2Z21) and the apo solution structure 
for wt-CVN (PDB code: 2EZM), that were also used for carrying out MD simulations. In 
the flexible protocol, we used the same two structures as a starting point to generate our 
ensemble of docking poses. Both the solution structure for wt-CVN (carbonyl oxygen of 
Asn53 and amide hydrogen of Asn42 bond distance: 5.7 Å) and the crystal structure for 
P51G-m4-CVN (carbonyl oxygen of Asn53 and amide hydrogen of Asn42 bond distance: 
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4.6 Å) have a Dpocket consistent with the open configuration. In the case of P51G-m4-
CVN, the ensemble of structures generated using the PRS approach resulted in a wider 
range of carbonyl oxygen of Asn53 to amide hydrogen of Asn42 bond distances 
consistent with the sampling of open and closed pocket conformations. Instead, the PRS 
generated ensemble of wt-CVN favored open binding pocket conformations with better 
accessibility for dimmanose; this contributed in attaining better orientations during our 
ensemble docking (Figure 5.6). As a result, we observe that the lowest energy docked 
pose of the mutant is missing side-chain hydrogen-bond interactions for residues Asn42 
and Gln78 in the case of P51G-m4-CVN as compared to the docked pose of wt-CVN. 
This explains the lower binding energy score for P51G-m4-CVN. Scoring function 
results from our rigid and best flexible docking pose are summarized in Table 5.2. 
Table 5.2. Rigid and BP-Dock docking results for wt-CVN and P51G-m4-
CVN. 
Protein Rigid RosettaLigand Score  
(kcal/mol) 
BP-Dock RosettaLigand Score 
(kcal/mol) 
wt-CVN -159.5 -291.74 
P51G-m4-CVN -256.28 -264.47 
 
The rigid docking approach predicts that the apo structure of the P51G-m4-CVN mutant 
should be a better binder when compared to the apo structure of wt-CVN. Instead, the 
opposite is found when flexibility is taken into account. The inclusion of flexibility in the 
docking protocol results in the prediction that wt-CVN is a better binder than the mutant. 
To confirm these results we also generated an ensemble of conformations for docking 
using the covariance matrix of last 10 ns of a 200 ns long MD simulation at 300 K in 
conjunction with BP-Dock. In this case as well, the mutant sampled both open and closed 
conformations whereas wild type only sampled open conformations. Moreover, the 
binding affinity predictions for the ensemble generated using the covariance matrix 
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approach are consistent with those presented in Table 5.2 and provide verification of the 
tighter binding by wild type.  
Table 5.3: Experimental data for wt and mutants CVN proteins 
Protein KD (µM) 
wt-CVN 16.0 ± 1.1 
P51G 212.8 ± 8.6 (two sites) 
m4 (m) 7.2 ± 0.5 
m4 (dimer) 39.7 ± 4.1 
P51G-m4 140.6 ± 8.6 
 
As a last test and to validate our computational predictions, ITC tests were 
performed to assess the binding of P51G-m4-CVN and related mutants to di-mannose 
(experimental work was performed by J. D. Maxwell from Dr. Ghirlanda’s group and 
ITC experiments were carried out by Andrey Bobkov from Sanford-Burnham Medical 
Research Institute). The experimental Kd values from ITC experiments are also reported 
in Table 5.3. Analysis of these results reveals that proteins containing a native proline at 
position 51 in the hinge region, e.g. wt-CVN and m4, display binding constants (Kd) in 
the low micromolar range at the high affinity site, assigned as domain B. In sharp 
contrast, the presence of glycine at position 51 results in a dramatic loss of affinity, with 
binding constants approximately 212.8 micromolar at that site. This data also confirms 
that domain A binds di-mannose with much lower affinity than domain B (405 µM vs 16 
µM in wt-CVN). 
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Figure 5.6: The top panel shows the ensemble of unbound structures obtained from PRS 
for ensemble docking.  The hydrogen bond between oxygen of Asn53 and amide 
hydrogen of Asn42 of the unbound structures is shown and labeled with the 
corresponding distance in Angstrom. The ensemble of wt-CVN (left) consists of 
conformations with only open binding pocket whereas P51G-m4-CVN (right) shows 
conformations with both open and closed binding pocket.  The approaching sugar to be 
docked is shown in cyan. The bottom panel shows the side-chain hydrogen-bond network 
for the lowest energy docked pose of wt-CVN (left) P51G-m4-CVN (right) after 
ensemble docking. The side chains that form a hydrogen bond with the sugar are shown 
in yellow and the hydrogen bonds in orange. The docked sugar is shown in cyan. 
 
In the case of P51G-CVN that has intact domains A and B, the differentiation 
between the two domains was not possible, which resulted in the appearance of two 
distinct sites each binding di-mannose with binding constants of 212.8 µM. However, the 
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effect of domain-swapped dimerization was assessed by the dimeric version of m4. This 
revealed that the binding constant for domain B is only slightly decreased from 7.2 µM in 
the monomer to 39.7 µM in the dimer. Taken together, these data paint a clear picture of 
the role of the hinge region in modulating the affinity of domain B for di-mannose, and 
confirm our computational observations that mutants containing P51G mutation in the 
hinge region are inferior binders. 
 5.4 Conclusions 
This chapter highlights the approach of utilizing both computational and 
experimental methods in unfolding the contributing factors for the binding affinity of the 
Manα(1→2)Manα glycan moiety and CVN. This study elucidates the role of side chain 
interactions in stabilizing the complex of di-mannose and P51G-m4-CVN, with N42, T57 
and E41 emerging as a key factor for strong binding to di-mannose. As shown here, N42 
also appears to stabilize the binding pocket; its absence alters the hydrogen bonding 
network within the protein and to the ligand, and abolishes binding. These effects add to 
other previously identified key interactions in CVN, such as the side chains Arg76 (20, 
53) along with main chain hydrogen networks (Vorontsov & Miyashita, 2011), 
suggesting that a complex interplay between hydrogen bonds contributes to the 
remarkable affinity and specificity of CVN for a(1-2) linked mannose. Furthermore, this 
study also provides significant evidence that the P51G mutation enhances the flexibility 
of the hinge region in a way that is detrimental to glycan binding which are fully 
supported by ITC measurements. The motion of the hinge region results in blocking the 
high affinity binding site by Asn53 in the mutant P51G-m4-CVN. Instead, the rigidity of 
the hinge region due to Pro51 in the case of wt-CVN alters the position of Asn53, 
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preventing it from blocking the binding site. Such rigidity maintains the binding pocket in 
an “open” conformation a large fraction of the time. The hairpin including Asn42 can 
become activated and also contribute to blocking the binding pocket. This is seen most 
prominently in the case of the mutant at higher temperature. Notably, a full survey of 
published structures of CVN and engineered mutants reveals that almost in all cases 
when glycan binding is observed the distance between Asn53 and Asn42 is larger than 4 
Å, indicating an open pocket, and in cases when binding is abolished the distance 
between these residues is small, suggesting a closed pocket blocking binding (L. G. 
Barrientos et al., 2002) (Matei et al., 2008) (Koharudin et al., 2008) (Carole A Bewley et 
al., 1998) (Laura G Barrientos, Louis, Ratner, Seeberger, & Gronenborn, 2003). This 
suggests that there is a mechanism where Asn53 temporary blocks the binding site in 
domain B or a symmetrically located residue in domain A. The fraction of the time this 
reversible blocking occurs should statistically correlate with the higher or lower binding 
affinity of wt-CVN and its analogs.  
Nonetheless, this study also highlights the importance of inclusion of flexibility in 
computational approaches for studying CVN proteins and the effect of mutations on their 
functionality. Indeed, computationally efficient approaches based on PRS can easily 
assess the effect of mutations on the binding affinity and specificity of cyanovirin-based 
lectins as compared to wild type. This also presents PRS as an efficient tool in the 
designing of novel glycan-binding agents based on CVN that can also be tailored to other 
glycans of interest.  
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CHAPTER 6 
 
ADAPTIVE BP-DOCK AND ITS APPLICATIONS 
 
6.1 Introduction 
Computational tools such as molecular docking provide an efficient and easier 
way to model protein-ligand interactions. BP-Dock, a protein-ligand docking tool 
developed in our lab can capture the functionally related motions that occur upon ligand 
binding through a coarse-grain modeling approach, PRS (Atilgan & Atilgan, 2009). BP-
Dock mimics the ‘conformational selection’ model of nature, in which the protein 
undergoes conformational sampling even before it binds to the ligand. Therefore, the 
success of BP-Dock rests in generating multiple receptor conformations that are sampled 
during the binding event. Chapters 3-5 of this thesis show the successful application of 
our ensemble docking approach BP-Dock, in understanding the binding energetics of 
several proteins. However, the use of multiple conformations for docking also increases 
computational times as it scales linearly with the number of receptor conformations in the 
ensemble (Korb et al., 2012). 
Here in this study, we extend our flexible docking approach to the induced fit 
docking model. Induced fit docking simulations allows the protein to sample backbone 
flexibility during the docking simulation. This can be a highly accurate technique for 
modeling bound complexes of protein and ligand allowing for conformational changes 
during the docking. However, the conformational sampling of protein and ligand during 
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the simulation can be quite computationally intensive, and this limits its application in 
large-scale virtual screening studies (Lexa & Carlson, 2012).  
To this aim, we developed an induced fit docking approach called Adaptive BP-
Dock that integrates BP-Dock with the flexible-backbone protocol of RosettaLigand 
(Davis & Baker, 2009) in an adaptive manner. The flexible backbone protocol of 
RosettaLigand allows full ligand flexibility by changing backbone and torsional angles of 
the ligand while adding restrained minimization on the receptor backbone to provide 
limited receptor flexibility. In Adaptive BP-Dock, as a first step we perturbed all the 
binding site residues simultaneously for an unbound protein, while optimizing the ligand 
orientation through flexible-backbone protocol of RosettaLigand. We generated 1000 
docked (receptor-ligand) trajectories for each perturbation (iteration) step and selected the 
lowest energy docked pose for the next iteration for a total of 10 iterations. With 
Adaptive BP-Dock, we aim to combine the potential of BP-Dock in providing full protein 
flexibility along with full ligand flexibility from RosettaLigand during the docking 
simulation. Overall, our docking analysis of a large dataset shows that Adaptive BP-Dock 
can easily capture binding induced conformational changes by simultaneous sampling of 
protein and ligand conformations.  
6.2 Methods 
6.2.1 Benchmark Protein Dataset 
As a retrospective assessment of our new Adaptive BP-Dock approach, we 
analyzed 5 different diverse sets of protein-ligand complexes and glycan-cyanovirin 
interaction from our previous work (Bolia et al., 2014; Bolia, Woodrum et al., 2014). The 
5 protein test sets includes flexible receptor of HIV-1 Protease (N = 20), Carbonic 
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Anhydrase II (N = 9), Alcohol Dehydrogenase (N = 8), Alpha-Thrombin (N = 13) and 
Cytochrome C Peroxidase (N = 18); where N is the number of bound (protein-ligand) 
complexes for each protein set. The different bound (holo) structures and one 
representative unbound (apo) structure for each protein set were retrieved from Protein 
Data Bank (PDB) (Berman et al., 2000). The complete list of all the proteins and ligands 
for these 5 protein test sets is same as Table 3.1. The glycan-cyanovirin study includes 
estimating binding affinities of CVN and its single point mutants (N = 9) for di-mannose 
sugar. Moreover, we also performed self and cross docking for Meiler and Baker set of 
10 pairs of co-crystallized receptor-ligand (bound) structures (Davis & Baker, 2009; 
Meiler & Baker, 2006). Furthermore, as the last test we attempted the docking of highly 
flexible receptor of HIV-1 Reverse Transcriptase (N = 25) and anti-cancer drug target 
Urokinase (N = 20). For all the protein test cases, we compared the performance of our 
Adaptive BP-Dock approach with flexible-backbone protocol of RosettaLigand. Overall, 
we had a large and diverse data set of 162 different protein-ligand complexes to evaluate 
the performance of Adaptive BP-Dock. The complete list of all the proteins and ligands 
for the HIV-1 Reverse transcriptase and Urokinase proteins are reported in Table 6.1. 
6.2.2 Adaptive BP-Dock Approach 
In Adaptive BP-dock, we followed the same approach of using PRS to model 
binding induced conformational changes, similar to BP-Dock. We begin with building 
Cα model of our protein and obtained the Hessian (for details, see Chapter 2) for our 
protein network using equation (2.2). However, instead of perturbing each residue in the 
network sequentially, we perturbed the pre-specified binding pocket residues  
 
  101 
Table 6.1: PDB codes of unbound and bound structures, chain length, RMSDs between 
bound and unbound structures, native peptides or ligands, and peptide sequences for the 
HIV-1 Reverse transcriptase and Urokinase proteins used in this study. 
 
Protein 
PDB Code 
Chain Length 
RMSD 
 Ligand  Bound Unbound (Å) 
(Holo) (Apo)   
HIV-1 Reverse Transcriptase 1DTQ 1DLO 556 2.948 FPT 
HIV-1 Reverse Transcriptase 1DTT 1DLO 556 2.612 FTC 
HIV-1 Reverse Transcriptase 1IKV 1DLO 556 2.574 EFZ 
HIV-1 Reverse Transcriptase 1IKW 1DLO 556 2.554 EFZ 
HIV-1 Reverse Transcriptase 1IKX 1DLO 556 2.419 PNU 
HIV-1 Reverse Transcriptase 1IKY 1DLO 556 2.413 MSD 
HIV-1 Reverse Transcriptase 1JLQ 1DLO 556 2.452 SBN 
HIV-1 Reverse Transcriptase 1TKT 1DLO 556 2.982 H12 
HIV-1 Reverse Transcriptase 1TKX 1DLO 556 2.384 GWB 
HIV-1 Reverse Transcriptase 1TKZ 1DLO 556 3.002 H16 
HIV-1 Reverse Transcriptase 1TL1 1DLO 556 2.967 H18 
HIV-1 Reverse Transcriptase 1TL3 1DLO 556 2.947 H20 
HIV-1 Reverse Transcriptase 1TV6 1DLO 556 3.21 CP9 
HIV-1 Reverse Transcriptase 2B5J 1DLO 556 3.183 3AC 
HIV-1 Reverse Transcriptase 2BAN 1DLO 556 3.516 357 
HIV-1 Reverse Transcriptase 2BE2 1DLO 556 2.76 R22 
HIV-1 Reverse Transcriptase 2HNY 1DLO 556 3.082 NVP 
HIV-1 Reverse Transcriptase 3I0R 1DLO 556 2.288 RT3 
HIV-1 Reverse Transcriptase 3I0S 1DLO 556 2.074 RT7 
HIV-1 Reverse Transcriptase 3IRX 1DLO 556 3.692 UDR 
HIV-1 Reverse Transcriptase 3IS9 1DLO 556 3.47 AC7 
HIV-1 Reverse Transcriptase 3LP2 1DLO 556 1.918 LP9 
HIV-1 Reverse Transcriptase 3M8P 1DLO 556 2.173 65B 
HIV-1 Reverse Transcriptase 3M8Q 1DLO 556 1.992 DJZ 
HIV-1 Reverse Transcriptase 3QO9 1DLO 556 4.054 QO9 
Urokinase 1C5X 4DVA 246 0.429 ESI 
Urokinase 1C5Y 4DVA 246 0.43 ESP 
Urokinase 1C5Z 4DVA 246 0.44 BAM 
Urokinase 1EJN 4DVA 246 0.404 AGB 
Urokinase 1F5K 4DVA 246 0.377 BAM 
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Table (6.1) continued 
Protein 
PDB Code 
Chain Length 
RMSD 
 Ligand  Bound Unbound (Å) 
(Holo) (Apo)   
Urokinase 1F5L 4DVA 246 0.379 AMR 
Urokinase 1F92 4DVA 246 0.397 UKP 
Urokinase 1GI7 4DVA 246 0.446 120 
Urokinase 1GI8 4DVA 246 0.429 BMZ 
Urokinase 1GI9 4DVA 246 0.43 123 
Urokinase 1GJ7 4DVA 246 0.409 132 
Urokinase 1GJ8 4DVA 246 0.416 133 
Urokinase 1GJA 4DVA 246 0.396 135 
Urokinase 1GJB 4DVA 246 0.465 130 
Urokinase 1GJC 4DVA 246 0.431 130 
Urokinase 1GJD 4DVA 246 0.405 136 
Urokinase 1O3P 4DVA 246 0.438 655 
Urokinase 1O5A 4DVA 246 0.416 696 
Urokinase 1O5B 4DVA 246 0.42 ESI 
Urokinase 1O5C 4DVA 246 0.408 CR9 
 
simultaneously by applying a random unit force, F (i.e. a random Brownian kick) in the 
XYZ direction. Here, by perturbing only the binding pocket residues, we are mimicking 
the forces exerted on the binding site when a ligand approaches the protein, as a first 
order approximation like random Brownian kicks. The response from all other residues 
was calculated using linear response theory as given by equation (2.19) and a perturbed 
conformation was generated using equation (3.1). As the perturbed conformation was 
coarse grained and contained only C-alpha atoms, we added the side chains back from the 
initial structure, and performed an energy minimization to relax the structure and relieve 
any steric clashes in the perturbed system. The all atom perturbed structure was energy 
minimized with 50 steepest descent iterations followed by 1000 conjugate gradient 
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iterations using the AMBER14 forcefield (Case et al., 2014), along with a GB solvation 
model (Tsui & Case, 2000). After the energy minimization, all side chains were repacked 
with Rosetta’s ligand_rpkmin algorithm (Davis & Baker, 2009; Meiler & Baker, 2006; 
Davis et al., 2009), so that any pre-existing clashes (according to Rosetta's energy 
function) can be resolved.  
 
Figure 6.1: Flowchart of the Adaptive BP-Dock method. In the first round of iteration: 
the unbound protein is (i) coarse grained to C-alpha model, then (ii) all the pre-specified 
binding site residues are perturbed by exerting random external forces simultaneously, 
and (iii) the fluctuation responses from all the residues in network is calculated using the 
PRS method to generate a new perturbed conformation. Side chains are added to the 
perturbed coarse-grained structure and an all-atom minimization is performed. The 
minimized perturbed structure is then docked using the flexible-backbone docking 
protocol of RosettaLigand for 1000 steps. The lowest energy docked pose is selected and 
perturbed again in the second round of iteration. Similarly, the iterations are repeated 10 
times with the best docked pose of the previous iteration except the first one where we 
start with the unbound structure. Lastly, the lowest energy docked pose from the final 
(10th) iteration is selected and re-evaluated with X-Score. For complete details, see 
Methods. 
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The repacked protein structure was then docked with RosettaLigand to compute 
1000 trajectories/models and the best docked pose among the models was used for 
generating a new perturbed structure for the next round of docking iteration. After 1000 
docking steps, the docked models were sorted based on total energy score and top 5% of 
the models were ordered again based on their interface delta energy scores as described 
earlier (Kaufmann & Meiler, 2012). The interface delta energy score is the total energy of 
the bound protein-ligand complex minus the total energy of the unbound protein when 
the ligand is separated from the binding site (i.e. 500 A ̊ away from the unbound protein). 
The best model with the lowest interface delta score was then selected as the lowest 
energy docked pose of the first iteration and used for perturbation in the second round of 
iteration. The process of perturbation and docking with RosettaLigand was performed 
iteratively for 10 cycles, until we observed a consistent decrease in the binding energy 
scores and formation of a well-converged distinct binding funnel in energy score/RMSD 
plots, which is considered as a successful indication of the convergence of the docking 
simulation. We sampled 1000 docking trajectories in an iteration of Adaptive BP-Dock 
docking (total 10000 protein-ligand docked complexes) and with each iteration, we see 
an overall decrease in the binding energy scores and formation of a nice docking funnel 
in the protein-ligand energy landscape. After 10 successful iterations, the final docked 
lowest energy pose was selected and re-scored using X-Score, which is an empirical 
scoring function developed to re-rank the protein-ligand complex to give a more accurate 
estimation of the binding free energies (Wang et al., 2002). The overall outline of 
Adaptive BP-Dock approach is shown in Figure 6.1. 
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6.3 Results and Discussion 
As a first test, we wanted to validate our new Adaptive BP-Dock approach using 
the same protein datasets that were tested earlier form our previous work with BP-Dock 
(Bolia et al., 2014; Bolia, Woodrum et al., 2014). We also assessed our Adaptive BP-
Dock approach on the cross-docking data set used for validating the docking protocol of 
RosettaLigand and compared it with their results (Davis & Baker, 2009; Meiler & Baker, 
2006). Furthermore, we also extended our approach to some more difficult docking test 
cases such as HIV-Reverse Transcriptase and Urokinase that are known to be highly 
flexible and have broad applications in drug discovery and design. 
 
Figure 6.2: (A) Front and (B) Top view of bound structure [PDB id: 1A3O] (cyan); 
unbound structure [PDB id: 2PC0] (green); and the final perturbed (magenta) 
conformation obtained from last iteration of Adaptive BP-Dock for unbound structure 
[PDB id: 2PC0] for one of test case from HIV-1 Protease (PR) data set. The ligand is 
shown in gray (A). The perturbed unbound structure can sample closed flap conformation 
similar to the bound structure whereas unbound structure has open flaps. 
 
6.3.1 Docking results for 5 protein-ligand datasets 
Previously, we have shown that BP-Dock approach gives better correlation with 
experimental binding affinities as compared to rigid bound and unbound docking for five 
different test sets of protein-ligand complexes: HIV-Protease (PR), carbonic anhydrase II 
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(CA II), alcohol dehydrogenase (AD), alpha-thrombin (AT) and cytochrome C 
peroxidase (CCP) (see Chapter 3). Therefore, we wanted to check if we could still 
capture similar or better results with our Adaptive BP-Dock approach. As described 
earlier (Bolia et al., 2014), we still have several bound (i.e. different ligands) structures 
for all these test cases but only one unbound structure. For both PR and CCP, we used the  
modeled unbound structure due to point mutations in their bound structures (see Methods 
for Chapter 3). Moreover, for PR, we used a wide-open conformation for the unbound 
structure to test if we can capture closed bound-like binding affinities with our Adaptive 
BP-Dock approach. Interestingly, with our Adaptive BP-Dock approach we were able to 
capture large backbone conformational changes even for the highly flexible receptor of 
PR. As shown in Figure 6.2(A), the unbound structure of PR is in open conformation 
(green) whereas bound structure is in closed form (cyan). In our Adaptive BP-Dock 
approach, we start with the open unbound conformation and perturb the binding site 
residues mimicking the ligand-binding induced event leading to a closed flap 
conformation in our final perturbed structure obtained from last iteration of Adaptive BP-
Dock (magenta). The top view of the receptors (Figure 6.2(B)) clearly shows the closing 
of flaps in unbound structure upon perturbation. This indicates the capability of our 
Adaptive BP-Dock approach in correctly predicting the binding-induced conformational 
changes even when we start with an unbound conformation of protein. Furthermore, we 
also performed docking for the bound and unbound crystal structures with the flexible 
docking protocol of RosettaLigand to have a better comparison with our Adaptive BP-
Dock approach. RosettaLigand incorporates full ligand flexibility by changing torsional 
angles and backbone of the ligand during the docking, and limited backbone flexibility by 
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adding restrained minimization of the receptor backbone at the end of every docking 
trajectory. However, RosettaLigand alone cannot sample large backbone conformational 
changes and therefore combining it with PRS in our Adaptive BP-Dock approach, can 
help us sample both full receptor and full ligand flexibility. Figure 6.3 shows the interface 
delta energy score/RMSD plots for HIV-1 Protease when docked with a peptide (PDB id: 
1HEG) to the unbound conformation (PDB id: 2PC0) of HIV-1 Protease using our 
adaptive BP-Dock docking and flexible-backbone docking protocol of RosettaLigand.  
 
Figure 6.3: The interface delta energy scores (kcal/mol) vs RMSD of the docked complex 
for apo HIV-1 protease (PDB id: 2PC0) docked with EDL peptide (PDB id: 1HEG) from 
(A) iterative Adaptive BP-Dock approach for 1st, 5th and 10th iteration (B) flexible-
backbone docking with RosettaLigand. 
 
We sample 1000 docking trajectories in an iteration of adaptive BP-Dock docking (total 
10000 protein-ligand docked complexes from 10 iterations) and with each iteration, we 
see an overall decrease in the binding energy scores and formation of a nice docking 
funnel in the protein-ligand energy landscape. Figure 6.3A shows the energy scores 
decreasing from 1st → 5th → 10th iteration along with a decrease in the RMSD of ligand 
in the docked pose compared to the position of native ligand obtained from the bound 
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experimental structure. This shows the advantage of incorporating backbone flexibility in 
docking that helps in obtaining better ligand placement inside the binding pocket of a 
protein. The lowest interface delta energy scores and X-Scores for the lowest energy 
docked pose from flexible bound (flexible protocol of RosettaLigand for bound 
structures), flexible unbound (flexible protocol of RosettaLigand for unbound structures) 
and Adaptive BP-Dock unbound (Adaptive BP-Dock approach for unbound structures) 
for all the five protein test sets are reported in Table 6.1. The experimental binding 
affinities for all the test cases obtained from LPDB (Roche et al., 2001) and Astex 
databases (Hartshorn et al., 2007) are also reported in Table 6.1. 
For all the 5 test sets, the X-Score energies of Adaptive BP-Dock unbound have 
better correlation with experimental binding energies than both flexible bound and 
unbound docking using RosettaLigand flexible-backbone protocol. The correlation plots 
of X-Score energies for (i) flexible bound, (ii) flexible unbound and (iii) Adaptive BP-
Dock unbound verses the experimental binding energies are plotted in Figure 6.3. 
Strikingly for AD and CCP, the X-Score energies for flexible unbound docking protocol 
have negative correlation (AD: R = -0.25; CCP: R = -0.25) with the experimental 
binding energies, but incorporating full receptor flexibility with Adaptive BP-Dock 
improved these correlations significantly (AD: R = 0.28; CCP: R = 0.37). Moreover, 
when we look at the correlation of the interface delta energies with experimental binding 
affinities, we observe similar patterns, where Adaptive BP-Dock approach with unbound 
structures has significant higher correlations compared to flexible unbound docking with 
RosettaLigand. Interestingly, for both CCP and PR, the interface delta energy correlations 
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for Adaptive BP-Dock unbound approach are even higher than the flexible bound 
docking. 
 The overall correlation coefficients (R) of X-Score energies with experimental 
binding affinities for all the 5 protein test sets clearly show the success of Adaptive BP-
Dock by incorporating backbone flexibility in unbound protein structures (R = 0.71). 
Interestingly, it is exactly similar to the flexible bound docking (R = 0.71) and higher 
than flexible unbound docking (R = 0.62). Moreover, the Adaptive BP-Dock approach 
has also higher correlation with experimental affinities than BP-Dock approach, as 
reported earlier (R = 0.65) for the five test sets (Bolia et al., 2014). We believe that by 
perturbing only the binding pocket residues helped in achieving better correlations as 
compared to BP-Dock approach where we perturbed all the residues in the protein one at 
a time, which might have averaged out the overall response. Moreover, our iterative 
induced fit docking approach based on PRS helps in incorporating receptor backbone 
flexibility while simultaneously optimizing the ligand conformation inside the binding 
pocket. The side chains lining the binding pocket reorient themselves to accommodate 
the ligand and this allows the docking simulation to search for new conformational space 
that helps in accurate prediction of protein-ligand docked pose as compared to ensemble 
docking. 
 Furthermore, the overall correlation coefficients (R) of interface delta energy scores 
with experimental binding affinities also show significantly higher improvement for 
Adaptive BP-Dock (R = 0.61) as compared to flexible unbound docking (R = 0.45) and 
are comparable to flexible bound docking (R = 0.69). Therefore, with Adaptive BP-Dock 
we can significantly improve binding affinity predictions in unbound structures by 
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incorporating larger backbone conformational changes in proteins mimicking the binding 
induced events upon ligand docking.  
 
6.3.2 Docking results for glycan-CVN binding 
 In this study, we performed a retrospective assessment of our new Adaptive BP-
Dock approach with our old BP-Dock method. Here, we tested glycan binding to 
Cyanovirin-N (CVN) and its mutants (Bolia, Woodrum et al., 2014). CVN is a 101 amino 
acid lectin that targets the mannose-rich glycans on the surface envelope of HIV and 
other enveloped viruses. Moreover, its potent activity against HIV through its multivalent 
interactions with oligomannoses on surface of gp120 makes it an interesting target for 
drug industry (see Chapter 5). Glycans are extremely flexible and therefore modeling 
them computationally has always been a challenge. Therefore, we chose CVN as a model 
system for investigating glycan-protein interactions and benchmarking our Adaptive BP-
Dock approach to glycan recognition.  
 Earlier, we have estimated binding affinities of CVN and its single point mutants 
for di-mannose with BP-Dock (Bolia, Woodrum et al., 2014). We have shown that single 
point mutations in CVN can have disrupting effects on its binding energies and proper 
modeling of receptor backbone flexibility plays a crucial role in correctly predicting the 
binding affinity patterns in CVN. In this study, we performed Adaptive BP-Dock docking 
for all the CVN and its single point mutants. The X-Score energies for the lowest energy 
docked poses of all CVN mutants are reported in Table 6.2 along with previously 
reported BP-Dock scores and experimental binding data (Bolia et al., 2014). The 
correlation between our Adaptive BP-Dock with BP-Dock approach for CVN test set is  
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Table 6.2: Interface Delta energy scores and X-Scores for Flexible Bound docking with 
bound structure; Flexible Unbound and Adaptive BP-Dock Unbound docking for 
unbound structure with available experimental data for 5 protein data sets. Higher 
negative values indicate a higher binding affinity prediction 
 
 
 
 
 
Protein 
PDB Code 
Chain 
Length 
RosettaLigand Score (kcal/mol) X-Score (kcal/mol) 
Exp. ∆G 
(kcal/mol) 
Flexible Backbone AdaptiveBP-Dock Flexible Backbone 
Adaptive
BP-Dock 
Bound Unbound Bound Unbound Unbound Bound Unbound Unbound 
(Holo) (Apo) (Holo) (Apo) (Apo) (Holo) (Apo) (Apo) 
 
 
 
 
 
 
 
 
 
HIV Protease 
 
 
 
 
 
 
 
 
 
 
1HBV 3IXO 198 -18.00 -10.45 -9.63 -10.43 -8.93 -8.66 -8.68 
1HEG 3IXO 198 -16.46 -10.77 -11.36 -10.03 -8.71 -8.62 -10.38 
1HIH 3IXO 198 -23.35 -13.18 -12.77 -11.40 -9.68 -9.40 -10.97 
1HIV 3IXO 198 -29.59 -18.76 -19.54 -12.36 -10.11 -10.36 -12.64 
1HPS 3IXO 198 -26.63 -18.19 -16.67 -11.97 -10.00 -9.84 -12.66 
1HTE 3IXO 198 -13.87 -10.64 -11.83 -9.26 -8.47 -8.39 -7.69 
1HTF 3IXO 198 -19.24 -11.33 -11.57 -10.32 -8.64 -8.61 -11.04 
1HTG 3IXO 198 -28.48 -19.99 -21.35 -12.78 -10.56 -10.89 -13.20 
1HVI 3IXO 198 -27.94 -18.64 -21.81 -12.32 -10.16 -10.93 -13.74 
1HVJ 3IXO 198 -27.12 -18.35 -20.37 -12.20 -10.27 -10.79 -14.26 
1HVK 3IXO 198 -29.03 -18.79 -17.45 -12.66 -10.36 -11.38 -13.79 
1HVL 3IXO 198 -26.34 -17.75 -18.59 -12.22 -10.01 -11.45 -12.27 
1HVS 3IXO 198 -26.51 -18.08 -19.17 -11.75 -9.06 -10.76 -13.81 
1SBG 3IXO 198 -23.20 -16.19 -13.53 -11.29 -9.55 -9.16 -10.38 
4HVP 3IXO 198 -24.15 -18.68 -11.36 -10.55 -9.60 -8.58 -8.33 
4PHV 3IXO 198 -31.67 -23.87 -22.71 -13.24 -11.28 -10.94 -12.56 
5HVP 3IXO 198 -20.95 -11.91 -14.59 -10.94 -8.75 -8.94 -10.50 
9HVP 3IXO 198 -26.62 -15.13 -14.50 -12.79 -9.64 -9.80 -11.38 
1A30 3IXO 198 -0.52 -9.68 -7.72 -4.20 -6.68 -6.62 -5.77 
1KZK 3IXO 198 -24.86 -16.13 -16.69 -12.08 -10.12 -9.81 -13.94 
 
 
 
 
Carbonic 
Anhydrase II 
 
 
 
 
1OQ5 2ILI 259 -12.75 -12.07 -10.51 -8.77 -8.84 -7.42 -10.29 
1AVN 2ILI 259 -4.13 -3.96 -4.10 -5.51 -5.48 -5.55 -2.88 
1CIL 2ILI 259 -10.99 -10.18 -9.26 -7.61 -7.51 -7.57 -12.94 
1CIM 2ILI 259 -10.41 -7.15 -7.50 -7.36 -7.29 -7.28 -12.10 
1CIN 2ILI 259 -11.02 -9.40 -8.11 -7.28 -7.31 -7.37 -11.97 
1CNW 2ILI 259 -9.93 -9.60 -7.64 -6.59 -6.77 -6.58 -10.60 
1CNX 2ILI 259 -9.52 -10.05 -8.62 -6.93 -6.90 -6.81 -10.11 
1CNY 2ILI 259 -10.87 -9.70 -8.38 -6.83 -6.81 -6.80 -10.78 
1OKL 2ILI 259 -13.65 -13.64 -11.98 -7.71 -7.69 -7.72 -12.39 
 
 
 
Alcohol 
Dehydrogenase 
 
 
 
 
1ADB 8ADH 374 -29.59 -18.93 -13.70 -10.48 -9.05 -8.17 -11.45 
1ADC 8ADH 374 -29.86 -18.81 -14.43 -10.79 -9.11 -8.28 -6.42 
1ADF 8ADH 374 -17.61 -16.75 -9.34 -8.56 -8.59 -5.02 -6.24 
1BTO 8ADH 374 -10.34 -8.83 -9.05 -6.68 -6.45 -6.47 -8.93 
1HLD 8ADH 374 -7.48 -6.19 -5.87 -6.27 -5.99 -6.03 -7.58 
1LDE 8ADH 374 -7.66 -6.94 -7.80 -6.19 -6.02 -6.09 -9.41 
1LDY 8ADH 374 -26.45 -6.76 -8.48 -10.78 -6.05 -6.37 -11.06 
3BTO 8ADH 374 -7.55 -8.98 -7.62 -7.19 -6.48 -6.38 -8.43 
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Table (6.2) continued 
 
 
 
 
 
pretty high (R = 0.86) and it also correlates extremely well with experimental binding 
data. This analysis suggests that Adaptive BP-Dock is a powerful in silico screening tool 
in assessing effect of mutations on binding affinities for glycan-CVN interactions or any  
 
Protein 
PDB Code 
Chain 
Length 
RosettaLigand Score (kcal/mol) X-Score (kcal/mol) 
Exp. ∆G 
(kcal/mol) 
Flexible Backbone AdaptiveBP-Dock Flexible Backbone 
Adaptive
BP-Dock 
Bound Unbound Bound Unbound Unbound Bound Unbound Unbound 
(Holo) (Apo) (Holo) (Apo) (Apo) (Holo) (Apo) (Apo) 
Alpha 
Thrombin 
1A4W 1C5L 274 -19.70 -16.80 -14.28 -9.50 -9.04 -8.65 -8.13 
1AE8 1C5L 298 -17.64 -16.31 -16.29 -8.65 -8.26 -8.52 -8.99 
1BMM 1C5L 295 -21.54 -18.56 -17.29 -9.66 -9.03 -8.91 -9.75 
1BMN 1C5L 292 -20.61 -17.13 -18.66 -10.11 -10.59 -10.55 -11.58 
1D3D 1C5L 290 -14.11 -19.76 -19.95 -7.82 -9.06 -9.05 -3.27 
1D3P 1C5L 290 -15.04 -21.38 -10.42 -9.79 -9.02 -8.96 -2.93 
1D4P 1C5L 290 -11.63 -18.47 -11.14 -8.94 -9.47 -7.32 -2.28 
1DWB 1C5L 298 -10.56 -9.84 -9.30 -6.73 -6.59 -6.61 -3.98 
1DWC 1C5L 298 -15.80 -15.42 -13.73 -9.08 -8.85 -8.77 -10.60 
1DWD 1C5L 298 -21.50 -19.90 -20.71 -11.38 -9.87 -9.91 -11.57 
1HDT 1C5L 303 -21.68 -18.12 -18.92 -9.86 -9.59 -9.73 -10.66 
1UVS 1C5L 268 -18.18 -17.63 -16.42 -9.10 -9.11 -8.87 -7.41 
1OYT 1C5L 306 -16.99 -15.49 -15.28 -9.43 -9.10 -9.12 -9.71 
 
 
 
 
Cytochrome 
C Peroxidase 
 
 
 
 
1AC4 1CCP 291 -5.02 -8.77 -6.95 -5.48 -6.42 -5.39 -3.85 
1AC8 1CCP 291 -9.18 -8.76 -8.58 -6.44 -6.31 -6.30 -4.78 
1AEB 1CCP 291 -6.80 -7.10 -6.63 -5.84 -5.78 -5.79 -4.81 
1AED 1CCP 291 -7.74 -7.55 -8.05 -6.12 -6.04 -6.08 -5.86 
1AEE 1CCP 291 -9.14 -9.08 -6.26 -6.57 -6.27 -5.55 -3.96 
1AEF 1CCP 291 -7.29 -7.22 -7.03 -6.24 -6.14 -6.14 -6.00 
1AEG 1CCP 291 -7.45 -7.32 -7.10 -6.24 -6.18 -6.20 -5.99 
1AEH 1CCP 291 -6.92 -7.25 -6.93 -6.24 -6.22 -6.21 -4.96 
1AEJ 1CCP 291 -7.93 -7.92 -7.33 -6.10 -6.04 -5.92 -5.21 
1AEK 1CCP 291 -9.58 -9.06 -9.35 -6.79 -6.81 -6.74 -4.92 
1AEM 1CCP 291 -9.05 -9.52 -9.71 -6.44 -6.41 -6.43 -4.92 
1AEN 1CCP 291 -10.58 -7.95 -10.65 -7.22 -6.22 -7.35 -7.07 
1AEO 1CCP 291 -9.16 -8.99 -9.26 -6.47 -6.32 -6.37 -5.02 
1AEQ 1CCP 291 -7.77 -7.72 -7.85 -6.34 -6.25 -6.27 -4.73 
1AES 1CCP 291 -6.15 -6.39 -6.30 -5.74 -5.71 -5.70 -4.33 
1AET 1CCP 291 -7.24 -6.53 -7.12 -5.83 -5.77 -5.81 -5.82 
1AEU 1CCP 291 -6.64 -6.79 -6.57 -6.09 -6.01 -6.08 -5.94 
1AEV 1CCP 291 -6.39 -6.33 -7.99 -6.98 -5.79 -6.83 -6.06 
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Figure 6.3: Correlation plots of X-Score binding energy scores obtained for lowest 
energy docked pose from Adaptive BP-Dock docking vs experimental binding energies 
for HIV-1 Protease (PR), carbonic anhydrase II (CA II), alcohol dehydrogenase (AD), 
alpha-thrombin (AT) and cytochrome C peroxidase (CCP). 
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glycan-lectin interaction, in general.  
6.3.3 Self and cross docking tests for Meiler and Baker dataset 
 To compare the performance of Adaptive BP-Dock approach with flexible  
backbone protocol of RosettaLigand, we used the cross-docking data set of 10 pairs of 
co-crystallized receptor-ligand structures that was also used earlier to evaluate the 
performance of RosettaLigand over years (Meiler and Baker set; Davis & Baker, 2009; 
Meiler & Baker, 2006). This test allows for self- and cross-docking experiments for each 
bound-protein pair in the study that are quite challenging owing to the large, flexible 
ligands and rotamer changes for multiple side chains (Davis & Baker, 2009). Here, we 
looked at different aspect of docking studies: to obtain better or true binding modes rather 
than estimating binding affinities. Introducing receptor backbone flexibility can alter the 
receptor-energy landscape significantly.  
Table 6.3: Binding energy scores (X-Scores) evaluated from X-Score for the lowest 
energy docked pose obtained from Adaptive BP-Dock for CVN and its mutants. The X-
Score values for BP-Dock and experimental Kd values have been adapted from ref. 
(Bolia, Woodrum et al., 2014). Higher negative values indicate a higher binding affinity 
prediction 
 
Protein Adaptive BP-Dock X-Score (kcal/mol) 
BP-Dock 
X-Score (kcal/mol) 
 
Experimental Kd 
P51G-m4-CVN -6.89 -7.58 low µM 
CVN(mutDB) -5.35 -4.68 no binding (L. G. Barrientos et al., 2006) 
E41A -6.02 -6.7 541 ± 118 µM 
E41G -6.23 -6.82 389 ± 73 µM 
N42A -5.46 -5.37 no binding 
T57A -5.78 -6.46 low mM 
R76A -6.82 -6.9 NA 
Q78G -6.78 -6.85 NA 
N53S -7.17 -7.06 low µM 
Correlation 0.86   
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Moreover, backbone flexibility can help in better accommodation of larger and flexible 
ligands inside the binding pocket, thus resulting in a lower RMSD of the ligand compared 
to the native structure as observed in the lowest energy docked pose. To this aim, we 
performed self and cross docking for the 10 bound protein pairs. The self- and cross-
docking RMSD observed from lowest energy docked pose for all the ten pairs with 
Adaptive BP-Dock are reported in Table 6.3. 
Table 6.4: RMSD values for self and cross docking for ten pairs of protein (Meiler and 
Baker set) with Adaptive BP-Dock docking. The RMSD values for RosettaLigand 
flexible-backbone protocol and AutoDock 4.0 have been adapted from ref. (Meiler and 
Baker set; Davis & Baker, 2009) to aid comparison. 
 
Receptor 
Adaptive BP-Dock RosettaLigand Protocol AutoDock 4.0 
Self Cross Self Cross Self Cross 
1AQ1 0.84 1.11 1.39 0.42 0.43 3.8 
1DM2 0.58 1.2 1.14 1.36 0.52 0.67 
1DBJ 0.68 1.08 0.46 1.22 0.9 1.22 
2DBL 0.74 0.5 1.35 0.85 1.26 0.96 
1DWC 0.77 0.57 1.15 8.23 5.92 2.64 
1DWD 0.62 0.76 4.47 1.34 4.01 5.76 
1FM9 0.34 1.08 5.72 8.39 3.09 4.2 
2PRG 0.77 1.45 8.3 4.07 2.77 4.57 
1P8D 0.54 0.87 1.39 2.24 2.11 4.82 
1PQ6 0.44 1.15 2.08 1.27 1.45 2.91 
1P8D 0.54 0.77 1.39 2.29 2.11 4.42 
1PQC 0.42 0.52 0.53 0.98 1.62 4.57 
1PQ6 0.44 0.42 2.08 3.61 1.45 3.65 
1PQC 0.42 0.88 0.53 2.2 1.62 2.73 
1PPC 0.86 0.85 1.62 1.16 3.69 2.64 
1PPH 0.64 0.93 1 5.63 0.75 3.93 
2CTC 0.5 0.87 0.73 3.64 5.07 4.44 
7CPA 0.48 0.53 4.62 4.6 6.25 5.04 
4TIM 1.33 0.73 0.95 1.34 1.39 1.37 
6TIM 0.93 1.4 1.25 0.7 1.19 2.58 
AVERAGE 0.64 0.88 2.11 2.78 2.38 3.35 
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 To aid comparison, we also added (adapted) the results of flexible backbone 
protocol of RosettaLigand and AutoDock 4.0 in Table 6.3, as reported earlier by Davis 
and Baker in their paper (Davis & Baker, 2009). Clearly, we see a significant 
improvement in the RMSD with the Adaptive BP-Dock approach for most of the cases as 
compared to both the flexible backbone protocol of RosettaLigand and AutoDock 4.0. 
Interestingly, for the challenging cases of 1DWC/1DWD, 1FM9/2PRG and 1PPC/1PPH 
pairs where RosettaLigand could not perform well, we see a drastic improvement in the 
RMSD obtained from Adaptive BP-Dock. Likewise, the average self and cross-docking 
RMSDs for all the 10 protein pairs also improve significantly with Adaptive BP-Dock 
approach (Self: 0.64 Å, Cross: 0.88 Å) as compared to the flexible backbone protocol of 
RosettaLigand (Self: 2.11 Å, Cross: 2.78 Å) and AutoDock 4.0 (Self: 2.38 Å, Cross: 3.35 
Å). This improvement can be attributed to the larger backbone conformational changes 
sampled during docking in Adaptive BP-Dock approach that cannot be sampled with 
constrained minimization alone. The flexible backbone protocol of RosettaLigand is 
efficient for receptors with modest backbone conformational changes, however, for 
highly flexible receptors one needs to sample large backbone conformational changes. 
Therefore, we believe that integrating PRS with RosettaLigand in Adaptive BP-Dock can 
significantly increase the accuracy of docking predictions for highly flexible receptors. 
6.3.4 Docking Results for HIV-1 Reverse Transcriptase and Urokinase 
 In the last section, we present the docking results for the highly flexible receptor of 
HIV Reverse Transcriptase (RT) and another promising drug target Urokinase (UROK). 
HIV-1 Reverse Transcriptase (RT) enzyme copies a single-stranded viral RNA genome 
into double-stranded DNA and this DNA then gets incorporated into host (mostly human)  
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Table 6.5: Interface Delta energy scores and X-Scores for Flexible Bound docking with 
bound structure; Flexible Unbound and Adaptive BP-Dock Unbound docking for 
unbound structure with available experimental data for HIV Reverse Transcriptase and 
Urokinase. Higher negative values indicate a higher binding affinity prediction. 
 
 
 
 
Protein 
PDB Code 
Chain 
Length 
RosettaLigand Score (kcal/mol) X-Score (kcal/mol) 
Exp. ∆G 
(kcal/mol) 
Flexible Backbone AdaptiveBP-Dock Flexible Backbone 
Adaptive
BP-Dock 
Bound Unbound Bound Unbound Unbound Bound Unbound Unbound 
(Holo) (Apo) (Holo) (Apo) (Apo) (Holo) (Apo) (Apo) 
HIV-1 Reverse 
Transcriptase 
1DTQ 1DLO 556 -21.30 -15.96 -14.86 -8.71 -9.07 -8.37 -11.29 
1DTT 1DLO 556 -19.16 -15.79 -14.47 -8.87 -9.24 -8.83 -11.39 
1IKV 1DLO 556 -12.58 -11.55 -9.34 -9.04 -9.43 -9.16 -8.63 
1IKW 1DLO 556 -14.02 -10.77 -6.80 -9.30 -9.54 -8.89 -11.81 
1IKX 1DLO 556 -17.78 -13.44 -13.56 -8.94 -9.00 -7.86 -11.19 
1IKY 1DLO 556 -21.85 -18.23 -18.52 -9.73 -10.15 -9.78 -11.34 
1JLQ 1DLO 556 -18.77 -15.00 -15.42 -9.33 -9.45 -9.08 -11.19 
1TKT 1DLO 556 -21.81 -12.44 -15.64 -10.27 -8.79 -8.19 -8.44 
1TKX 1DLO 556 -15.61 -8.14 -11.99 -9.28 -7.58 -8.67 -10.35 
1TKZ 1DLO 556 -19.49 -12.42 -15.25 -10.37 -9.97 -10.14 -9.09 
1TL1 1DLO 556 -19.26 -15.76 -16.42 -10.21 -6.31 -9.95 -8.81 
1TL3 1DLO 556 -20.14 -12.19 -15.30 -10.45 -10.42 -8.09 -8.51 
1TV6 1DLO 556 -24.13 -17.30 -7.09 -6.33 -10.55 -9.97 -7.41 
2B5J 1DLO 556 -18.10 -19.69 -10.60 -11.60 -9.93 -10.54 -12.49 
2BAN 1DLO 556 -20.35 -19.31 -16.13 -11.31 -10.51 -10.13 -12.35 
2BE2 1DLO 556 -22.58 -14.23 -19.26 -10.30 -9.78 -9.69 -11.94 
2HNY 1DLO 556 -18.98 -14.05 -10.74 -9.02 -7.79 -8.44 -8.14 
3I0R 1DLO 556 -20.97 -15.24 -15.97 -10.62 -10.88 -10.59 -11.70 
3I0S 1DLO 556 -19.33 -14.21 -15.20 -10.54 -11.06 -10.19 -12.35 
3IRX 1DLO 556 -25.74 -15.87 -16.17 -10.40 -9.30 -10.36 -12.35 
3IS9 1DLO 556 -25.24 -13.30 -17.30 -9.97 -9.07 -10.02 -8.81 
3LP2 1DLO 556 -4.99 -5.55 -21.73 -6.38 -6.17 -9.57 -9.14 
3M8P 1DLO 556 -24.95 -18.26 -19.34 -10.48 -7.20 -9.58 -11.91 
3M8Q 1DLO 556 -24.70 -3.29 -20.51 -12.83 -5.40 -12.87 -13.07 
3QO9 1DLO 556 -18.65 -6.97 -14.71 -9.74 -6.59 -8.45 -8.13 
Urokinase 
1C5X 4DVA -13.9717 -12.87 -12.70 -7.66 -7.66 -7.65 -7.51 -9.17 
1C5Y 4DVA -12.3931 -11.66 -11.20 -7.13 -7.13 -7.13 -6.99 -5.77 
1C5Z 4DVA -11.6014 -14.51 -10.76 -6.89 -6.89 -8.83 -6.77 -5.51 
1EJN 4DVA -19.0515 -16.77 -16.51 -9.11 -9.11 -8.51 -8.38 -7.71 
1F5K 4DVA -10.8488 -10.24 -8.68 -6.76 -6.76 -6.79 -6.70 -5.14 
1F5L 4DVA -11.7506 -10.97 -10.83 -7.36 -7.36 -7.49 -7.21 -7.24 
1F92 4DVA -18.8209 -12.17 -14.73 -9.45 -9.45 -8.67 -8.69 -8.50 
1GI7 4DVA -13.3669 -13.31 -12.32 -7.87 -7.87 -7.92 -7.54 -6.19 
1GI8 4DVA -14.0209 -14.79 -12.32 -7.58 -7.58 -7.84 -7.29 -6.93 
1GI9 4DVA -14.1232 -15.56 -12.93 -7.50 -7.50 -7.79 -7.27 -7.17 
1GJ7 4DVA -21.2491 -17.88 -17.76 -9.13 -9.13 -9.14 -8.80 -10.82 
1GJ8 4DVA -13.9814 -13.84 -12.73 -8.11 -8.11 -8.23 -7.78 -9.55 
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Table (6.5) continued 
 
 
Figure 6.4: Correlation plots of X-Score binding energy scores obtained for lowest 
energy docked pose from Adaptive BP-Dock docking vs experimental binding energies 
for HIV-1 reverse transcriptase (RT) and Urokinase (UROK) 
 
genome starting HIV-1 replication cycle (Sarafianos et al., 2001). Therefore, it has 
always been a very important drug target for antiretroviral agents. Indeed, RT can sample 
large variety of possible conformational changes upon ligand binding and this also makes 
it a very challenging target for in silico drug design. On the other hand, Urokinase-type 
 
Protein 
PDB Code 
Chain 
Length 
RosettaLigand Score (kcal/mol) X-Score (kcal/mol) 
Exp. ∆G 
(kcal/mol) 
Flexible Backbone AdaptiveBP-Dock Flexible Backbone 
Adaptive
BP-Dock 
Bound Unbound Bound Unbound Unbound Bound Unbound Unbound 
(Holo) (Apo) (Holo) (Apo) (Apo) (Holo) (Apo) (Apo) 
Urokinase 
1GJA 4DVA -17.1023 -15.65 -14.48 -8.26 -8.26 -7.97 -7.73 -7.44 
1GJB 4DVA -15.9348 -17.80 -16.47 -8.51 -8.51 -8.81 -8.32 -8.71 
1GJC 4DVA -17.8206 -17.88 -15.32 -8.63 -8.63 -8.70 -8.36 -8.71 
1GJD 4DVA -17.019 -16.76 -15.17 -8.86 -8.86 -8.72 -8.44 -7.17 
1O3P 4DVA -14.9699 -15.53 -13.02 -8.15 -8.15 -8.27 -7.84 -9.14 
1O5A 4DVA -17.5484 -17.19 -13.28 -8.60 -8.60 -8.54 -8.24 -8.81 
1O5B 4DVA -13.0438 -11.88 -11.93 -7.48 -7.48 -7.46 -7.52 -7.92 
1O5C 4DVA -14.021 -13.77 -11.92 -8.49 -8.49 -8.57 -8.15 -7.17 
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plasminogen activator (uPA) or Urokinase (in general) plays an important role in the 
regulation of diverse physiological and pathological processes such as cell division, 
adhesion, regulation, evolution of malignant tumors and migration of malignant cells and 
tumor metastasis (Duffy, 2004; Blasi & Carmeliet, 2002). Therefore, UROK has always 
been considered as a promising target for development of anti-cancer drugs and because 
of these reason we decided to include it as one of the test cases along with RT in our 
study. Likewise to 5 protein data sets we tested earlier, we selected different bound 
structures (i.e. with different ligands) but only one unbound structure for both RT and 
UROK with available experimental binding data from PDB-bind database (Wang et al., 
2005). We performed both Adaptive BP-Dock docking for unbound structure and 
flexible-backbone protocol docking for bound & unbound structure for comparison. The 
lowest interface delta energy scores and X-Scores from the three docking approaches for 
RT and UROK protein test sets along with experimental binding energies are reported in 
Table 6.4. The correlation plots X-Score energies for (i) flexible-backbone bound, (ii) 
flexible-backbone unbound and (iii) Adaptive BP-Dock unbound vs the experimental 
binding free energies for the RT and UROK test sets are also plotted in Figure 6.4. The 
X-Score energies of Adaptive BP-Dock unbound docking have a higher correlation (RT: 
R = 0.44; UROK: R = 0.72) with experimental binding energies compared to flexible 
unbound docking (RT: R = 0.16; UROK: R = 0.52) for both RT and UROK test sets. 
Indeed, the Adaptive BP-Dock X-Score energies for UROK have even better correlation 
(R = 0.72) than the flexible bound docking (R = 0.65). Moreover, the interface delta 
energy scores also show that Adaptive BP-Dock correlates better with experimental data 
than flexible unbound docking for both RT and UROK proteins. Therefore, clearly our 
  120 
method allows substantial protein backbone flexibility even for highly flexible receptors 
such as HIV-1 protease (PR) and HIV-1 reverse transcriptase (RT) and allows a rapid 
large-scale virtual screening of diverse ligands for these highly challenging drug targets. 
6.4 Conclusion 
 In this study, we introduce a new induced fit protein-ligand docking approach 
called Adaptive BP-Dock that highlights the importance of incorporating receptor 
flexibility during docking simulation for accurate estimation of binding affinities and 
ligand placement inside the binding pocket of protein. The simultaneous protein and 
ligand conformational sampling helps in capturing bound-like conformation even in an 
unbound structure. The comparative analysis of unbound docking with bound receptor 
docking suggests that by mimicking the ligand-induced binding events through 
perturbation of the binding site residues in an unbound structure, we can simulate similar 
changes that would occur upon ligand binding. Therefore, Adaptive BP-Dock can be 
utilized as an in silico tool for virtual screening of novel drugs where only an unbound 
structure or a holo-structure in complex with a different ligand is available. 
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CHAPTER 7 
CONCLUSION 
This thesis presents multi-scale computational methods that elucidate our 
understanding of protein-ligand interactions. It has been well known for years that 
proteins undergo conformational changes upon ligand binding; yet, modeling these 
conformational changes computationally remains a challenging problem. In Chapter 2, 
we presented coarse-grained network-based models that enable us to describe the 
fluctuation dynamics and collective motions of the proteins in a fast and efficient way. 
One such network based model, Perturbation Response Scanning (PRS) allows us to 
capture conformational changes associated with ligand binding by perturbing the residues 
with random external forces. These external forces mimic the forces exerted by the ligand 
on the binding site residues as a first order approximation. The strength of PRS lies in the 
fact that it does not require the selection of the most relevant mode related to functional 
motion. Indeed, the most relevant modes are automatically induced upon perturbation of 
the individual residues of the protein. Moreover, the required CPU time for PRS is 4 
orders of magnitude less than MD simulations. Thus, with PRS we can easily (i) capture 
conformational changes upon binding, (ii) identify key residues that mediate long-range 
communication and find allosteric pathways, and (iii) predict the functionally important 
sites in proteins.   
In Chapter 3, we utilize the capability of PRS in capturing binding-induced 
conformational changes towards protein-ligand docking. Here, we presented a flexible 
ensemble-docking approach called BP-Dock (Backbone Perturbation-Docking) that is 
based on PRS. BP-Dock uses a two-step multi-scale approach to integrate both backbone 
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and side-chain conformational changes of a receptor into docking while providing full 
ligand flexibility from RosettaLigand. This ensemble docking approach was applied to 
unbound structures of several proteins including highly flexible HIV-1 Protease. 
Unbound docking is challenging, as the unbound receptor does not already include the 
conformational changes that are associated with ligand binding and, therefore it becomes 
important for the docking approach to model those conformational changes explicitly. 
Using a large and diverse dataset of 494 protein-ligand docking cases, we show that BP-
Dock can efficiently model backbone flexibility in docking for recapitulating the 
experimental binding affinities, even when an unbound structure is used. For example, 
the unbound structure of HIV-1 Protease is in open conformation and the bound structure 
is in closed form. However, with PRS we were able to push the most relevant modes of 
binding in the unbound structure of HIV-1 Protease to generate a new conformation that 
mimics the bound conformation with closed flaps. Therefore, the success of our approach 
rests in generating a wide range of binding site conformations sampled during binding, 
even in the absence of a ligand that can help us to improve the accuracy of unbound 
docking. 
We extended the application of BP-Dock in modeling peptide-protein interactions 
using PICK1 as our model system. PICK1 protein has roles in several neurodegenerative 
disorders and contains a single PDZ protein-protein interaction domain, which is 
promiscuous and shown to interact with over 60 PDZ peptides. These PDZ peptides have 
varied sequences and exhibit different binding specificities for PICK1 protein. Therefore, 
PDZ-PICK1 interactions are one of the challenging cases of peptide-protein docking and 
understanding the mechanism of PDZ-PICK1 recognition is crucial for therapeutic 
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purposes. To this aim, we used our BP-Dock approach to present comprehensive results 
reporting the binding affinities of all the major PICK1 interacting proteins for the first 
time. We also investigated the effect of mutations on PICK1 protein to PDZ peptide 
binding by analyzing the docked poses of wild type and mutant PICK1 proteins with PDZ 
domain peptides to further aid in the understanding of the determinants of PDZ-PICK1 
interactions. Experimental validation of our results show that by incorporating binding 
induced conformational changes through PRS in BP-Dock, we can correctly predict the 
binding affinity changes due to mutations in the PICK1 protein; which were unlikely to 
be achieved if a single crystal structure of PICK1 was used in our analysis. This work is 
of great importance, which may aid in the development of new drugs aimed at regulating 
specific PICK1 interactions. 
Furthermore, we investigated glycan–lectin interactions and tested our 
computational approach to glycan recognition in cyanovirin (CVN) in Chapter 5. Protein-
glycan interactions are crucial to many biological processes such as immune recognition, 
pathogen infection, protein processing and regulation of cell-surface receptors, etc. 
Moreover, they present a fascinating problem to study in particular, as glycans are highly 
flexible and are not free entities but instead attached to large protein surfaces, which 
makes it even harder to model them computationally or to characterize them 
experimentally. In order to elucidate the process of glycan-protein recognition we choose 
cyanovirin (CVN) as our model system. CVN is a small lectin that binds to 
oligomannosides of gp120 on HIV viral envelope. It is an ideal system to study because it 
is small, robust to mutations and easier to characterize experimentally. Therefore, using 
our BP-Dock approach, we dissected the energetics of CVN in specific di-mannose (α(1-
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2) linked mannose) recognition. We investigated the energetic contribution of individual 
amino acids lining the binding pocket of CVN to di-mannose binding through BP-Dock 
docking of di-mannose to single point CVN mutant models. Our results indicate the 
importance of E41 and T57 positions in forming side-chain hydrogen bond interactions 
with di-mannose. Mutation of E41A/G and T57A lead to significant decrease in the di-
mannose binding due to the rearrangements of the hydrogen bond network that 
reverberate throughout the binding pocket. Moreover, N42 position is crucial for the 
stability of the binding pocket and mutation of N42 to Alanine not only disrupts the 
hydrogen-bonding network of the protein with the di-mannose sugar but also within the 
protein, and that abolishes glycan binding. Therefore, our results highlight the importance 
of hydrogen bond interactions in the remarkable affinity and specificity of CVN for di-
mannose. Our predictions were also verified by the experimental characterization of the 
mutants.  
Additionally, we also investigated the role of hinge flexibility and conformational 
dynamics in glycan binding to CVN using PRS. The hinge region is an integral part of 
the high affinity binding site of CVN and, mutation in this region can alter the binding 
properties of CVN and di-mannose interactions. Our results showed that P51G mutation 
enhances flexibility of the hinge region in CVN, which results in blocking of the binding 
site due to the formation of hydrogen bond between carbonyl oxygen of N53 and amide 
hydrogen of N42. This hydrogen bond formation blocks the binding site and results in the 
decreased binding affinity of di-mannose for CVN. Therefore, using our experimentally 
verifiable computational approach based on PRS, we were able to explore the 
conformational flexibility of CVN that regulates CVN-glycan interactions. Nonetheless, 
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these results present new avenues to integrate computational predictions and 
experimental analysis for the efficient design of novel glycan-binding agents based on 
CVN, which can be tailored to other glycans of interest in future. Moreover, using our 
flexible PRS based approach we can also explore multivalency in lectins that bind to 
complex and flexible glycans. 
In Chapter 6, we presented an induced fit docking approach, Adaptive BP-Dock 
that can model protein flexibility during docking by integrating PRS and RosettaLigand. 
Adaptive BP-Dock is developed as a user-friendly software in Python that will be readily 
available to the scientific community via Ozkan group website. Adaptive BP-Dock can 
prove to be a powerful in silico screening tool that samples both protein and ligand 
flexibility during protein-ligand docking. It also offers opportunities to be adapted for 
protein-protein docking and include peptide design to protein-peptide docking studies. 
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Table A.1: Inter residue hydrogen bond network in P51G-m4-CVN for the 
specific Domain B residues considered in the study 
 
Residue # Donor Residue 
Donor 
Atom 
Acceptor 
Residue 
Acceptor 
Atom 
H-bond 
distance 
41 
 
GLU41 N LYS48 O 2.853 
LYS48 N GLU41 O 2.902 
42 
 
ASN42 ND2 THR57 OG1 2.908 
ASN42 ND2 LYS74 O 2.902 
GLY45 N ASN42 OD1 2.831 
57 
 
THR57 N PHE54 O 3.062 
ASN42 ND2 THR57 OG1 2.908 
LYS74 N THR57 O 2.973 
76 ARG76 N ASP44 OD1 2.901 
78 GLN78 N THR75 O 2.889 
53 
 
ASN53 N ASN37 O 2.926 
ASN53 ND2 ASN53 OD1 3.081 
GLU56 N ASN53 O 3.136 
 
 
Table A.2: Melting temperatures of the proteins used in this study are outlined.  The 
proteins unfold irreversibly, preventing a rigorous analysis of folding thermodynamics. 
 
Protein 
Tm (˚C) 
 
P51G-m4-CVN 59 
E41A 53.4 
E41G 55.3 
N53S 53.6 
T57A 50.6 
N42A 48.2 
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Table A.3: Complete analysis of hydrogen bond network for the lowest energy docked 
pose of P51G-m4-CVN and single point mutants for P51G-m4-CVN 
 
Backbone Side Chain 
Residue Atom 
H-Bond 
Distance Role Residue Atom 
H-Bond 
Distance Role 
P51G-m4-
CVN 
 
 
 
Asn42 N 3.097 DONOR Glu41 OE2 2.874 ACCEPTOR 
Asn42 O 2.839 ACCEPTOR Thr57 OG1 2.827 ACCEPTOR 
Asp44 N 2.922 DONOR Thr57 OG1 2.827 DONOR 
Ser52 O 3.139 ACCEPTOR Arg76 NE 2.988 DONOR 
Asn53 O 2.967 ACCEPTOR Arg76 NH2 2.871 DONOR 
Lys74 O 2.984 ACCEPTOR Gln78 NE2 2.915 DONOR 
CVN(mut)DB 
 
 
 
Ala42 O 2.948 ACCEPTOR Glu56 OE1 3.269 ACCEPTOR 
Ala42 N 3.146 DONOR     
Asp44 N 2.872 DONOR     
Ser52 O 2.998 ACCEPTOR     
Asn53 O 2.792 ACCEPTOR     
Lys74 O 3.043 ACCEPTOR     
N42A 
 
 
Ala42 O 3.083 ACCEPTOR Asp44 OD1 2.965 ACCEPTOR 
Ser52 O 3.3 ACCEPTOR Asp44 OD1 2.729 ACCEPTOR 
Asn53 O 2.883 ACCEPTOR Asn53 OD1 2.881 ACCEPTOR 
ASN53 O 3.117 ACCEPTOR Thr57 OG1 2.959 ACCEPTOR 
T57A 
 
 
 
 
Asn42 O 2.976 ACCEPTOR Asp44 OD1 2.826 ACCEPTOR 
Asp44 N 2.997 DONOR Asp44 OD1 3.476 ACCEPTOR 
Asp44 N 2.997 DONOR     
Ser52 O 2.983 ACCEPTOR     
Asn53 O 2.804 ACCEPTOR     
ASN53 O 2.805 ACCEPTOR     
Lys74 O 2.758 ACCEPTOR     
E41A 
 
 
 
 
Asn42 N 3.201 DONOR Asp44 OD1 2.811 ACCEPTOR 
Asn42 O 2.669 ACCEPTOR Asp44 OD1 2.97 ACCEPTOR 
Asp44 N 3.216 DONOR Asn53 OD1 2.855 ACCEPTOR 
Ser52 O 3.523 ACCEPTOR     
Ser52 O 2.99 ACCEPTOR     
Asn53 O 2.891 ACCEPTOR     
Asn53 O 2.913 ACCEPTOR     
E41G 
 
 
 
Asn42 O 2.833 ACCEPTOR Asn42 OD1 2.931 ACCEPTOR 
Asp44 N 3.227 DONOR Asn42 OD1 2.793 ACCEPTOR 
Ser52 N 2.777 DONOR Thr57 OG1 2.915 ACCEPTOR 
Ser52 O 2.828 ACCEPTOR Thr57 OG1 2.915 DONOR 
Ser52 O 2.915 ACCEPTOR     
Lys74 O 3.504 ACCEPTOR     
 
 
 
N53S 
 
 
 
 
Asn42 O 2.966 ACCEPTOR Asp44 OD1 2.774 ACCEPTOR 
Asp44 N 3.115 DONOR Asp44 OD1 2.877 ACCEPTOR 
Asp44 N 3.147 DONOR Ser53 OG 3.274 ACCEPTOR 
Ser52 O 3.204 ACCEPTOR Ser53 OG 3.274 DONOR 
Ser53 O 2.733 ACCEPTOR Arg76 NE 2.78 DONOR 
Ser53 O 2.811 ACCEPTOR Arg76 NH2 2.689 DONOR 
Lys74 O 2.857 ACCEPTOR     
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Figure A.1: Thermal denaturation profiles of E41A (red circles), E41G (black squares), 
N53S (green triangles), T57A (blue upside down triangles), and N42A (orange 
diamonds).  The unfolding transitions were monitored at 202 nm from 4 to 90˚C using 20 
µM protein in 15 mM potassium phosphate.  The melting points are 53˚C, 55˚C, 53˚C, 
50.6˚C, and 48˚C, respectively. 
 
 
 
Figure A.2: 1H-15N heteronuclear single quantum coherence (HSQC) spectra of P51G-
m4-CVN without di-mannose (red) and with 12.5 molar equivalents of di-mannose 
(black). 
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Figure A.3: 1H-15N heteronuclear single quantum coherence (HSQC) spectra of E41A (A) 
and E41G (B) from titrations with increasing amounts of di-mannose (red to black).  
Resonances are well dispersed and resemble that of the P51G-m4-CVN spectrum, 
indicating the two mutants are well folded.  Example plots and fitting of molar 
equivalents versus normalized peak shift are shown for a single resonance (E41A in C; 
and E41G in D).  Average Kd from the fits for E41A and E41G are 541 µM and 389 µM, 
respectively. 
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Figure A.4: The hydrogen bond network for (A) E41A and (B) E41G:di-mannose 
complex obtained from BP-Dock docking. The di-mannose sugar is shown in cyan. The 
residues that form hydrogen bond with the sugar are shown in yellow and the backbone 
hydrogen bond interactions are shown in magenta and side chain interactions in green. 
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Figure A.5: Probability of the distance between carbonyl oxygen of Asn53 and amide 
hydrogen of Asn42 (Dpocket) in the case of wt-CVN and the P51G-m4-CVN mutant at 300 
K and 330 K from 800 ns MD simulations. Three conformations with Dpocket close to 5 Å, 
3.5 Å and 2.5 Å are detected. On the right hand side, time averaged (over a period of at 
least 20 consecutive nanoseconds) Asn53 and Asn42 structures consistent with each of 
the three conformations (peaks in the graph) are depicted alongside idealized 
representations of hinge behavior (light blue) and hairpin behavior (light green). 
 
 
 
